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Abstract 
The results presented in this thesis have focussed attention on the 
biological role of the E2 glycoprotein of RRV and the viral functions 
associated with neutralization epitopes. Previous work had defined three 
such epitopes on E2 of RRV at amino acids 216 (epitope a), 232, 234 (epitope 
bl) and 246, 248, 251 (epitope b.2.) by the selection of monoclonal antibody 
(mAb) escape mutants. An additional epitope (~ had been defined by 
competitive binding assays. It was postulated that these epitopes formed 
part of a major neutralization domain on E2 (Vrati et al., 1988). 
This hypothesis was examined by raising antisera to the parental 
RRV T48 in mice and comparing the neutralization mAb resistant 
variants by this antisera with T48. A triple mAb resistant variant of T48 
altered in epitopes ,a, bl and b2. (Tv161) was neutralized three to eight fold 
less efficiently by hyperimmune sera than T48. Neutralization of variants 
with changes in single epitopes was not altered. RRV NB5092, which is 
over 2% diverged from T48 in its nucleotide sequence (Faragher et al.,1988) 
could not be distinguished from T48 using these sera. It was concluded 
that a significant proportion of the antibodies present in a hyperimmune 
response to RRV were directed at this group of epitopes and therefore that 
this region could be a target for a synthetic vaccine. 
To explore this further, four synthetic peptides, representing most of 
the primary amino acid sequence between amino acids 209 and 253, were 
used to raise antisera in mice. The reactivity of these sera with RRV was 
examined in a range of assays. Anti-peptide sera bound to RRV very 
specifically in a direct ELISA. However, these sera did not neutralize RRV 
nor did they bind to the virus in a capture ELISA. This suggested that the 
conditions of binding RRV to the plastic surface in a direct ELISA. partially 
denatured the virus exposing regions on E2 that were recognized by anti-
V 
peptide antibodies. However, in native v1nons these epitopes were not 
exposed. In support of this neither rnAbs nor polyclonal antibodies raised 
against RRV bound to the peptides in a variety of assays. It was concluded 
that either the antigenic determinants in this region were discontinuous 
or, that if continuous sequence loops existed their secondary structure was 
constrained such that antibodies raised to synthetic peptides did not 
recognize the loops, or that individual peptides contained insufficient 
residues to mimic such structures. 
It had previously been shown that two variants of T48 with single 
amino acid alterations in the b2 epitope penetrated faster than T48 in 
cultured BHK cells (Vrati, 1986). This work was extended here by 
demonstrating that all changes in the b2 epitope from the T48 sequence 
gave fast penetration in BHK cells and that fast penetration also occurred 
in Vero cells. Changes at epitopes a orb 1 did not alter penetration rate in 
either cell line. Examination of the penetration rates of five geographic 
variants of RRV with or without differences from T48 at epitope 122., 
indicated that all had fast penetration compared to T48. The fast 
penetration of PB629 and GG2227 which have only a single amino acid 
difference from T48 in E2 (Leu67 ~Ile) indicated that changes elsewhere in 
the genome, possibly towards the N-terminus of E2, could give fast 
penetration. The wide range of amino acid substitutions in epitope b2 that 
produced fast penetration and the fast penetration of the geographic 
variants suggests that there may be a specific conformation on the surface 
of T48 virions that produces slow penetration in tissue culture. Changes at 
epitope b2 could destabilize or alter this conformation leading to fast 
penetration. The mechanism of the increased rate of penetration is not 
clear but preliminary evidence suggested that a faster rate of attachment to 
cells may be involved. 
V1 
Having partially defined a domain which was involved in both 
neutralization and cell entry it was of interest to define further regions of 
the structural glycoproteins of RRV which could be involved with cell 
recognition and entry. This was approached by limited passaging of RRV 
NB5092 in avian cells. Variants of RRV NB5092 selected by passaging in 
CEFs had single, non-conservative amino acid alterations in E2 at either 
amino acids 4 or 218. Both changes affected neutralization by mAbs; the 
variants altered at 218 were neutralized less efficiently by mAb T10C9 
(epitope a) while the variant altered at amino acid 4 was neutralized less 
efficiently by mAbs NB3C4 (epitope bl) and TlDll (epitope ~- Variants with 
the 218 alteration were attenuated for growth in mice while the variant 
altered at 4 had a pattern of mouse tissue growth somewhat different to 
NB5092. Thus alterations in neutralization epitopes on E2 were associated 
with passaging RRV in avian tissue culture and with changes in growth_ of 
the passaged virus in mice. 
To extend this work on passaging, RRV strains T48 and NB5092 were 
passaged in human and mosquito cells. Several amino acid changes in E2 
were found following passage in human cells. These were at 178 
(Arg--"7Leu) and 119 (Asn--"7Tyr) for NB5092 passaged in SW13 cells, while 
in the same cell line, one clone of T48 had a Pro162--"7Ser alteration. Only 
one change was found in NB5092 and T48 passaged in the other human 
cell lines examined; one clone of T48 had an amino acid change at 11 
(Ala--"7Thr) after 10 passages in 293 cells. These changes did not alter 
neutralization by the available mAbs. Thus passaging RRV in human 
cells selected for changes at a different set of amino acid positions to 
passaging in avian cells and did not select changes in defined 
neutralization epitopes. Passaging RRV in mosquito cells did not select 
variants altered in their E2 sequence. 
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Chapter I 
General Introduction 
2 
1.1 Alphavirns classification and biology 
Ross River virus (RRV) is an Australian alphavirus. The 
alphaviruses are small, enveloped, positive strand RNA viruses classified 
in the family Togauiridae. There are currently 26 recognized alpha viruses 
(Westaway et al.,1985); six serological complexes have been defined on the 
basis of their antigenic relationships, primarily in cross-neutralization 
tests (Calisher et al.,1980 ). These are the Eastern equine encephalitis 
(EEE), Middelburg (MID), Ndumu (NDU), Semliki Forest (SFV), 
Venezuelan equine encephalitis (VEE) and vVestern equine encephalitis 
(WEE) virus complexes (Table 1.1). The first three complexes contain a 
single virus type, while the remaining three contain a number of types and 
subtypes. RRV, the subject of this thesis, is a subtype within the SFV 
complex. 
Alphaviruses are arboviruses maintained in nature by biological 
transmission betvveen susceptible vertebrate hosts and haematophagous 
arthropod vectors, usually mosquitoes (Chamberlain, 1980). The basic 
vertebrate hosts are either wild birds or rodents; man-mosquito cycles also 
occur with Chikungunya (CHIK), O'nyong nyong CONN) and, more 
recently, RRV (Chamberlain, 1980; Marshall and Miles, 1984). 
Alphaviruses have a world wide distribution in tropical and temperate 
regions and appear to be maintained in localized ecological niches. This 
may favour gradual divergence and speciation as viruses adapt to local 
hosts and vectors (Chamberlain, 1980). 
1.2 Alphavinises and disease 
Although alphaviruses are generally regarded as not causing 
disease symptoms in their natural hosts and vectors the evidence for this is 
limited (Chamberlain, 1980). In alphavirus infections in animals, humans 
Table 1.1 
Serological classification of alphaviruses* 
Complex Species 
Eastern equine F:F:F~ 
encephalitis (EEE) 
Middelburg (MID ) MID 
Ndumu (NDU) NDU 
Semliki Forest (SFV) SFV 
Venezuelan equine 
encephalitis (VEE) 
Western equine 
encephalitis (WEE) 
Chikungunya (CHIK) 
Getah (GET) 
Mayaro (MAY) 
VEE 
vVEE 
Highlands J (HJ) 
Fort Morgan (FM) 
Sindbis (SIN) 
Aura 
* From Calisher et al. (1980) 
Subtype 
CHIK 
GET 
Sagiyama (SAG) 
Bebaru (BEB) 
Ross River (RRV) 
MAY 
Una 
VEE 
Everglades (EVE) 
Mucambo (MUC) 
Pixuna (PIX) 
Cabassou (CAB ) 
SIN 
Whataroa (WHA) 
Kyzylagach (KZH) 
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and birds two maJor syndromes are seen (Shope, 1980): encephalitis, 
associated vvith infections by EEE, \NEE and VEE and arthritis, fever and 
rash caused by infection with a wide range of alphaviruses such as RRV, 
CHIK, ONN and Mayoro (MAY). The equine encephalitis viruses occur 
exclusively in the Americas where they are responsible for outbreaks of, 
often fatal, disease in man and animals. CHIK and ONN have caused 
epidemics in Africa involving millions of human cases (Shope, 1980). 
Vaccination is only used against the equine encephalitides, mainly in 
horses and pheasants but also in laboratory workers (Ardans, 1982; Eisner 
and Nusbaum, 1983; Nathanson and Miller, 1982). 
There have been four alphaviruses isolated in Australia, these are 
RRV (Doherty et al.,l963a), Sindbis (SIN), Getah (GET) (Doherty et 
al.,1963b), and Barmah Forest virus (BF) (Marshall et al.,1982a). Of these 
RRV is the most frequently associated with disease (Shope, 1980). 
1.3 RRV: biology and epidemiology 
1.3.1 Association of RRV with epidemic polyarthritis 
The prototype T48 strain of RRV was isolated from Aedes vigilax 
mosquitoes collected near Townsville, Queensland, in 1959 (Doherty et 
al.,1963a). Serological evidence indicated that this virus was the likely 
aetiological agent of the disease epidemic polyarthritis (Doherty et 
al.,1963a; Doherty et al.,1964). However, despite many attempts, RRV was 
not isolated from clinical cases of epidemic polyarthritis until an outbreak 
which spread through the Pacific islands between 1979-1981. This epidemic 
involved tens of thousands of people and RRV was readily isolated from 
patients with epidemic polyarthritis, finally confirming its role in the 
disease (Aaskov et al.,1981a; Marshall and Miles, 1984; Rosen et al.,1981; 
Tesh et al.,1981). RRV has subsequently been isolated from clinical cases of 
epidemic polyarthritis in Australia (Aaskov et al.,1985). 
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The predominant clinical symptom of epidemic polyarthritis 1s 
arthralgia, usually of the small joints of the extremities; this may be 
accompanied by a macropapular rash, usually on the trunk (Mudge and 
Aaskov, 1983). Other, more non-specific, symptoms reported include 
paraesthesia, low grade fever, myalgia, chills and mild lymphadenopathy 
(Marshall and Miles, 1984). Complete recovery is normal although in some 
cases the course of the disease is prolonged beyond a few weeks (Mudge 
and Aaskov, 1983). 
Symptoms of a disease resembling epidemic polyarthritis were first 
reported in Australia, in the Murrumbidgee area of N e,v South Wales, in 
1928 (Nimmo, 1928; Edwards, 1928). Further outbreaks were recorded in 
New Guinea, northern Australia and the Solomon islands during the 
Second World War (Halliday and Horan, 1943; Dowling, 1946). Since then 
there have been many outbreaks of epidemic polyarthritis in Australia 
with especially large episodes recorded in the Murray Valley in 1956 
(Anderson and French, 1957), 1971 (Seglenieks and Moore, 1974), 1974 and 
1984 (Marshall and Miles, 1984; Hawkes et al.,1985). In north-eastern 
Australia annual outbreaks of epidemic polyarthritis occur (Doherty et 
al.,1971; Clarke et al.,1973; Doherty, 1974; Aaskov et al.,l98lb). The disease 
has been diagnosed in all states of Australia, including Tasmania (Mudge 
et al.,1981) and antibodies to RRV are widespread in man and animals 
throughout eastern Australia (Doherty et al.,1966). Clinical symptoms 
appear to vary between epidemics (Anderson and French, 1957; Seglenieks 
and Moore, 1974; Mudge,1977; Aaskov et al.,l98lb; Rosen et al.,1981). In a 
recent outbreak in New South Wales (Hawkes et al.,1985), arthralgia was 
the most common clinical finding, followed by lethargy, rash and 
headache. The estimated subclinical to clinical ratios vary widely between 
epidemics with recent outbreaks of RRV appearing to cause epidemic 
polyarthritis in a much greater proportion of infections than previously 
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reported (Hawkes et al.,1985 ). This may relate to the level of viraemia 
which could reflect the ability of humans to act as hosts during particular 
epidemics. Taken together with the variation in clinical symptoms, this 
may reflect strain differences of RRV. 
1.3.2 Mosquito vectors of RRV 
RRV has been isolated from at least nine species of mosquito, 
comprising five genera; other species transmit RRV experimentally 
(Marshall and Miles, 1984; I.D. Marshall, pers. comm.). Most Australian 
isolates have come from either Aedes vigilax or Culex annulirostris. In 
temperate regions Culex annulirostris may be more important in 
maintaining primary cycles than as an epidemic vector because many 
outbreaks of epidemic polyarthritis occur in autumn when the numbers of 
this mosquito have decreased (Marshall and Miles, 1984). During the 
Pacific Island epidemic Aedes polynesiensis appears to have been the 
principal vector, although other species were probably involved (Rosen et 
al.,1981; Marshall and Miles, 1984). Thus RRV is able to utilize a number 
of different mosquito species as vectors, although some may be more 
efficient than others (Marshall and Miles, 1984). 
1.3.3 Vertebrate hosts ofRRV 
A number of native and domestic mammals and marsupials have 
been implicated as potential vertebrate hosts for RRV, but no definitive host 
has been identified (Doherty et al.,1966; Whitehead, 1969; Doherty et 
al.,1971; Gard et al.,1973). It is probable that different mammals or 
marsupials are important in separate enzootic foci. The outbreak of 
epidemic polyarthritis in the Pacific islands has convincingly 
demonstrated that humans can act as the principal host of RRV during 
epidemics (Marshall and Miles, 1984). RRV has been isolated once from 
birds (Whitehead et al.,1968 ), but serological data (Doherty et al.,1966, Gard 
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et al.,1973; Marshall et al.,1982b) and the results of experimental infections 
of birds (Whitehead, 1969; Marshall and Miles, 1984) suggest that birds 
have little role in the ecology of RRV. 
1.3.4 Geographic variants ofRRV 
Enzootic variants of RRV appear to exist in regions geographically 
isolated from each other. Restriction digest analysis of single stranded 
cDNA synthesized against viral RNA defined three genetic types from 15 
RRV geographic isolates (Faragher et al., 1985). Isolates of RRV from 
Nelson Bay in New South Wales (Gard et al.,1973) differed in antigenic and 
biological properties from the prototype T48 strain. A notable difference 
being the low virulence in mice of the NB5092 strain, isolated from Nelson 
Bay, compared with the mouse virulent T48 strain isolated in north 
Queensland (Gard et al.,1973; Woodroofe et al.,1977). The extent of genetic 
divergence between these two strains is in the order of 2% as deduced from 
nucleotide sequencing studies of the entire genomes of RRV T48 and 
NB5092 (Faragher et al.,1988). There is no information relating genetic 
type of RRV to virulence in humans. 
1.3.5 Pathogenesis of RRV infection 
The pathogenesis of epidemic polyarthritis is not well understood. 
The failure to isolate virus from clinical cases and the presence of 
antibodies in patients at the time of clinical presentation initially led 
physicians to believe that the disease was immune-mediated with an 
incubation period of 9-12 days. However, the outbreak of epidemic 
polyarthritis in the Pacific demonstrated that the incubation period of the 
disease could be as short as 2-3 days, supporting a primary viral role in 
disease symptoms (Rosen et al.,1981). Activated macrophages and 
monocytes are prominent features of the inflamed joints (Clarris et 
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al.,1975; Fraser et al.,1981). In addition there is a genetic association of 
epidemic polyarthritis with HLA type (Fraser et al.,1980 ). 
A limitation in experimental studies of RRV is the lack of an 
appropriate animal model; the commonly used mouse model for RRV 
pathogenesis does not produce polyarthritis. However, this animal has 
proved very useful for comparative studies on viral pathogenesis with the 
T48 and NB5092 strains of RRV (Murphy et al.,1973; Mims et al.,1973). T48 
is rapidly lethal in mice up to three weeks old, killing virtually 100% of 
infected mice. NB5092 is relatively avirulent, killing less than 50% of 
neonatal mice infected with the virus and is asymptomatic in older mice. 
Outbred mice injected peripherally with RRV T48 or NB5092 developed 
extensive muscle necrosis and paralysis of the hind limbs. Lesions in the 
central nervous system (CNS) of NB5092 infected mice were minimal and 
did not coincide with clinical symptoms of hind leg paralysis. Neonatal 
mice infected with T48 died before CNS changes could be observed (Murphy 
et al.,1973; Mims et al.,1973). It was concluded that hind leg paralysis and 
death in mice was due to massive muscle damage. In contrast, Seay and 
Wolinski (1982) reported that seven-day old Balb/c mice injected 
peripherally with RRV T48 developed encephalomyelitis with focal 
necrosis in the cerebellum, brainstem and spinal cord in addition to severe 
myositis. From these studies it appears that strain and age of mice as well 
as strain of virus may be important in the pathogenesis of RRV in mice. 
1.4 Alphavirus structure and genome organization 
1.4.1 Alphavirus structure 
The most extensive studies of alphavirus structure have been done 
with SIN and SFV which have very similar physical properties (reviewed 
by Harrison, 1986). Electron microscopy reveals a roughly spherical 
particle, approximately 60nm in diameter, with icosahedral symmetry. 
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The virion consists of a nucleocapsid core, containing the RNA genome, 
surrounded by a host derived, lipid membrane. Within the membrane are 
embedded glycoprotein spikes composed of the virus encoded proteins E 1 
and E2. A third glycoprotein, E3, is found in association with the 
glycoprotein spikes of SFV (Garoff et al.,1974). Small amounts of the viral 
6K protein have been demonstrated in the membrane of SIN (Nitschko and 
Schlesinger, 1990). 
Using cryoelectron microscopy of vitrified particles and computer 
generated reconstruction, Fuller (1987) determined the three dimensional 
structure of SIN at 3.5nm resolution. The spikes of the virion are columnar 
trimers of the E 1 and E2 heterodimer, arranged on a T=4 lattice. The lipid 
bilayer is polyhedral and surrounds a smooth, fenestrated, T=3 
nucleocapsid. Thus a complete SIN virion contains 240 copies of each of the 
spike proteins arranged as 80 trimeric spikes, and 180 copies of the capsid 
protein. This gives rise to two types of spike-capsid interactions. Spike 
trimers near the five-fold axes interact tightly with triplets of capsid 
elements whereas those on the three-fold axes interact more loosely 
(Fuller, 1987). Similar predictions have been made for SFV (Vogel et 
al.,1986). This is in contrast to the 1:1 capsid to spike heterodimer ratio 
previously predicted (von Bonsdorf and Harrison, 1975). 
Details of the glycoprotein structure at high resolution are not 
known. The association of E 1 and E2 as non-covalently linked heterodimers 
has been demonstrated for SFV (Ziemieki and Garoff, 1978) and SIN (Rice 
and Strauss, 1982). The studies with SIN demonstrated that three such 
heterodimers form a cross-linkable cluster in the viral surface thus 
linking the microscopy and chemical predictions (Harrison, 1986). E2 is 
more exposed on the virus surface as judged by susceptibility to iodination 
by lactoperoxidase (Sefton et al.,1973; Dalrymple et al.,1976). Chang and 
Trent (1987) have suggested that the less hydrophilic El may form the 
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inner core of the glycoprotein spike. In SIN, both E 1 and E2 are 
glycosylated with each protein containing both simple and complex 
carbohydrate chains (Mayne et al.,1985). El of RRV, SFV, EEE and ONN 
contains a single glycosylation site (Garoff et al.,1980; Dalgarno et al.,1983; 
Chang and Trent, 1987; Levinson et al.,1990). The oligosaccharides are 
partly masked in the virus as measured by the ratio of glycosidase 
sensitivity of intact virus to sensitivity of detergent solubilized glycoprotein, 
suggesting that some of the glycosylation sites are on lateral surfaces of the 
projecting proteins, rather than at the outer tip (McCarthy and Harrison, 
1977). 
Hydrophobic sequences at the car boxy termini of E 1 and E2 span the 
lipid bilayer, probably as an alpha helix (Garoff et al.,1980). Fuller (1987) 
has proposed that the columnar nature of the spikes in SIN suggests that 
the six transmembrane helices associated with the structure lie in a 
bundle beneath the stalk of the spike. This would stabilize the trimer and 
may be essential for its formation as Kielian and Helenius (1985) have 
shown that proteolytically derived ectodomains of the spike polypeptides 
. 
are monomenc. 
The lipid bilayer is host-derived and its composition reflects the cells 
in which the virus was grown (Laine et al.,1973; Luukonen et al.,1976; 
Luukonnen et al.,1977). Fuller (1987) has predicted that the bilayer is a 
polyhedral structure, bent at the position of the spikes, rather than a 
smooth sphere; this may require less distortion of the ratio of inner leaflet 
surface area to outer leaflet surface area during budding. 
The nucleocapsid core consists of a complex of the capsid and viral 
RNA genome. The amino-terminal half of the capsid protein is poorly 
conserved among alphaviruses but is rich in arginine, lysine and praline 
residues, suggesting that this region interacts with the negatively charged 
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RNA. The remainder of the capsid protein is more strongly conserved and 
may interact with the cytoplasmic domain of E2 (Harrison, 1986). A 
specific binding site on the capsid protein for the cytoplasmic domain of E2 
has been demonstrated using anti-idiotypic antibodies (Vaux et al., 1988). 
El has only a dipeptide on the cytoplasmic side of the membrane (Rice et 
al.,1982). 
1.4.2 Structure of the alphavirus genome 
The alphavirus genome consists of a single strand of positive 
polarity RNA with a sedimentation coefficient of 498. This RNA is capped 
at the 5' end and polyadenylated at the 3' end (Strauss and Strauss, 1986). 
The complete genome has been sequenced for SIN, SFV, VEE, ONN and 
RRV (Strauss et al.,1984; Takkinen, 1986; Faragher et al.,1988; Kinney et 
al.,1989; Levinson et al.,1990); partial sequence data is available for MID, 
WEE and EEE (Strauss et al., 1983; Hahn et al.,1988; Chang and Trent, 
1987). The genome length is between 11-12 kb depending on the virus. The 
complete sequences of two strains of RRV (NB5092 and T48) have been 
determined (Faragher et al., 1988). NB5092 has a genome of 11,674 
nucleotides while T48 is 11,883 nucleotides long. The difference in genome 
size results from insertions and deletions in the non-coding regions, but 
there are no cliff erences in the size of the coding regions of the two strains. 
The genome organizations of RRV and other alphaviruses are similar. 
During alphavirus replication the infecting positive strand of 498 RNA 
serves as a template for the synthesis of a full length minus strand. This 
minus strand serves as a template for the synthesis of a 268 subgenomic 
RNA from ,vhich the structural proteins are translated and for genome 
length pl us stranded RN A. 
The SIN replication strategy is depicted in Fig 1.1. The 5' two-thirds 
of the genome encodes the nonstructural proteins which have a replicase 
Figure 1.1 
Alphavirus replication strategy* 
A schematic representation of the translation and processing of the 
nonstructural and structural proteins of SIN. Translated regions of the 
genome and of subgenomic 268 RNA are shown as open boxes; 
untranslated regions are represented by single lines. Structural and 
nonstructural processing intermediates are indicated and the final protein 
products are shown as heavy lines. The nsPl, nsP2 and nsP3 produced by 
processing of the readthrough polyprotein are shown as dashed lines as 
their contribution to the pool of final products is probably minor. Triangles 
represent stop codons for termination of translation of the structural and 
nonstructural polyproteins; the opal codon between the nsP3 and nsP4 
genes is represented by the open triangle. 
* Adapted from Faragher (1987) 
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function and must be translated first. The 3' third of the genome encodes 
the structural proteins and is translated from the subgenomic 26S RNA. 
For RRV, a 5' untranslated (UT) region of 80 nucleotides is followed by a 
single open reading frame (ORF) of 5,586 nucleotides terminated by an opal 
codon (UGA). This ORF encodes a polyprotein of 1,862 amino acids 
(Faragher et al.,1988). Little is known of the RRV nonstructural proteins 
but by analogy with SIN (Strauss and Strauss, 1986), the polyprotein is 
post-translationally cleaved into the three nonstructural proteins: nsPl, 
nsP2 and nsP3. After the opal codon this ORF continues for a further 1,851 
nucleotides encoding nsP4 which is translated by readthrough of the opal 
codon to give smaller amounts of a second polyprotein which is cleaved to 
nsPl, nsP2, nsP3 and nsP4. In SFV and ONN the opal codon is replaced by 
an arginine codon (Takkinen, 1986; Strauss et al.,1988), and nsP4 synthesis 
is not regulated by readthrough. 
The nonstructural protein genes are followed by an UT region 
between the nonstructural and structural protein genes. This contains 
three in-frame stop codons which ensure termination of the readthrough 
polyprotein. Differences in the position and number of stop codons in this 
junction region are found between RRV T48 and NB5092, SIN, SFV and 
MID (Faragher et al.,1988; Ou et al.,1982). 
Translation of the structural polyprotein genes occurs from the 26S 
subgenomic RNA in a different reading frame to the nonstructural protein 
genes and begins 45 nucleotides, for RRV NB5092, or 48 nucleotides for 
RRV T48, from the 3' terminal nucleotide of the nsP4 gene (this nucleotide 
also represents the 5' terminal nucleotide of the 26S subgenomic RNA). For 
both NB5092 and T48 an ORF of 3,762 nucleotides encodes a structural 
polyprotein of 1,284 amino acids; this is followed by a 3' UT region of 
approximately 348 nucleotides for NB5092 and 524 nucleotides for T48 
(Faragher et al.,1988). 
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1.4.3 Conserved sequences in alphavirns genomes 
There is little conservation of nucleotide sequence between 
alphaviruses even though amino acid sequences may be reasonably 
conserved (Bell et al.,1984). Conserved nucleotide sequences must be under 
strong selection pressure during RNA replication and are likely to be 
involved as regulatory elements in replication and assembly (Strauss and 
Strauss, 1986). Four conserved regions of nucleotide sequence have been 
identified for alphaviruses. These are (1) a 19 nucleotide element adjacent 
to the poly-A tract at the 3' end of the genome; (2) a 51 nucleotide region in 
the 498 RNA approximately 150 nucleotides from the 5' end; (3) a 21 
nucleotide sequence in the junction region between the nonstructural and 
structural protein genes and (4) a less conserved element at the 5' end of 
the genomic RNA (Strauss and Strauss, 1986). 
The sequences at the 19 nucleotide region adjacent to the poly-A tail 
and the 5' 51 nucleotide element may be involved in minus strand 
synthesis by cyclization of the viral RNA and simultaneous recognition by 
the transcriptase complex (Ou et al.,1983; Strauss and Strauss, 1986; 
Levinson et al.,1990). Conservation of these sequences is important for 
efficient replication in both vertebrate and mosquito cells (Kuhn et al., 1990; 
Niesters and Strauss, 1990). 
The 21 nucleotide element in the junction region includes the 19 
nucleotides coding for the C-terminus of nsP4 and the first two nucleotides 
of the 268 RNA (Ou et al.,1982; Faragher et al.,1988; Levinson et al.,1990 ). It 
has been suggested that the complement of this sequence in the minus 
strand may be the promoter for transcription of 268 RNA (Ou et al.,1982 ). 
The sequence at the 5' end of the genomic RNA is less conserved 
among alphaviruses than the previous three sequences (Strauss and 
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Strauss, 1986). The first 22 nucleotides are approximately 80% conserved 
between SIN and RRV (Faragher et al.,1988 ). The complement of this 
sequence is predicted to form a stem and loop structure in the 3 ' end of the 
genomic minus strand RNA which may be the replicase binding site for 
the initiation of plus strand RNA transcription (Strauss and Strauss, 
1986). 
Most alphaviruses have repeat sequences in the 3' UT region (Ou et 
al.,1981; Faragher and Dalgarno, 1986; Levinson et al.,1990). RRV NB5092 
contains only a single copy of a 49 nucleotide repeat element found in four 
copies in T48 thus it is apparent that in a particular virus type, variations 
in the number of repeats can be accommodated. Site-directed mutagenesis 
has been used to examine the SIN 3' UT region (Kuhn et al.,1990 ). Almost 
all mutations in this region had a deleterious effect on virus replication 
and in many cases this effect was more severe in mosquito cells than avi_an 
cells. This suggests that although there is considerable sequence plasticity 
in the 3' UT region, the conservation of this region, and elements within it, 
is important for viral replication. The differential host effects suggest that 
host cell proteins may be involved in interactions with this region and that 
it may represent a compromise between sequences that allow the most 
efficient replication in mosquitoes and those that are most efficient in 
vertebrates. 
The 51 nucleotide 5' sequence may be a recognition site for 
encapsidation as this would explain why 268 RNA is not encapsidated 
(Strauss and Strauss, 1986). This has been disputed by Weiss et al. (1989) 
who implicate a region betvveen nucleotides 7 46-1,226 in SIN 
encapsidation. Mapping of defective interfering (DI) RNAs from SIN and 
SFV to define structures within the RNA required for RNA replication and 
encapsidation (reviewed by Schlesinger and Weiss, 1986) has shown that 
only sequences in the 162 nucleotide region at the 5' terminus (thus 
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excluding most of the conserved 5' 51 nucleotide region) and in the 19 
nucleotide element at the 3' terminus are specifically required for 
replication and packaging of DI virus RNA (Levis et al.,1986 ). 
1.5 Replication of alphaviruses 
1.5.1 Cell attachment and entry 
Alphavirus replication requires that the virus attach to and enter a 
susceptible cell. This is followed by penetration of the nucleocapsid into the 
cytoplasm, uncoating and translation of the RNA genome; RNA 
replication and translation are followed by virus assembly and release 
from the cell. 
Like many other enveloped viruses, alphaviruses are believed to 
enter cells by receptor mediated endocytosis. SFV and, to a lesser extent, 
SIN, have served as the paradigms for most alphavirus entry studies 
(reviewed by Kielian and Helenius, 1986). Cultured cells are able to bind 
large numbers of SIN or SFV virions with estimates ranging from 5xl04 to 
1.5xl06 particles bound per cell (Birdwell and Strauss, 197 4; Fries and 
Helenius, 1979; Smith and Tignor, 1980). Pierce et al. (1974) demonstrated 
two types of binding using SIN; weak, in which virus could be washed 
from the cells with high ionic strength buffer and strong, which was 
virtually irreversible. It was suggested that weak binding involved ionic 
interactions between the virion and the cell surface while the strong 
binding involved receptor recruitment. Once tight binding occurs it is 
virtually irreversible (Marsh and Helenius, 1980). Based on experiments 
with proteases and neuraminidase, attachment sites on cultured cells are 
proteinaceous and sialic acid is not required for virus binding (Smith and 
Tignor, 1980). 
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No specific host-cell receptor for alpha viruses has been identified. 
Helenius et al. (1978) demonstrated binding of SFV glycoprotein spikes to 
human and murine histocompatibility antigens. However, Oldstone et al. 
(1980) showed that cells lacking these proteins could be productively 
infected with SFV and therefore that histocompatibility antigens were not 
required for alphavirus infection. This observation is supported by 
chemical cross-linking studies of SIN bound to cells which identified a 
90kD protein as the major protein at or adjacent to the SIN binding site 
(Maasen and Terhorst, 1981). In all cases one must consider that the 
productive receptor may be different to the proteins identified in cell 
binding studies (Dimmack, 1982) and that the situation in vivo may be 
different again. In arthropod cells it has been argued (Brown and 
Condreay, 1986) that there is no evidence for a specific receptor-mediated 
entry. However, Hase et al. (1989), using electron microscopy, claim to 
have demonstrated receptor mediated endocytosis of SFV in mosquito cells. 
In cultured cells, entry through the plasma membrane follows 
translocation of receptor bound virus to clathrin coated pits which are 
internalized as coated vesicles. Virus is delivered to endosomes where the 
acid pH triggers a conformational rearrangement of the glycoprotein spike 
leading to fusion of the endosomal and viral membranes which releases 
the nucleocapsid into the cytosol (Helenius et al.,1980; Marsh and 
Helenius, 1980; Kielian and Helenius, 1985). This fusion reaction is 
postulated to be analogous to that occurring with the influenza virus 
haemagglutinin during cell entry (Marsh and Helenius, 1989). Release of 
the nucleocapsid into the cytosol is concurrent with uncoating of the viral 
RN A which is translated to form the viral replicase/transcriptase. 
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1.5.2 Replication of the alpha virus genome. 
The viral replicase complex must have at least four activities: (1) 
initiation of minus-strand synthesis, (2) initiation of genome length plus-
strand synthesis, (3) initiation of subgenomic 268 RNA synthesis, and (4) 
elongation and completion of initiated chains (Strauss and Strauss, 1986). 
The four nonstructural proteins (nsPl, nsP2, nsP3 and nsP4) must 
function as the viral replicase/transcriptase complex, although an active 
replicase complex has not been isolated. Host cell components may also 
play a role in the viral replicase (Barie et al.,1983). By mapping 
temperature sensitive mutants of SIN which are defective in RNA 
synthesis at the non-permissive temperature (RNA- ts mutants), Hahn et 
al. (1989a) have shown that nsP4 probably contains the viral replicase 
activity. Initiation of minus strand synthesis maps to nsPl (Hahn et 
al.,1989b), which has also been associated with SIN RNA 
methyltransferase activity involved in 5' capping (Mi et al.,1989). 268 RNA 
synthesis appears to be initiated by nsP2, which may also be involved in 
minus strand synthesis (Hahn et al.,l989b). The high net positive charge of 
this protein suggests that it may be involved in RNA binding (Levinson et 
al.,1990). In addition a protease activity required for cleavage of the 
nonstructural polyproteins appears to reside in nsP2 (Ding and 
Schlesinger, 1989; Hahn et al.,l989b). The functions of nsP3 are 
unresolved. The C-terminal region of this protein is highly variable 
between alphaviruses both in amino acid sequence and in length (Strauss 
et al.,1988; Davis et al.,1989; Kinney et al.,1989 ) and thus functional activity 
may reside in the N-terminal region. To explain the differences in 
regulation of nsP4 synthesis between SIN which has an opal stop codon at 
the 3' end of the nsP3 gene and SFV which has no opal codon and therefore 
synthesizes relatively large amounts of nsP4, it has been suggested that 
nsP34 may be the active form of nsP4 (Hardy and Strauss, 1988; Li and 
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Rice, 1989). Peranen et al. (1988) have demonstrated that nsP3 of SFV is a 
phosphoprotein and speculated that its phosphorylation may be involved in 
regulation of some RNA synthesis steps. Phosphorylation of this protein 
has also been demonstrated for SIN (Hardy and Strauss, 1988). 
1.5.3 Translation of the 26S subgenomic RNA and processing of the 
structural proteins 
Translation of the 268 subgenomic RNA is initiated at an AUG 
codon which is 45-48 nucleotides from the 5' end of the 26S RNA in RRV 
(Faragher et al.,1988). The capsid protein is translated first and cleaved 
from the nascent polypeptide chain by an autocatalytic activity believed to 
function as a serine protease (Hahn et al., 1985; Melancon and Garoff, 
1987). This cleavage exposes the precursor to the E2 polypeptide (PE2, also 
known as P62) in which a hydrophobic leader sequence is recognized by the 
cellular signal recognition particle, forming a complex consisting of the 
nascent polypeptide, mRNA, ribosomes and signal recognition particle. 
This complex binds to receptors on the endoplasmic reticulum (ER), 
allowing transport of PE2 through the membrane (Bonatti et al., 1984). 
Glycosylation of PE2 occurs as the nascent polypeptide moves into the 
lumen of the vesicle (Schlesinger and Schlesinger, 1986). A hydrophobic 
sequence of, in RRV, 60 amino acids ( the 6K protein) probably acts as a 
signal sequence to initiate transport of E 1 across the membrane of the ER 
after proteolytic cleavage releases PE2 (Welch and Sefton, 1980). The 6K 
peptide is cleaved from E 1, possibly by signal peptidase (Schlesinger and 
Schlesinger, 1986). 
1.5.4 Host cell modification of virus proteins 
Initial glycosylation of the E 1 and PE2 proteins occurs in the rough 
endoplasmic reticulum (RER) (Sefton, 1977) by the attachment of mannose-
rich side chains to asparagine residues located within potential 
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glycosylation sites consisting of Asn-X-Ser/Thr triplets. Thes e 
oligosaccharides are processed by host enzymes in the ER and Golgi t o 
form either complex oligosaccharides containing the peripheral sugars N-
acetyl-D-glucosamine, galactose, sialic acid and fucose or a high mannose 
type (Kornfeld and Kornfeld, 1985). Intermediate types are also found 
(Davidson and Hunt, 1985) and the extent of processing depends on both the 
cell type and the position of the glycosylation site in the polypeptide 
(Keegstra et al.,1975; Burke and Keegstra, 1979; Hsieh et al.,l983a; 
Davidson and Hunt, 1983; Hsieh et al.,l983b). In mosquito cells complex 
oligosaccharides are not formed (Stollar et al.,1976; Luukonen et al.,1977; 
Hsieh and Robbins, 1984) indicating that the peripheral sugars in complex 
chains are not required for viral assembly or infectivity. The major role for 
added oligosaccharides may be in protein folding and stability (Schlesinger 
and Schlesinger, 1986). 
Fatty acylation of El and PE2 occurs either late in the ER (Berger 
and Schmidt, 1985), in the cis or medial Golgi (Quinn et al.,1983) or in an 
intermediate compartment between the ER and the cis Golgi (Bonatti et 
al.,1989). Long chain fatty acids, mostly palmitic acid (Schmidt et al.,1979), 
are added to cysteine residues in the transmembrane domains of El and 
PE2. N on-fatty-acylated proteins are defective in virus assembly 
(Schlesinger and Malfer, 1982). The fatty-acyl groups may also have a role 
in membrane fusion (Schmidt and Lambrecht, 1985). In addition, the 6K 
protein is highly palmitoylated and this appears necessary for virus 
assembly and budding (Nitschko and Schlesinger, 1990; Nitschke et 
al., 1990). 
1.5.5 Assembly, maturation and release of vims 
The complexing of capsid proteins with the 498 RNA genome to form 
the nucleocapsid occurs rapidly and specifically; this is possibly connected 
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with the demonstrated binding of the capsid protein to the 60S ribosomal 
subunit, which process n1ay have a role in virus assembly (Ulmanen et 
al.,1976). The capsid protein does not bind to the 268 viral RNA (Ulmanen 
et al.,1976). Coombs and Brown (1989) have suggested that the SIN capsid 
protein packages segments of the genome into nucleoprotein beads to form 
the nucleocapsid structure. 
During transport through the cellular organelles to the plasma 
membrane, PE2 is cleaved to E2 and E3 by a trypsin-like cleavage adjacent 
to a pair of basic residues. The timing of this cleavage and the enzyme 
involved are not clearly defined. While a cathepsin type protease in the 
Golgi has been proposed (Dalgarno et al., 1983; Schlesinger and 
Schlesinger, 1986), Nairn and Koblet (1988) and Knipfer and Brown (1989) 
have raised the possibility that some cleavage of PE2 occurs earlier in the 
RER. This cleavage may be due to a host enzyme which is not restricted to 
a particular compartment or to virus mediated proteolysis. In contrast, 
cleavage of PE2 late in the trans Golgi or in a post-Golgi compartment is 
suggested by the results of de Curtis and Simons (1988). It appears that this 
event may occur in a number of compartments or in a continuous manner 
depending on the sys tern examined. 
Cleavage of PE2 results in structural alterations to the heterodimer 
and may be essential for maturation of alphaviruses (Schlesinger and 
Schlesinger, 1986). However, a SIN mutant with a glycosylation site 
introduced at the PE2 cleavage point produced infectious virus with 
similar titres to control SIN even though the PE2 cleavage was abolished 
(Russell et al.,1989). Presley and Brown (1989) used low doses of the 
ionophore monensin to inhibit cleavage of PE2 and den1onstrated PE2 
incorporation into infectious virus, replacing E2. Lobigs and Garoff (1990) 
showed that cleavage of PE2 is essential for the exposure of the fusion 
function of the SFV viral spike, suggesting that cleavage of PE2 exerts a 
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conformational effect on El making it susceptible to low pH. Following PE2 
cleavage, E3 remains non-covalently associated with the El/E2 
heterodimer of SFV but not of SIN or RRV (Mayne et al.,1984; Martin et 
al.,1979). 
Viral glycoproteins are thought to arrive at the plasma membrane 
via transport vesicles which fuse with the cell surface (Garoff et al.,1982). 
El was not transported to the cell surface when an aberrant form of PE2 
was produced by a ts mutant of SFV at the non-permissive temperature, 
but was retained in the microsomal vesicles (Hashimoto et al.,1981). On 
this basis it has been suggested that PE2 is required for transport of E 1 to 
the plasma membrane (Schlesinger and Schlesinger, 1986). A model for 
virus assembly and budding proposes an initial interaction between the 
nucleocapsid and a few glycoprotein spikes at the cell surface to form a 
"nucleation patch". Additional glycoprotein spikes would then translocate 
into this patch with concomitant displacement of host membrane proteins. 
Protein-protein interactions between additional molecules of E2 and the 
capsid proteins would drag the plasma membrane around the spherical 
nucleocapsid, leading to fusion of the bilayers and release of virions (Garoff 
and Simons, 197 4). A similar model has been proposed by Vogel et al. 
(1986). In support of this model an E2-capsid protein association has been 
demonstrated for SFV with cross-linking reagents (Ziemiecki and Garoff, 
1978) and using monoclonal anti-idiotypic antibodies (Vaux et al.,1988). 
Alterations in monovalent cation transport associated with the appearance 
of virus glycoproteins in the membrane may facilitate virus release (Ulug 
et al.,1989). This is consistent with the suggestion that the charge of the 
viral envelope is a major determinant in virus release (Strauss et al.,1980; 
Garry et al.,1985). 
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1.6 Functional domains of alphavirus glycoproteins El and E2 involved in 
cell entry 
The alpha virus glycoproteins E 1 and E2 form the external surface of 
the virus and must be involved in such functions as cell attachment, 
recognition of cell surface receptors and membrane fusion. Their role in 
alphavirus assembly has already been discussed. Because these proteins 
mediate receptor recognition they could also be virulence determinants at 
least partly defining cell and tissue tropism and vector specificity. As El 
and E2 exist as a heterodimer (Ziemieki and Garoff, 1978), the structure of 
which may be further modified by the quaternary conformation of the viral 
spike, it is likely that the functional dissection of E 1 and E2 may lead to 
oversimplification when determinants on both proteins are required for 
certain functions. 
The structural protein genes for a number of alphaviruses have been 
sequenced (SIN, SFV, RRV, VEE, WEE, EEE and ONN; Rice and Strauss, 
1981; Garoff et al.,1980; Dalgarno et al.,1983; Johnson et al.,1986; Hahn et 
al.,1988; Chang and Trent, 1987; Levinson et al.,1990) and the apparent 
organization in terms of ectodomains, membrane spanning domains and 
cytoplasmic domains is conserved. Bell et al. (1984) analysed the N-
terminal amino acid sequence of the glycoproteins of eight alphaviruses 
and demonstrated that although the sequence varied between viruses , 
residues important in secondary structure such as cysteines, pralines, 
glycines and aromatic amino acids tended to be conserved suggesting that 
the three dimensional structures of E 1 and E2 are similar in all 
alphaviruses. Examination of the complete, colisted, amino acid sequences 
for El and E2 of RRV, SFV and SIN (Dalgarno et al.,1983 ) supports this 
conclusion. As the three dimensional structure of the alphavirus spike 
glycoproteins has not been determined, the definition of functional 
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domains on E 1 and E2 1s currently limited to the linear amino acid 
sequence. 
The respective roles of El and E2 in receptor binding have not been 
resolved. As the two proteins exist as a heterodimer in a trimeric spike, 
interactions with receptors may involve sites on both proteins and/or 
complex conformational rearrangements. Removal of E2 from SFV virions 
by protease digestion produced particles containing predominantly El but 
which had virtually normal infectivity. This suggests that El alone is 
sufficient for infection of cultured cells (Omar and Koblet, 1988). However, 
it is unclear whether this is receptor mediated or results from exposing a 
fusion domain on E 1 that interacts directly with the cell plasma 
membrane. A priori it would seem that the potential for exposing cryptic 
domains on E 1 following the removal of E2 is high. Antiserum to E2 but not 
to El inhibits binding of VEE to cells. In addition some E2 specific 
monoclonal antibodies (mAbs) inhibit virus attachment to cells in tissue 
culture (Roehrig et al., 1988). Further evidence of a role for E2 in cell entry 
is provided by SIN variants selected for rapid penetration of BHK cells. The 
increased rate of penetration of most of these variants is caused by an 
amino acid alteration at amino acid 114 of E2 (Ser~Arg), suggesting that 
this protein is able to modulate cell entry (Davis et al.,1986; Polo et al.,1988; 
Russell et al.,1989). Rapid penetrating variants of RRV T48 with changes 
at amino acids 246 and 248 of E2, have also been described (Vrati, 1986). 
There is good indirect evidence that El is the viral fusogen. This has 
been demonstrated with fusion mutants of SIN (Boggs et al.,1989), in SFV 
with E2 proteolytically removed (Omar and Koblet, 1988) and in 
recombinant expression systems (Kondor-Koch et al., 1983). E 1 is also 
responsible for haemolysis of erythrocytes in vitro (Yamamoto et al.,1981; 
Lenard and Miller, 1981; Vaananen and Kaarianen, 1979). This appears to 
be analogous to alphavirus induced cell fusion (Vaananen and Kaarianen, 
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1980). Haemagglutinating activity is associated ·with E 1 for alpha viruses 
(Dalrymple et al.,1976; Helenius et al.,1976; Simizu et al.,1984), however, 
E2 is the viral haemagglutinin for VEE (France et al.,1979 ). These 
functions of El all relate to fusion with cell membranes and do not require 
cellular proteins (Mooney et al.,1975) although there is an absolute 
requirement for cholesterol or other ~-OH sterols and mildly acid pH 
(Mooney et al.,1975; White and Helenius, 1980; Kielian and Helenius, 1984). 
It has been postulated (Garoff et al.,1980; Rice and Strauss, 1981) 
that fusion activity resides in a hydrophobic domain near the N-terminus 
of E 1. In RRV this consists of the 17 amino acids forming residues 80-96, 
which are identical to the corresponding region in SFV and only differ 
from SIN in three amino acids (Dalgarno et al.,1983). This domain is in a 
region of 58 amino acids which is almost entirely conserved between RRV 
and SFV, with only one (conservative) amino acid substitution. This degree 
of conservation is far greater than the overall level (75%) between these two 
viruses (Dalgarno et al.,1983). Chang and Trent (1987) have postulated that 
for EEE, a seven amino acid sequence located at the C-terminus of this 
region and in a predicted antigenic domain, may interact with the cellular 
receptor and induce changes in the fusion domain leading to penetration. 
Omar and Koblet (1988) have predicted that there is more than one 
hydrophobic peptide mediating fusion. This is supported by the observation 
that haemolytic activity can be separated from haemagglutinating activity 
on El using mAbs (Chanas et al.,1982). Monoclonal antibodies to E2 can 
also block haemagglutination and this may be a function of the El/E2 
heterodimer in intact virus (Schmaljohn et al.,1983; Boere et al,1984). 
Currently a case can be made for either El or E2 being involved in 
receptor recognition, however, it seems likely that the fusion component of 
cell entry involves E 1. 
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1.7 Definition of neutralizing antigenic determinants on alphavirus 
glycoproteins 
Neutralization determinants (epitopes ) on viral proteins are a subset 
of antigenic sites which are functionally important because antibodies 
recognizing these sites provide protection from viral infection and may be 
involved in recovery from infection (Casals, 1963). Thus the identification of 
neutralization epitopes and an understanding of the mechanism of 
neutralization are important for the design of vaccines. Neutralization 
epitopes may also define functional domains involved in virus replication. 
For example sites on E2 involved in penetration in tissue culture of SIN 
and RRV show alterations in neutralizing mAb reactivity (Olmsted et 
al.,1984; Olmsted et al.,1986; Russell et al.,1989; Vrati, 1986). 
Polyclonal antisera raised against intact or partially denatured 
virus reflect the specificities and affinities of the total antibody population 
and are thus not useful for examining or defining single regions of viral 
proteins or specific determinants such as neutralization epitopes. Antisera 
raised against purified E 1 or E2 of SIN showed that neutralizing antibodies 
were directed to E2 while El had haemagglutinating activity (Dalrymple et 
al.,1976). In contrast the use of mAbs has enabled definition and study of 
individual epitopes and domains of E 1 and E2 (reviewed by Roehrig, 1986). 
The selection of mAb resistant variants (escape mutants) has allowed the 
mapping of these epi top es on the linear amino acid sequence of the 
structural proteins. 
For RRV, three neutralization epitopes have been mapped on E2 by 
selecting mAb escape mutants and competition binding assays (CBAs) 
(Vrati et al.,1988). Five mAbs were used in CBAs to define three 
overlapping epitopes; a (defined by mAbs TlOC9 and T4D2), b (mAbs NB3C4 
and T1E7) and c (mAb TlDll). Epitopes a and c were topographically 
,....... 
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distinct but were united by epitope b. Three of these mAbs (T10C9, NB3C4 
and T1E7) were used to select neutralization resistant variants of both RRV 
T48 and RRV NB5092. Nucleotide sequencing defined amino acid changes 
on E2 which abolished neutralization by the selecting mAb. These were: E2 
216 for mAb T10C9 (epitope ru; E2 232 and 234 for mAb NB3C4 (epitope bl); 
and E2 246, 248 and 251 for mAb T1E7 (epitope b2). These epitopes are 
within 30 amino acids of each other in the primary sequence of E2 and are 
located between the two predicted glycosylation sites at Asn 200 and Asn 
262 in hydrophilic regions of the protein. Other sites can also influence 
neutralization; for example mAb NB3C4 is affected by a deletion of seven 
amino acids between residues 55-61 of E2 (Vrati et al., 1986). 
Four neutralization determinants have been identified on SIN, one 
on El, (Chanas et al.,1982; Schmaljohn et al.,1983; Stec et al.,1986) and 
three on E2 (Roehrig et al.,1982; Schmaljohn et al.,1983; Stanley et al.,1985; 
Stec et al.,1986; Olmsted et al.,1986; Davis et al.,1987). The E2 sites have 
been mapped to residues 181, 186, 190 (epitope E2a), 214 and 216, (epitope 
E2b) and 62, 96 and 159, (epitope E2c) by selection of escape mutants 
(Strauss et al.,1987; Stec et al.,1986; Davis et al.,1987; Pence et al.,1990). 
Like RRV, sites outside these defined regions can affect neutralization of 
SIN; for example a Serll4--1Arg change in E2 affects epitope E2c (Davis et 
al.,1986). 
Antigenic sites of SFV, VEE and WEE have been mapped 
topographically using CBAs (Boere et al.,1984; Roehrig and Mathews, 1985; 
Hunt and Roehrig, 1985) but no sequence data on escape mutants has been 
published. 
The mechanism of virus neutralization by antibodies is poorly 
understood (for reviews see Dimmack, 1984, 1987; McCullough, 1986). 
Neutralization may depend not only on properties of the virus but also the 
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antibody and the host cell; mechanisms established in vitro using cultured 
cells may have little relationship to those occurring in vivo where other 
aspects of the immune system are involved (Schmaljohn et al., 1982; 
Dimmack, 1984). 
A general mechanism of alphavirus neutralization by polyclonal 
antisera, based on in vitro experiments with neutralization of VEE by 
mAbs, has been proposed (Roehrig et al., 1988). This model envisages that 
in an immune host, antibodies of varying specificities act to limit virus 
dissemination. Some neutralizing antibodies bind to E2 at epitopes involved 
in cell attachment and block virus association with cell receptors. Virions 
not neutralized in this way may be neutralized by antibodies of other 
specificities for which the mechanism of neutralization is not obvious. For 
example, binding of some mAbs can alter the virus glycoprotein 
conformation such that the virus-receptor interaction is enhanced and 
stabilized on some cell types, even though the virus is effectively 
neutralized. Virus infectivity is efficiently neutralized, possibly 
analogously to post-attachment neutralization in flaviviruses (Gollins and 
Porterfield, 1986). Virions that escape neutralization prior to attachment 
may be neutralized by binding of antibody post-adsorption. Those cells 
supporting a productive virus infection can be destroyed, probably via 
immune cell mechanisms, following non neutralizing antibody binding to 
virion epitopes expressed on the infected cell surface (Schmaljohn et 
al.,1982). 
1.8 The role of alphavirus glycoproteins in virulence determination 
Virulence of a virus may be defined by the severity of disease caused 
in a particular host. This will reflect a combination of host factors 
including age, nutritional status, concurrent infections and genetic type 
and virus factors such as speed of replication, cell and tissue tropism. 
'Z1 
Studies of alphavirus virulence typically use the mouse as a laboratory 
model and frequently use virus strains that are mouse adapted. The 
disease produced in mice may or may not relate to that seen in humans or 
other animals in the field and thus laboratory studies of alphavirus 
pathogenesis must be interpreted cautiously if used as a model for clinical 
disease. 
Studies with RRV (Faragher et al.,1988) and VEE (Kinney et al.,1989) 
have compared the complete genome sequences of virulent and attenuated 
strains of these viruses. For RRV there were 284 nucleotide differences 
representing 48 amino acid differences between the mouse virulent T48 
strain and NB5092 which is of low virulence for mice. In addition there 
were deletions and insertions in the non-coding regions. Such a large 
number of alterations make determination of virulence factors very 
difficult. In RRV T48 a deletion of amino acids 55-61 of E2 is associated 
with reduced virulence in mice (Vrati et al.,1986) supporting the concept 
that E2 is a determinant of virulence. There were only 11 nucleotide 
changes between the attenuated TC-83 strain of VEE, derived by passage in 
tissue culture, and its virulent parent. Six of these were coding changes, 
leading to five nonconservative amino acid changes in E2 and one 
conservative amino acid change in E 1. This strongly points to E2 as a 
primary determinant of virulence in VEE. However, a single nucleotide 
alteration in the 268 RNA 5' untranslated region may to be involved in 
reduced RNA synthesis and decreased early virus production in vivo 
suggesting that this may be the mechanism of attenuation (Mecham and 
Trent, 1983; Johnson et al.,1986). 
The low mouse virulent strain of RRV, NB5092 can be rapidly 
selected for virulence by serial passage in mice (Taylor and Marshall, 
1975a; Meek et al.,1989). Variants selected in this way had amino acid 
changes in E2. These changes were not essential for increased virulence 
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as plaques picked from passage of virus without the changes in E2 \Vere 
virulent. Virulence enhancement probably proceeded via an alteration in 
the nonstructural proteins, leading to increased replicative efficiency in 
mice, followed by selection for changes in E2. These changes in E2 may 
further enhance virulence, possibly by altering tissue tropism (Meek et 
al.,1989). 
The virulence in mice of a number of strains of SIN has been 
characterized (reviewed by Griffin, 1989). Virulence depends on the strain 
of virus, age of mice and route of inoculation; most strains are lethal for 
neonatal mice by either the subcutaneous or intracerebral route of 
inoculation; all strains of SIN are avirulent in adult mice inoculated 
subcutaneously, however, some strains are lethal for adult and weanling 
mice inoculated intracerebrally. The neurovirulent NSV strain, selected by 
passage in mouse brain, is lethal for weanling mice by intracerebral 
inoculation. This increased virulence appears to be due to enhancement of 
viral replication in neurons rather than to a fundamental change in 
tropism (Griffin, 1989). The parental and the neurovirulent strains can be 
distinguished by several mAbs (Stanley et al.,1985). Nucleotide sequencing 
showed two amino acid changes in each of El and E2 (Lustig et al.,1988). 
In a complex series of experiments, the use of a transcribable complete 
cDNA clone of the SIN genome (Rice et al.,1987) allowed changes in the 
NSV structural glycoproteins to be made against a constant genetic 
background (Lustig et al.,1988). This showed that the changes in both El 
and E2 of the NSV strain were required for neurovirulence in weanling 
mice but regions of the genome outside the envelope glycoproteins were 
also involved in determining virulence (Lustig et al.,1988). 
Selection of SIN (Barie et al.,1981; Olmsted et al.,1984; Russell et al 
1989) and VEE mutants (Johnston and Smith,1988) with accelerated 
penetration in tissue culture coselects for reduced virulence in mice. In 
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SIN this is associated with a change in rnAb neutralization involving the 
E2c epitope (Olmsted et al., 1984; Olmsted et al.,1986; Russell et al.,1989) 
due to an E2 Ser114~Arg change (Davis et al.,1986). This is the only 
change necessary for both attenuation and increased penetration (Polo et 
al.,1988). Russell et al. (1989), using another strain of SIN showed that 
some fast penetrating variants failed to cleave PE2 to E2 and E3 due to the 
introduction of a glycosylation site at the cleavage point. This was 
associated with a loss of neurovirulence for both neonatal and adult mice 
mice. Mutants of this strain with the Ser114~Arg change were also 
selected, these variants were attenuated in neonatal mice by subcutaneous 
inoculation but remained virulent in both ages of mice by intracerebral 
injection (Russell et al.,1989). 
Thus a number of factors including the envelope glycoproteins may 
determine alphavirus virulence. Changes in mAb reactivity are often 
correlated with changes in virulence indicating that alterations in surface 
proteins have occurred. Similar complexity with regard to virulence exist 
for other viruses. For poliovirus loci involved in attenuation are distributed 
in several regions of the genome including the 5' UT region, and altered 
antigenicity correlates poorly with virulence changes (Evans et al.,1985; 
Omata et al.,1986; Kawamura et al.,1989; Westrop et al.,1989; Moss et 
al.,1989). In contrast mAb resistant variants of rabies virus with a single 
amino acid change from arginine or lysine at position 333 in the surface 
glycoprotein are attenuated for mice (Tuffereau et al.,1989). The practical 
importance of identifying changes that are involved in attenuation lies in 
the potential instability of live attenuated vaccines if only one or two 
mutations are required for reversion to virulence. Changes involved with 
altered virulence may also provide insight into the mechanisms of disease 
pathogenesis and evolution of new viruses and diseases. 
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1.9 Evolution and adaptation of alphaviruses 
1.9.1 Evolution of RNA viruses 
In contrast to the highly stable DNA genomes of eukaryotes, where 
the rate of nucleotide substitutions, in functional genes, averages only 
about l0-9 nucleotide substitutions per site per year (Holland et al.,1982 ), 
RNA viruses have a very high rate of mutation. This has been estimated 
for a number of RNA viruses (reviewed by Smith and Inglis, 1987) and 
depending on the virus and the method used, a base misincorporation 
frequency of around l0-3-10-5 per genome replication occurs. For 
alphaviruses estimates range from l0-3 to <l0-6.8 (Stec et al.,1986; Durbin 
and Stollar, 1986). The high error rate is probably due to a lack of 
proof-reading by the RNA polymerases involved in viral replication 
(Holland et al.,1982) although such an activity is claimed for the influenza 
virus RNA polymerase (Ishihama et al.,1986). 
Based on studies with the bacteriophage Q~, Domingo et al. (1978) 
have proposed that an RNA virus population is in a dynamic equilibrium 
with viable mutants arising at a high rate but being strongly selected 
against in competition with the wild-type. This has been termed a 
"quasispecies" in which the genome is statistically defined but individually 
indeterminate, in that most individual genomes will differ at one or more 
positions from the population consensus sequence. Such heterogenous 
populations should be capable of rapid adaptation to a changing 
environment because of the high proportion of variants in the population 
(Domingo et al., 1978). Given the very high potential evolution rate of RNA 
viruses it is obvious that some constraints must act on the population. The 
need for conservation of protein structure and function, glycosylation sites, 
codon preferences, RNA secondary structure and conserved sequences 
involved in protein recognition act as powerful selective forces to stabilize 
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virus populations (Strauss and Strauss, 1986; Steinhauer and Holland, 
1987). 
1.9.2 Evolution and divergence of alphavirnses 
It has been suggested, on the basis of genome organization, 
sequence similarities in the replicase proteins and the folding of the capsid 
proteins, that the positive strand RNA viruses have evolved from a 
common ancestor as a result of recombination, mutation and selection 
(Strauss and Strauss, 1988). Thus a number of apparently unrelated plant 
viruses have been postulated to be members of a "sindbis like" superfamily. 
In addition SIN has been likened to an enveloped picornavirus on the basis 
of similarities between its capsid protein sequence and predicted folding 
and those of the VP3 capsid proteins of picornaviruses (Fuller and Argos, 
1987). 
Nucleotide and amino acid sequence compansons of alpha viruses 
reveal that even in regions where amino acid sequence is conserved, the 
codon usage has been essentially randomized (Strauss and Strauss, 1986). 
Thus the evolutionary divergence among alphaviruses is extremely 
extensive and the conservation of amino acid sequences presumably 
results from functional requirements (Bell et al.,1984). 
By comparing the amino acid sequences available for the structural 
and nonstructural proteins for SIN, SFV, RRV, ONN, VEE, WEE, EEE and 
MID, Levinson et al. (1990 ) have proposed phylogenetic trees for each 
protein. vVhen the E2 sequences are compared, the viruses form similar 
subgroups to those predicted by serology ( Cali sher et al., 1980; see Table 
1.1). This is expected as serological comparisons based on differences in 
neutralizing epitopes will predominantly reflect differences in E2. When 
E 1 and the capsid protein are considered the subgroups are less distinct; 
SFV, RRV and ONN form the SFV subgroup; EEE and VEE belong to the 
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EEE subgroup; SIN defines a separate subgroup and, based on limited 
data, MID forms a unique subgroup. WEE is in a special category as it is a 
recombinant virus (Hahn et al.,1988; see below). 
Studies with RRV have shown the existence of a range of genetic and 
antigenic types (Faragher et al.,1985; Woodroofe et al.,1977) . Similar 
studies have been performed for SIN (Olsen and Trent, 1985), the VEE 
complex (Young and Johnson, 1969; Trent et al.,1979), Getah (Morita and 
Igarishi, 1984) and the WEE complex (Trent and Grant, 1980) and have 
also demonstrated a range of genetic types. Alphaviruses appear to evolve 
by divergence in isolated ecological niches over substantial, but unknown, 
time-frames with one estimate of nucleotide divergence being a maximum 
of 0.1-0.2% per year (Hahn et al.,1988). Members of the subgroups defined 
by Levinson et al.,(1990) seem to be evolving at the same rate, however, 
individual proteins appear to evolve at different rates; nonstructural 
proteins diverge more slowly than structural proteins, while E2 evolves 
more rapidly than El and the capsid protein (Levinson et al.,1990). 
Whether this divergence is simply by genetic drift that is, the 
gradual accumulation of random mutations or by adaptation and selection 
in new hosts and vectors probably depends on the circumstances. In 
practice a combination of both possibly operates. Given that transmission 
between a vertebrate host and a mosquito vector often involves very low 
numbers ofvirions (Burness et al.,1988) the potential of the "founder effect" 
(reviewed by Smith and Inglis, 1987) may be quite high in alphavirus 
evolution. 
The requirements for replication in a mosquito vector and a 
vertebrate host may exercise a powerful constraining force on alphavirus 
evolution. To become fixed in the population, any mutation which 
enhances replication in one host must not be selected against in the second 
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(Burness et al.,1988). Kuhn et al. (1990) have demonstrated that changes in 
the 3' UT region of SIN can have a differential effect on virus replication in 
mosquito cells and vertebrate cells suggesting that regulatory sequences 
may reflect a compromise between the most efficient nucleotide sequence 
in host and vector. With RRV, Taylor and Marshall (1975b) demonstrated 
that alternating passages of the low virulence NB5092 strain between mice 
and mosquitoes did not select for changes in mouse virulence whereas 
passage in mice alone rapidly selected for virulence. In support of this, 
analysis of the E2 gene of RRV from a number of isolates made during a 
major epidemic in the Pacific islands demonstrated that only a single 
nucleotide change, altering amino acid 219, occurred in the course of the 
epidemic (Burness et al.,1988). Viruses which do not alternate between 
different hosts, on the other hand, may undergo high rates of evolution 
during epidemics (Kew et al.,1981; Nottay et al.,1981; Takeda et al.,1984; 
Evans et al.,1985; Buonagurio et al.,1986; Hahn et al.,1986). 
Recently Hahn et al. (1988) have convincingly demonstrated that 
WEE is a recombinant between an EEE-like virus and a SIN-like virus. 
This is the first evidence of recombination between alphaviruses. It 
explains the paradoxical serological and pathological properties of WEE 
and indicates the importance of the EEE nonstructural and capsid 
components of the virus in causing encephalitis compared to the SIN-like 
glycoproteins. Recombination, rather than gradual evolutionary 
divergence, is a potentially powerful mechanism for the emergence of new 
types of alphaviruses (Levinson et al.,1990). 
1.9.3 Adaptation and selection of alphavirnses in tissue culture 
Passaging in tissue culture is a common method of prepanng 
attenuated or laboratory adapted strains of viruses. Examples of successful 
vaccines produced in this way include the yellow fever 17D strain (Theiler 
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and Smith, 1937), the Sabin oral poliovirus vaccine strains (Sabin, 1965) 
and, for alphaviruses, the TC-83 vaccine strain of VEE (Berge et al.,1961 ). 
Passaging in tissue culture appears to select variants, either pre-existing 
in the virus population or arising by mutation, which eventually outgrow 
the wild-type to become the dominant population. This may produce a 
population which is altered in its growth rate and tissue tropism and may 
thus be attenuated for the natural host. 
The molecular basis of selection in tissue culture is unclear and 
probably varies between viruses. To grow in a particular cell line a virion 
must be able to attach to the cell surface, bind to a productive receptor, 
enter the cell, replicate, assemble and escape from the cell. Adaptation to 
growth in a particular cell line may select variants with enhanced 
recognition of a cell surface receptor or with the ability to overcome some 
other barrier to cell recognition and entry. For alphaviruses this may be 
evident as changes in the surface glycoproteins El and E2. Some possible 
examples of this are given below. 
Adaptation of SIN to mouse plasmacytoma cells was associated with 
an increased negative surf ace charge on the virion leading to an enhanced 
ability to initiate infection of these cells (Symington and Schlesinger, 1975; 
Symington and Schlesinger, 1978). Changes occurred in both El and E2 
based on biochemical analysis, but no sequence data was given. Similarly 
enhanced infectivity was obtained by incubating the cells with heparin 
suggesting that surface charge on cells and virions was involved in cell 
attachment and entry (Symington and Schlesinger, 1978). In a second 
example, the attenuated TC-83 strain of VEE was generated by passaging 
the virulent TRD strain in tissue culture; after 45 serial passages in 
guinea pig heart cells the TRD strain had become avirulent for mice (Berge 
et al.,1961). There were 11 nucleotide differences between the TC-83 and 
TRD genomes, six of which resulted in amino acid changes Of these, five 
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occurred in the E2 protein and all five were non-conservative (Kinney et 
al.,1989 ). Finally, selection of SIN for rapid release or rapid penetration in 
BHK cells was associated with changes at either amino acid 114 of E2 or 
the introduction of a glycosylation site at amino acid one of E2 which 
prevented cleavage of PE2 (Davis et al.,1986; Russell et al.,1989 ). 
E2 is the most variable alphavirus protein and appears to be largely 
responsible for strain evolution (Levinson et al.,1990 ). It is possible that E2 
is important in adaptation to new hosts and that changes in this protein 
reflect this. Definition of such changes could help to define functional 
domains on E2. 
1.10 Scope and outline of the thesis 
Alphaviruses, particularly SIN and SFV, provide a well 
characterized system for study of the interactions of arboviruses and cells 
at the molecular level. In addition these viruses are frequently important 
pathogens of humans and other animals (Shope et al.,1980) and have been 
used in extensive studies of viral pathogenesis. There are, however, many 
unanswered questions about alphavirus biology and molecular virology. 
The natural cycling between vertebrate and invertebrate hosts raises many 
fascinating issues particularly with regard to cell receptors and protein 
structure and function. Answers to these may illuminate the mechanisms 
involved in alphavirus evolution, adaptation to new ecological conditions, 
the maintenance of enzootic foci and development of epidemics. 
RRV is the most important alphavirus in Australia and 
surrounding regions causing frequent disease outbreaks (Marshall and 
Miles, 1984). In recent years it has been well characterized genetically 
(Dalgarno et al.,1983; Faragher et al.,1985; Faragher and Dalgarno, 1986; 
Faragher et al.,1988 ) and antigenically (Vrati et al.,1988 ). This has 
provided the opportunity for further study at the level of molecular and cell 
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biology. This thesis describes studies of the E2 glycoprotein of RRV; its role 
in immunogenicity, cell entry and its response to serial passage in cell 
culture. 
In Chapter 2 studies on the antigenic structure of RRV are 
described. Neutralization of mAb resistant variants of RRV, altered in one 
or three neutralizing epitopes, by polyclonal antisera raised against the 
parental virus was examined to test the hypothesis that these epitopes 
represented an immunodominant site on RRV (Vrati et al.,1988 ). In 
further studies four short synthetic peptides were used to examine the 
antigenic structure of this neutralization domain on RRV. This was done 
by raising antisera to the peptides in mice and examining the reactivity of 
these antisera with RRV in a variety of immunological assays. Peptides 
were also examined for their ability to bind to antibodies raised to RRV. 
The study of this neutralization domain is continued in Chapter 3 by 
measuring the rate of penetration in tissue culture of variants of RRV 
resistant to individual m.Abs and thus with single amino acid alterations 
in E2. The penetration rate of variants with changes in epitopes a, b 1 and 
b2 were determined in Vero and BHK cells and compared with the rates for 
the parental T48 and several field isolates of RRV. Growth kinetics and 
RNA synthesis kinetics in tissue culture were also examined. Binding 
studies with RRV were performed on cultured cells. In addition further 
variants of RRV resistant to mAb T1E7 were selected in an attempt to map 
permissible amino acid changes at this epitope. 
Chapter 4 continues the examination of the envelope glycoproteins by 
determining the changes that occurred in these proteins on passaging 
RRV in chick embryo fibroblasts. RRV replicates poorly in birds (see 
earlier) and it was reasoned that by passaging the virus in avian cells 
insights into structure-function relationships of the glycoproteins might be 
.... 
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developed. It was of particular interest to determine whether changes 
occurred in the neutralization epitopes already defined on RRV E2 and 
implicated in penetration. The passaging of RRV in avian cells is 
described together with the results of antigenic, biological and genetic 
analysis of passaged variants. 
In Chapter 5 a similar approach is taken by passaging RRV strains 
1n human and arthropod cell lines. Passaged virus populations were 
subjected to genetic and antigenic analysis of the E2 gene and changes in 
this gene compared with those found following passage in avian cells. 
Chapter 6 provides a general discussion of the work presented in 
this thesis. 
Chapter2 
Studies on a neutralization domain of RRV E2 using anti-viral and 
anti-peptide antibodies 
38 
39 
2.1 Introduction 
Virus neutralizing antibodies are regarded as being of primary 
importance in recovery and protection from alphavirus infections (Casals, 
1963). During such infections antibodies are produced to both E 1 and E2 but 
neutralizing antigenic determinants are found predominantly on E2 
(Dalrymple et al.,1976). However, some neutralizing mAbs are directed to 
sites on El (Chanas et al.,1982; Schmaljohn et al.,1983; Boere et al.,1984). 
The process by which antibodies neutralize alphaviruses is poorly 
understood (see Chapter 1), and characterization of the structure and 
function of neutralization determinants may help in understanding the 
mechanism of neutralization and the functional importance of 
neutralizing epitopes. 
Three neutralization determinants have been defined on E2 of RRV 
T48 and NB5092 by the selection of variants resistant to neutralizing mAbs 
(Vrati et al.,1988). These epitopes, designated a, bl and b2, are defined by 
single amino acid changes in E2 and are associated with resistance to 
mAbs T10C9, NB3C4 and T1E7 respectively. The three epitopes are within a 
region of the primary polypeptide sequence of E2 bounded by the two 
glycosylation sites at amino acids 200 and 262 (Dalgarno et al.,1983) and are 
defined by residues 216 (.a), 232, 234 (bl) and 246, 248, 251 (b2). A 
multiepitope variant resistant to all three mAbs was also selected (Vrati et 
al.,1988). 
As the three dimensional structure of E2 has not been resolved it is 
not possible to specify the spatial relationship of these three epitopes. 
Although RRV variants resistant to one mAb are neutralized normally by 
the other two, the mAbs compete with each other in CBAs. This suggests 
that the epitopes are functionally independent but topographically close. It 
has been proposed that these epitopes plus another, epitope c, which has 
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been defined by CBAs and which interacts with epitope b, represent 
separate but interacting parts of a single, major neutralizing determinant 
on E2 (Vrati et al.,1988). 
To extend this work two questions were asked: (1) Are epitopes a, b 1 
and b2 significant in a normal polyclonal immune response, and if so is 
any one epitope dominant? (2) Are synthetic peptides representing the 
primary amino acid sequence around the neutralization epitopes able to 
elicit neutralizing antibodies against RRV and bind to anti-RRV 
antibodies? 
Synthetic peptides have been used to define antigenic regions of a 
number of viruses important in human and animal health, eg poliovirus 
(Emini et al.,1983), foot and mouth disease virus (Bittle et al.,1982; Pfaff et 
al.,1982; Geysen et al.,1984, 1985; Meleen et al.,1987), influenza virus 
(Green et al., 1982; Shapira et al.,1984), human immunodefficiency virus 
(Kennedy et al.,1986), Human T cell leukaemia virus Type I (Copeland et 
al.,1986) and feline leukaemia virus (Elder et al.,1987). For polio and foot-
and-mouth disease viruses, synthetic peptides induce antibodies which 
neutralize virus and protect animals from challenge (Bittle et al.,1982; 
Emini et al.,1983; DiMarchi et al.,1986). Such peptides have the potential to 
form the basis of safe synthetic vaccines (Arnon, 1986). This approach has 
not been used to examine the antigenic structure of an alphavirus. 
In this chapter, the importance of the defined neutralization 
determinants of RRV E2 in a polyclonal immune response has been 
examined. In addition studies have been made of the antigenicity and 
immunogenicity of four synthetic peptides representing the primary 
amino acid sequences around epitopes a, b 1 and b2. It is concluded that a 
substantial proportion of the neutralizing antibodies in a polyclonal 
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hyperimmune response recognize the combination of these epitopes and 
that the epitopes are probably conformationally discontinuous. 
2.2 Materials and Methods 
2.2.1 Virus stocks 
The prototype T48 strain of RRV (Doherty et al.,l963a) was from the 
Yale Arbovirus Research Unit ( New Haven, Conn. USA). It had been 
passaged approximately ten times in mice when received. The NB5092 
strain of RRV (Gard et al.,1973) was from Dr.I. D. Marshall (John Curtin 
School of Medical Research, Australian National University, Canberra, 
Australia). Virus was plaque purified on Vero cell monolayers and 
working stocks were prepared in BHK cells. Virus was assayed by plaque 
formation on Vero cell monolayers (Newton et al.,1981) and titres are 
expressed as plaque forming units per ml (pfu/ml). 
The mAb resistant variants of RRV T48 used are given below, with 
the amino acid change, position in E2 and epitope in brackets: Tv42 
(Thr2l6-,I1e, a), Tv61 (Lys234-,Gln, bl), Tvl (Asp246-,Asn, b2). These 
variants were selected with mAbs TlOC9, NB3C4 and TlE7 respectively. 
Tvl61 (Thr216-,Ile, a; Lys234-,Asn, bl; Asp246-,Asn, b2) was selected 
sequentially with all three mAbs (Vrati et al.,1988). Stocks of these variants 
were grown in BHK cells and assayed for mAb resistance, at a 1:50 mAb 
dilution, before use. 
2.2.2 Cells 
BHK monolayers were grown in Glasgow Minimum Essential 
Medium (GMEM) supplemented with 8% bovine serum (BS). Vero cells 
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were grown in Medium 199 enriched with lactalbumin hydrolysate (M199 
LAH) plus 10% BS. Cell cultures were incubated at 36° in 5% CO2. 
2.2.3 Virus purification 
This essentially followed the method of Ou et al. (1981). Two roller 
bottles of BHK cells were infected with RRV (moi-0.25). Four hours post 
infection (pi) one roller bottle was pulsed with 5µg/ml of actinomycin D 
(AMD; Merck, Sharpe and Dahme, NJ, USA) for 30 min. Following this, 
the growth medium was removed and the monolayers washed twice with 
Hank's balanced salt solution (HESS). Medium was replaced with Eagle's 
minimal essential medium (EMEM) containing 2% dialysed foetal calf 
serum CFCS) and 5µCi/ml [5-3H]-uridine (NEN Research Products, Boston, 
MA, USA). Supernatants were harvested 24 hours post-infection and 
pooled. Following clarification (10,000 rpm, 10 min, 4°), virus was 
precipitated by addition of one-fourth volume of 40% polyethylene glycol 
(PEG; Koch-Light Laboratories, UK) in HESS (no BSA) and mixing for 2 
hours at 4°. PEG precipitates were collected by centrifugation (Sorvall GSA 
rotor, 10,000 rpm, 50 min). Pellets were resuspended in 4 to 5 ml of NET 
buffer (0.15M NaCl; O.OlM Tris, pH7.5; 0.002M EDTA) and centrifuged 
(27,000 rpm, 90 min) through a 5-25% sucrose gradient in NET. Peak 
gradient fractions were identified by liquid scintillation counting, pooled 
and stored at -70°. 
2.2.4 Antisera 
Polyclonal antiserum was produced in Balb/c mice (6-8 weeks old), 
immunized intraperitoneally (ip) with 106 pfu of sucrose gradient purified 
RRV T48 without adjuvant. Mice were boosted ip with the same dose of 
virus at 21 days and again 14 days later. Blood was collected from the 
orbital plexus into heparinized capillary tubes (Monoject Scientific, St 
Louis MO, USA); plasma was separated by centrifugation and stored at 
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-20°. [Balb/c mice were used because the mAbs described by Vrati et al. 
(1988) were produced in this breed]. Other polyclonal antibodies were 
produced as ascitic fluid in outbred Walter and Elisa Hall Institute mice 
(Tikasingh et al., 1966). Polyclonal rabbit anti-RRV serum was a gift from 
Dr. I.D. Marshall. The immunoglobulin fraction was concentrated from 
this serum by ammonium sulphate precipitation. 
Monoclonal antibodies T1E7, TlOC9 and NB3C4 (Vrati et al.,1988) 
were used as high titre mouse ascitic fluid. 
2.2.5 Synthetic peptides and conjugation to carrier proteins 
Synthetic peptides were prepared by Dr. G. W. Tregear, Howard 
Florey Institute, University of Melbourne, Parkville, Victoria. The 
sequence and position of the peptides in the primary amino acid sequence 
of RRV E2 is shown in Fig. 2.1. Peptides 1, 2 and 4 were conjugated 
through their terminal cysteine residues to bovine serum albumin (BSA; 
Sigma, St Louis, MO, USA) or keyhole limpet haemocyanin (KLH; Sigma) 
using the heterobifunctional linker m-maleimidobenzoyl-N-
hydroxysuccinimide (MBS; Boehringer Mannheim, West Germany) (Liu et 
al.,1979; Green et al., 1982). 4mg KLH or BSA in 0.25ml lOmM phosphate 
buffer (pH 7.0) was reacted with 0. 7mg MBS (dissolved in dimethyl 
formamide, 24.8mg/ml) and stirred for 30 min at 37°. The reaction mixture 
was passed down a Sephadex G-25 column equilibrated with 50mM 
phosphate buffer (pH 6.0) to remove free MBS. The KLH-MB or BSA-MB 
was then incubated with 5mg of peptide in phosphate buffered saline (PBS, 
pH 7.2) at room temperature and the pH adjusted to 7.0-7.5 with lM KOH. 
The mixture was stirred at room temperature for three hours, divided into 
aliquots and stored at -20°. 
Peptides 1, 2 and 3 were also coupled (through free amino residues ) 
to KLH or BSA using glutaraldehyde (Reichlin, 1980). Peptide (1mg) in 10-
Figure 2.1 
Location of synthetic peptides and neutralization epitopes on glycoprotein 
E2ofRRVT48 
Peptide 1 Peptide 2 Peptide 3 
209 220 225 237 244 253 
GT ~STDKTINTCKIDQC HAAVTSHDKWOFTSPFVPRADO~ARRGK 
hl 
Peptide 4 
The amino acid sequence of the E2 glycoprotein of RRV T48 from residue 
209 to 253 is shown. Residues are numbered from the N-terminus of E 2 
(Dalgarno et al., 1983). Synthetic peptide sequences are underlined. Amino 
acids defining neutralization epitopes fL. bl and b2 (Vrati et al.,1988 ) are in 
bold type. 
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20µ1 PBS (pH 7.2) was mixed with 5mg of KLR or 7mg of BSA in 1ml of 
PBS. Glutaraldehyde (21mM) in PBS (0.5 ml) was added dropwise over 30-
40 min with constant mixing and the reaction allowed to proceed at room 
temperature overnight, before dialysing against PBS. The conjugate was 
divided into aliquots and stored at -20°. For estimating immunizing doses 
the efficiency of conjugation was assumed to be approximately 20% for 
each method (Green et al., 1982). 
2.2.6 Immunization and priming of mice with peptide-KI.JI conjugates 
Groups of 5-6 outbred Swiss white mice were injected ip with 10-50µg 
of peptide-KLH, diluted in PBS (pH 7.2), mixed with an equal volume of 
Freund's incomplete adjuvant (FIA; Difeo Laboratories, Detroit, Michigan) 
in a final volume of 100 µI. Mice were bled before and, at seven day 
intervals, after immunization. Boosting was with the same dose of peptide-
KLH in FIA 28 days after the primary immunization and again at 14 to 21 
day intervals to a maximum of four boosts. Titres did not increase after the 
second boost. To examine the necessity for conjugation, one group was 
immunized with free peptide 4 (lOµg/mouse; in PBS, 1:1 with FIA in a total 
volume of 100 µl). For convenience each group of mice was allocated an 
alphabetical code letter. The groups of mice, immunogen and method of 
coupling to KLH are summarized in Table 2.1. 
To assay for priming by peptides (see results), mice in groups B and 
E were divided into two sub-groups 28 days after the primary 
immunization; one sub-group was boosted with the appropriate peptide-
KLH conjugate and the other with the equivalent of 106 pfu of UV-
inactivated RRV T48. Mice in groups H and J were treated in the same 
fashion but after hyperimmunization (three boosts). Control mice (no 
previous immunization) were injected with the equivalent of either 106 or 
107 pfu of UV-inactivated RRV T48. Sera from boosted or control mice were 
Table 2.1 
Immunization of mice with synthetic peptides* 
Group No. of mice Immunogen Coupling agent 
B 5 Peptide 1-KLH 1VIBS 
C 6 Peptide 1-KLH Glutaraldehyde 
D 6 Peptide 2-KLH Glutaraldehyde 
E 6 Peptide 3-KLH Glutaraldehyde 
H 6 Peptide 2-KLH 1VIBS 
J 6 Peptide 4-KLH 1VIBS 
K 6 Peptide 4 
*For immunization 10-50µg of peptide or peptide-KLH was injected into 
mice 8-12 weeks old. The peptide or peptide-KLH was diluted in PBS and 
mixed with an equal volume of FIA to give a final injection volume of 100µ1. 
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collected five, seven or ten days after injection and examined for RRV 
binding in ELISA and neutralization assays. 
2.2.7 Enzyme linked immunosorbent assays (ELISA) 
Direct ELISA. Antigen (purified RRV, conjugated or free peptide, 
BSA or KLH) was adsorbed to round-bottomed, 96-well, polyvinylchloride 
(PVC) microtitre trays (Titertek, Flow Laboratories) by adding 25µ1 of an 
appropriate dilution to each well, incubating at 37° for 2 hours and leaving 
at 4 ° overnight. All dilutions were in PBS (pH 7 .2). Trays were washed with 
5% skim milk powder in PBS (milk/PBS) to remove unadsorbed antigen 
and to block the wells. Antiserum diluted in 5% milk/PBS was added and 
incubated for two hours at 37°. Wells were washed with Tween 20 (0.02% in 
PBS; Sigma) and 25µ1 of goat anti-mouse immunoglobulin conjugated to 
horse radish peroxidase (1:600 in milk/PBS; Bio-Rad, Richmond, CA, USA) 
was added. Incubation was for 30 min at 37°; the wells were washed with 
Tween 20 as above and 100µ1 of ABTS (2,2-Azino bis 3-ethylbenzthiazoline 
sulphonate; Boehringer Mannheim) lmg/ml in O.lM citrate phosphate 
buffer (pH 4.0), hydrogen peroxide (0.006%) was added to each well. Trays 
were incubated for 15 min at room temperature; OD (410nm) was 
determined with a Dynatech MicroELISA II automated plate reader. 
Capture ELISA. Rabbit anti-RRV immunoglobulin (1:2000 in PBS) 
was adsorbed to PVC microtitre trays (50µ1/well). After washing and 
blocking with milk/PBS, purified RRV T48 was added (50µ1/well) and the 
trays incubated at 37° for two hours. Wells were washed with milk/PBS 
and antiserum (50µ1 per well) added. After two hours incubation, antibody 
binding was determined as described for the direct ELISA. The assay was 
standardized such that polyclonal antiserum to RRV had the same titre in 
the capture ELISA as in the direct ELISA. Monoclonal antibodies T10C9, 
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T1E7 and NB3C4 also bound to RRV with similar or slightly higher titres 
in the capture ELISA compared to the direct assay. 
2.2.8 Competi ti.on binding as.says 
An approximately 105-fold molar excess of peptide was incubated (60 
min, 37°) with a concentration of mAb chosen to be within the linear region 
of the antibody-virus binding curve in ELISA. Controls consisted of the 
same amount of mAb incubated with either PBS or purified virus. The 
peptide-mAb mixture or the controls were assayed in an ELISA for binding 
to RRV as measured by the OD (410nm); assays were in quadruplicate. 
Inhibition of binding was estimated by the OD obtained with mAb plus 
peptide compared with the OD obtained with mAb plus PBS. 
2.2.9 Plaque reduction neutralization assays (PRNA) 
Approximately 100-200 pfu of virus (120µ1 in HESS, pH 7 .2) was 
incubated (60 min, 37°) with 120 µl of monoclonal or polyclonal antibodies 
diluted in HESS, or with anti-peptide sera and assayed, in duplicate, for 
infectivity by plaque formation on Vero cell monolayers. Percent plaque 
reduction was calculated relative to virus controls incubated with normal 
mouse serum or ascitic fluid. Antibody titres were expressed as the 
reciprocal of the dilution producing a fifty percent reduction in plaque 
numbers. This dilution was estimated by interpolation. 
2.2.10 Immunoprecipitation of RRV by anti-peptide sera 
[5-3H]-uridine-labelled RRV T48, (-3000 cpm in 20µ1 PBS, 
representing -450ng of viral protein, estimated by Bio-Rad protein assay), 
prepared as described in 2.2.3, was mixed with an equal volume of mouse 
antiserum or normal mouse serum and incubated at 37° for 60 min. 50µ1 of 
a 10% (w/v) suspension of washed, formalin-fixed Staphylococcus aureus 
cells (Calbiochem, La Jolla, CA, USA.) was added and the mixture 
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incubated (37°, 60 min) with frequent m1x1ng. Cells were pelleted by 
centrifugation, washed and resuspended tvvice before precipitation with 
5% trichloracetic acid (TCA) on 20mm glassfibre discs. Radioactivity was 
determined in a Beckman liquid scintillation counter. vVashing and 
resuspension were in TNA (NaCl, 0.2M, Tris pH 7.5, 0.05M, EDTA, lmM, 
0.1 %BSA, 0.5% Triton-X 100). 
Titration with polyclonal anti-RRV in the immunoprecipitation 
assay indicated that this system was of relatively low sensitivity compared 
to the ELISA, where the same antiserum had a ten fold higher titre (data 
not shown), although the antigen was the same for both. This low 
sensitivity was probably due to the low specific activity of the labelled 
virus:-1 cpm / 1000 pfu. 
2.3 Results 
2.3.1 Neutralization of RRV variants by anti-RRV T48-sera 
It has been postulated that epitopes a, b 1 and b.2. form part of a major 
neutralization domain on RRV E2 (Vrati et al.,1988). To analyse the 
contribution of these epitopes to neutralization in a polyclonal immune 
response, antiserum was prepared against RRV T48 in five Balb/c mice 
(Methods; 2.2.4). Using PRNAs, sera were titrated against the following 
mAb resistant RRV T48 variants: Tvl (epitope b2), Tv42 (epitope a), Tv61 
(epitope b 1), and Tv161 (epitopes a, b 1 and b2) and against RRV NB5092. 
NB5092 has five amino acid differences from T48 in E2 (Faragher et al., 
1988); one of these, at position 251, is within epitope b2 and is probably 
responsible for the difference in neutralization of these two strains by mAb 
T1E7 (Vrati et al.,1988). 
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RRV variants with amino acid changes in single epitopes (ie Tv l, 
Tv42, Tv61 and NB5092) could not be differentiated from T48 1n 
neutralization assays (Table 2.2). However, a consistent difference 1n 
neutralization titre was obtained between T48 and Tv161 using sera 
collected from mice after the second boost, with differences in the 50% 
neutralization point of 3 to 8 fold (Fig 2.2). These assays were repeated four 
times with similar results. Similar differences were obtained with sera 
from the same mice following a third boost and titration of this serum from 
mouse 3 is shown in Fig 2.2. Sera collected at days seven and fourteen after 
the primary immunization showed no differences in neutralization titre 
between RRV T48 and Tv161 in PRNA using two-fold dilutions across a 
range of 90% to less than 20% neutralization (data not shown). Sera from 
the five mice titrated independently gave similar results. 
2.3.2 Studies with synthetic peptides 
It appeared from the results above that the region defined by epitopes 
a, b 1 and b2 is significant in neutralization and could be a potential 
candidate for a synthetic vaccine. As the three dimensional structure of E2 
has not been determined, the structure of the epitopes and the surrounding 
regions is undefined. If there were epitopes with significant continuous 
structure in this area they might be mimicked by synthetic peptides. To 
investigate the antigenicity and immunogenicity of this region, four 
peptides representing the primary amino acid sequences around epi tapes 
a, b 1 and b2 (Fig 2.1) were synthesized, coupled to KLH and used to 
immunize groups of mice (Table 2.1). 
Table 2.2 
Neutralization of RRV mAb escape variants and RRV NB5092 by 
polyclonal antisera to RRVT481 
RRVstrain 
T48 
Tvl 
Tv42 
Tv61 
NB5092 
1 
3.1 
3.0 
3.2 
3.3 
3.1 
Mouse number 
2 
3.9 
3.7 
3.7 
3.8 
3.9 
3 
4.1 
3.9 
4.0 
3.9 
4.0 
4 
3.1 
3.3 
3.1 
3.0 
3.0 
5 
3.6 
3.5 
3.4 
3.5 
3.5 
lThe neutralization titre, for each virus with serum from each mouse, is 
shown as the reciprocal of the log10 dilution of antiserum causing 50% 
neutralization of virus plaque formation. Two-fold dilutions of antisera 
were used and the 50% endpoints were estimated by interpolation. Assays 
for all five viruses were perf armed in parallel. 
Figure 2.2 
Neutralization ofRRVT48 and Tv161 by polyclonal anti-T48-sera 
Neutralization of RRV T48 and Tv161 was measured by PRNA using 
polyclonal antisera raised against RRV T48. Sera raised in five Balb/c mice 
,vere t itrated independently. Approximately 220 pfu of each virus were 
incubated with each dilution of serum for 60 min at 36°. Controls were 
incubated with 1:400 normal serum. Duplicate 100µ1 aliquots of each 
incubation were plaque assayed on Vero cell monolayers and the 
percentage neutralization at each dilution calculated as the reduction in 
mean plaque numbers compared to the controls. 
The percent neutralization of T48 (solid line) and Tv161 (broken line) 
by serum collected from each mouse seven days after the second boost are 
shown for serum dilutions between 1:400 and 1:6400 (panels A-E). Panel F 
shows the titration of serum from mouse 3 collected seven days after the 
third boost. 
A mouse 1 
B mouse 2 
C mouse 3 
D mouse 4 
E mouse 5 
F mouse 3, third boost 
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2.3.3 Direct ELISA titrations of sera from mice immunized with synthetic 
peptides 
In preliminary studies, sera from each mouse were screened in a 
direct ELISA for antibodies reacting with RRV or with the immunizing 
peptide conjugated to BSA. Sera from all mice immunized with peptide-
KLH reacted with KLH but not with BSA. By 14 days after immunization, 
most mice had produced antibodies which reacted with the immunizing 
peptide (data not shown). Reactivity with RRV was not detected at 14 days 
but, with some sera, was present at 21 to 28 days after immunization. One 
group of mice (K) were immunized with unconjugated peptide 4; no 
antibodies to RRV were detected in these mice (data not shown). 
Development of peptide antibodies that reacted with RRV depended on the 
method of conjugation of the peptide to KLH. Peptides 1 and 2 did not 
produce antibodies against RRV when conjugated using glutaraldehyde 
although antibodies that reacted with the appropriate peptide-BSA 
conjugate were produced. These anti-peptide antibodies did not react in an 
ELISA with the same peptide conjugated using MBS. Peptides 1 and 2 
contain internal lysines which may produce conformational constraints on 
the peptide due to the E amino group of the lysine binding to KLH through 
glutaraldehyde. For this reason peptide 4 was not conjugated using 
glutaraldehyde. 
To quantify the above observations for individual mice, anti-peptide 
sera which reacted with RRV were titrated, in a direct ELISA, against the 
appropriate peptide-BSA complex and against RRV. Representative sera 
from mice immunized with peptides 1-3 coupled to KLH were also titrated 
against the appropriate unconjugated peptide (Table 2.3). Mice in groups 
B, E, H and J immunized with peptides 1, 2, 3 and 4 respectively, produced 
antibodies which bound to RRV. The titres varied between mice within a 
group. The lowest antibody titres were obtained with peptide 3, while 
Table 2.3 
lSera were tested in ELISA for RRV and peptide binding. In these 
assays the end point was taken as being 0.1 OD units above the controls. 
Shown are maximum titres (irrespective of the time of harvest), measured 
as the reciprocal of the end point dilution, in a direct ELISA using the 
indicated antigens. Data is only shown for those groups of mice which 
produced antibodies which reacted with RRV 
ND not determined. 
* binding below this dilution was not examined. 
t number indicates the identity of the mouse within the group. 
Table 2.3 
ELISA titres of sera from mice immunized with synthetic peptides 1 
ET,TSA titre against indicated antigen 
Group Immunogen Mouse no.t RRV Peptide-BSA Peptide 
B PEP 1-KLH 1 20480 64000 ND 
4 2560 64000 4000 
5 5120 32000 ND 
H PEP 2-KLH 1 1280 64000 ND 
2 640 64000 ND 
3 <10 64000 ND 
4 >1280 64000 16000 
5 320 64000 ND 
6 160 64000 ND 
E PEP 3-KLH 4 640 8000 <500* 
5 40 ND ND 
6 80 32000 ND 
J PEP 4-KLH 1 2560 ND ND 
2 2560 ND ND 
3 >2560 ND ND 
4 2560 ND ND 
5 2560 ND ND 
6 >2560 ND ND 
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peptide 4 produced the most consistent response. When unconjugated 
peptides were used as antigen in the ELISA, titres were 4-16 fold lower 
than those with peptide-BSA (Table 2.3). 
2.3.4 Amino acid sequence specificity of anti-peptide sera 
To determine the specificity of E2 sequence recognition of the anti-
peptide sera, representative sera from mice immunized with peptides 1, 2 
or 3 coupled to KLH, were titrated against RRV T48 and against variants 
Tvl, Tv42 and Tv61 in a direct ELISA (Table 2.4). Anti-peptide 1 serum had 
the same reactivity towards T48, Tvl and Tv61 but had a greater than four 
fold reduction in titre against Tv42 which has an amino acid alteration in 
the peptide 1 sequence (Thr216~I1e). Antiserum to peptide 2 reacted with 
T48, Tvl and Tv42 but did not bind to Tv61 which has a change in the 
peptide 2 sequence (Lys234~Gln). Peptide 3 antiserum reacted with T48, 
Tv42 and Tv61 but not with Tvl which has an alteration in the peptide 3 
sequence (Asp246~Asn). These results demonstrate the sequence 
specificity of the binding of the anti-peptide sera to the region of RRV E2 
represented by the immunizing peptide; it is also clear that this region 
must be exposed under the conditions of the assay. 
2.3.5 Examination of anti-peptide sera for neutralizing activity 
To determine whether antibodies against the synthetic peptides 
neutralized RRV, the sera were tested in PRNA. No neutralizing activity 
was demonstrated at dilutions as low as 1:2 with sera collected from 
primary immunizations or after multiple boosts. The addition of 
complement had no effect (data not shown). 
Table 2.4 
The specific binding of anti-peptide antibodies to RRV T48 and the variants 
Tvl, Tv42 and Tv61 in a direct ELISAl 
Antisera T48 
Peptide 1 >1280 
Peptide 2 >1280 
Peptide 3 160 
Virus 
Tvl 
>1280 
>1280 
<20 
Tv42 
320 
>1280 
320 
Tv61 
>1280 
<20 
320 
lSera from mice immunized with peptides 1, 2 or 3 coupled to KLH and 
which reacted with RRV T48 in a direct ELISA were tested for binding to 
Tvl, Tv42 and Tv61 in a direct ELISA. Twofold serum dilution intervals 
were used; titres are the reciprocal of the end point dilutions, where the 
end point was taken as being 0.1 OD units above the controls. 
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2.3.6 Mice immunized with synthetic peptides were not primed to respond 
to a sub-immunogenic dose of RRV 
Work with poliovirus (Emini et al.,1983 ) and cholera toxin (Jacob et 
al.,1986) has shown that synthetic peptides which fail to induce 
neutralizing antibodies can prime animals for a neutralizing response 
when the immunized animal is exposed to an otherwise sub-immunogenic 
dose of virus or toxin. To examine whether mice immunized with RRV 
peptides were primed for an immune response to RRV, two mice 
immunized with peptide 1-KLH (from group B) and three immunized with 
peptide 3-KLH (from group E) (Table 2.1) were injected, 28 days after 
primary peptide immunization, with the equivalent of 106 pfu of UV-
inactivated RRV T48. The remaining three mice in each group were 
boosted with peptide-KLH. Unprimed control mice were injected with the 
equivalent of 106 or 107 pfu of UV-inactivated RRV. All mice were bled five 
and ten days after injection. No neutralizing activity was detected in mice 
boosted either with peptides or inactivated virus nor in control mice 
injected with 106 pfu of inactivated RRV. Mice in group B boosted with 
peptide had a 4-32 fold rise in ELISA titre against RRV; the two mice 
boosted with inactivated RRV gave no rise in titre. Control mice injected 
with 107 pfu of inactivated RRV produced antibodies which reacted with 
RRV in an ELISA; these were not tested for neutralization. Mice were also 
tested for priming by injection of the equivalent of 106 pfu of inactivated 
RRV after multiple immunizations with peptides 2 or 4. None of the sera 
tested neutralized RRV at a 1:2 serum dilution (data not shown). It was 
concluded that mice immunized with peptides 1,2, 3 or 4 were not primed 
to produce a neutralizing response to small doses of inactivated RRV. 
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2.3.7 Tmmunoprecipitation of RRV 
Because antibodies from mice immunized with peptides 1-4 bound to 
RRV in an ELISA but did not neutralize the virus the following question 
arises: does RRV adsorbed to a PVC solid phase bind antibodies differently 
to free virus? To examine the binding of anti-peptide antibodies to RRV in 
solution, sera from mice immunized with peptides 1, 2, 3 or 4, conjugated 
to KLH, were tested for their ability to bind 3H-uridine labelled RRV in an 
immunoprecipitation assay (Methods; 2.2.10). Only 3% of virus was 
precipitated in the presence of anti-sera against peptide 1, 2 or 3, the same 
as with normal serum. Anti-peptide 4 sera precipitated an average of 25% 
of virus. Polyclonal anti-serum against RRV T48 precipitated 88% of virus 
(data not shown). Thus only anti-peptide 4 serum was able to bind 
significantly to free RRV. 
2.3.8 Binding assays of anti-peptide sera in capture ELISA 
Direct adsorption of viruses to PVC in an ELISA creates the 
potential for partial denaturation of viral proteins and the exposure of 
cryptic epitopes (McCullough et al.,1985; Olmsted et al.,1986). To determine 
whether cryptic epitopes recognized by anti-peptide sera were exposed 
when RRV was bound directly to the ELISA trays, a capture ELISA was 
developed (Methods; 2.2. 7). This assay avoided direct adsorption of RRV to 
a plastic surface by coating the wells with rabbit anti-RRV antibodies. 
Added virus was then bound by these antibodies, and mouse anti-peptide or 
anti-RRV sera were assayed for binding to the "captured" virus. 
Anti-peptide sera to peptides 1, 2, 3 or 4 which reacted ,vith RRV in a 
direct ELISA, were assayed for binding to RRV in a capture ELISA; no 
sera bound to RRV at dilutions down to 1:10 (data not shown). This assay 
was repeated several times with the same result. Control anti-RRV 
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polyclonal and monoclonal antibodies bound to RRV with similar titres in 
the capture assay and in the direct assay. It was concluded that the 
adsorption of RRV to a plastic surface distorted E2 and exposed epitopes 
specifically recognized by antibodies raised to peptides from the 
corresponding regions. 
2.3.9 Testing the antigenicity of synthetic peptides 
In addition to being potential immunogens, synthetic peptides have 
been used to define continuous antigenic sites on proteins by their ability to 
bind monoclonal and polyclonal antibodies raised against the intact protein 
(reviewed by Van Regenmortel, 1989). To examine whether antibodies 
raised against RRV could bind to the synthetic peptides, mAbs TlOC9, 
NB3C4 and T1E7 and polyclonal antiserum were assayed, in an ELISA, for 
binding ~o unconjugated peptides 1, 2 and 4 or to peptides 1, 2 and 3 coupled 
to KLH or BSA. None of the antisera bound to KLH or BSA; rnAb T1E7 did 
bind to peptide 3-KLH at high antibody concentrations but only marginally 
above the background binding to the KLH-glutaraldehyde control. There 
was no significant binding of the other antibodies to any of the peptides or 
peptide conjugates tested (data not shown). 
2.3.10 Competition binding assays 
Peptides bound to a solid phase as in the ELISA may not be able to 
adopt an appropriate conformation for antibody recognition (Van 
Regenmortel, 1989). To examine whether antibodies to RRV bound peptides 
in solution, the binding of peptides 1, 2, 3 and 4 to mAbs T10C9, NB3C4 and 
T1E7 was tested in competition binding experiments (Methods; 2.2.8). A 
large excess of peptide was incubated with a low concentration of mAb, 
chosen to be in the linear region of the mAb/RRV binding curve in an 
ELISA, so that changes in free antibody concentration should be readily 
apparent. Samples were assayed for binding to RRV in an ELISA. There 
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was no inhibition of binding to RRV of any of the mAbs with any of the 
peptides. However, whole virus inhibited 90% of T1E7 and NB3C4 binding 
and 70-80% of T10C9 binding in this assay system. 
2.4 Discussion 
2.4.1 Characterization of a major neutralization domain of RRV 
Neutralization assays using polyclonal antisera to RRV T48 suggest 
that a significant proportion of the neutralizing antibodies produced in 
hyperimmune mice are directed to the region on E2 defined by epitopes a, 
b 1 and b2. Hyperimmune sera from five individual mice showed a 3-8 fold 
decrease in 50% neutralization titre against the triple epitope variant, 
Tv161, compared to T48 indicating that the altered site was poorly 
recognized by a proportion of the neutralizing antibodies. Variants 
changed at single amino acids showed no difference in neutralization 
titres compared to RRV T48. Thus no single epitope is immunodominant 
but the sum of these determinants comprises a detectable neutralization 
domain. 
RRV NB5092 has five amino acid changes from T48 in E2 and three 
in El (Faragher et al.,1988). As previously reported (Gard et al.,1913 ) and 
confirmed here, it is neutralized to the same extent as RRV T48 by 
polyclonal anti-T48-sera. Only one of the amino acid differences in E2 
(residue 251 in epitope b2) is within an established neutralization epitope. 
This may be responsible for the resistance of this isolate to mAb T1E7 
(Vrati et al.,1988). 
Similar results have been found with SIN. Variants selected 
sequentially for resistance to three mAbs, two with epitopes on E2 and one 
which binds to El were neutralized less efficiently by polyclonal serum 
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raised against the parental virus (Stec et al.,1986). When a variant of SIN 
selected for rapid growth in BHK cells was compared with the parental 
virus in polyclonal neutralization tests, both viruses were neutralized 
equally well by antiserum to the parental virus, however, the parental 
strain was only marginally neutralized by antiserum against the variant 
(Barie et al.,1981). This variant has a single amino acid change 
(Serll4--,Arg) in E2 which may cause a significant conformational change 
in the surface of E2 (Davis et al.,1986). 
In viruses other than alphaviruses an amino acid change in a 
single epitope can significantly alter the reactivity of the virus with 
polyclonal antibodies. This may vary in the course of the immune response 
and be dependent on the species and the individual animal in which the 
antiserum is raised. For example, six out of ten mAb selected variants of 
influenza B virus were significantly different from the parent virus using 
primary ferret antisera, with differences in titre of 4-16 fold (Webster and 
Berton, 1981). When the comparison was made using goat hyperimmune 
serum only three of the variants had four fold differences in titre and one 
had a two-fold difference from the parent virus. On the other hand most 
mAb resistant variants of influenza A virus could not be distinguished 
from the parental virus using polyclonal antisera (Laver et al.,1979; 
Webster and Laver, 1980; Gerhard and Webster, 1978). Monoclonal 
antibody resistant variants of vesicular stomatitis virus altered at single 
epitopes (A or B) could be distinguished from the parent virus using 
hyperimmune serum with differences of 3-9 fold in titre (Lefrancois and 
Lyles, 1983). When primary sera were used, larger differences (30-70 fold) 
were observed between the epitope A variants and the wild-type. However, 
the epitope B variant could not be differentiated from the wild-type. A mAb 
resistant variant of a human rotavirus had a greater than ten fold increase 
in resistance to polyclonal hyperimmune serum compared with the parent 
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virus (Dyall-Smith et al.,1986). Because hyperimmune serum would be 
expected to contain neutralizing antibodies to rriany different determinants 
it was postulated that a single amino acid change (leading to a new 
potential glycosylation site) altered an immunodominant antigenic site. 
Significant changes in neutralization due to alterations at a single 
epitope could be important in vaccine production where a vaccine might be 
rendered ineffective by a single amino acid change in a critical antigenic 
determinant. Two diverged isolates of RRV, T48 and NB5092, appear not to 
have changed substantially in neutralization epitopes, furthermore single 
epitope variants of T48 were not detectably different from the parent virus 
in neutralization by primary or hyperimmune sera. This suggests that a 
vaccine for RRV would give wide protection, covering existing and evolving 
strains of the virus. 
Epitopes a, bl and b2 are defined by amino acids 216(a), 232 and 
234(b 1) and 246, 248 and 25 l(b2) on RRV E2. Thus these epitopes are very 
close together in the primary polypeptide sequence. Although the three 
dimensional structure of E2 has not been resolved, several interesting 
features of this region can be defined from the primary amino acid 
sequence (Dalgarno et al.,1983). It is bounded by glycosylation sites at 
amino acids 200 and 261; it is an extremely hydrophilic region with 
hydrophilic spikes at epitopes b 1 and b2 and there are four cysteine 
residues, strongly conserved between alphaviruses. These could be 
involved in disulphide bonds and determine protein folding and stability. 
The hydrophilicity plus the presence of the glycosylation sites indicate that 
this region is likely to be on the surface of the E2 protein, as would be 
anticipated from the presence of the mAb epitopes. Sites outside this region 
of the primary sequence are also involved in neutralization of RRV; a 
deletion at amino acids 55-61 (Vrati et al.,1986) affects epitope bl, 
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suggesting that these regions of the primary polypep tide may fold into 
apposition in the tertiary structure. 
2.4.2 Synthetic peptides as immunogens and antigens 
Linear regions of E2 containing neutralization epitopes could 
potentially form the basis of synthetic peptide vaccines for RRV. This was 
investigated for epitopes a, b 1 and b2 using four synthetic peptides covering 
most of the amino acid sequence from residues 209 to 253 of E2. Peptides 
coupled to KLH were strongly immunogenic in mice and anti-peptide sera 
specifically recognized RRV in a direct ELISA. However, anti-peptide 
antibodies did not neutralize RRV nor did they bind to RRV in a capture 
ELISA. 
It appears that the reactivity of the anti-peptide antibodies with RRV 
was dependent on partial denaturation of the virus when it was bound to a 
plastic surface. Thus anti-peptide sera did not neutralize RRV nor did they 
bind to the virus in a capture ELISA. In immunoprecipitation experiments 
antibodies to peptide four (the longest of the peptides) precipitated 25% of 
added virus but antisera to the other three peptides did not precipitate 
RRV. As there was no binding in the capture ELISA, it is possible that 
partial denaturation of a proportion of the virus had occurred during viral 
purification, leading to recognition by anti-peptide four serum; this 
denatured virus may not have been bound in the capture ELISA. 
Denaturation of viral antigen on binding to a solid phase has been 
described for SIN and foot-and-mouth disease virus (FMDV) (Olmsted et 
al.,1986; McCullough et al.,1985). 
Monoclonal or polyclonal antisera to RRV did not bind to either free 
or conjugated peptide. This indicated that either the peptides did not 
contain enough amino acids involved in antibody binding or that the 
peptides were unable to present these residues in an appropriate 
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conformation. It was concluded that the peptides examined did not mimic 
significant portions of antigenic sites. This, together with the failure of 
anti-peptide sera to bind to native RRV, suggests that the neutralization 
epitopes in the region of E2 between amino acids 209 and 253 are 
discontinuous with secondary or tertiary folding of the primary polypeptide 
sequence bringing critical amino acids together. 
The complexity of predicting whether peptides can mimic antigenic 
sites can be seen by considering the examples of influenza virus and 
FMDV. For FMDV, antibodies raised to peptides representing a prominent 
antigenic loop at amino acids 133 to 158 of VPl neutralize the virus and 
protect animals from challenge (Bittle et al.,1982; DiMarchi et al.,1986). 
Acharya et al. (1989) reported the crystallographic structure of FMDV and 
suggested that the success of this region in producing peptide 
immunogens probably relates to an unusual combination of marked 
protrusion of the loop and very limited structural constraints for antibody 
recognition. On the other hand, for influenza virus, antigenic site A is 
formed by a prominent loop in the region of 140 to 146 of the three 
dimensional structure of the haemagglutinin molecule (Wiley et al.,1981). 
Although this is a target for neutralizing antibodies and undergoes 
antigenic drift (Air and Laver, 1986), peptides corresponding to this region 
have not produced antibodies that react with native virus CJ ackson et 
al.,1982; Shapira et al.,1984; Nestorowicz et al.,1985). It appears that 
peptides are unable to form the correct conformation for antibody 
recognition of the intact loop (Shapira et al ,.1984). 
These examples demonstrate that predicting regions of a protein 
which can be used as synthetic immunogens is difficult even with a three 
dimensional structural model. Thus it is speculative to attempt to predict 
the structure of the RRV E2 neutralization epitopes between amino acids 
209 and 253 based on the failure of peptides to raise antibodies that reacted 
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with native RRV. As discussed above, it seems likely that the antigenic 
sites in this region are largely discontinuous but this does not exclude the 
possibility of antigenic loops formed by stretches of continuous sequence 
which are conformationally constrained and not mimicked by peptides. 
Chapter3 
Examination of early events in cell entry of RRV using penetration and 
binding assays and the selection of further variants of RRV resistant to 
mAbT1E7 
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3.1 Introduction 
Although alphaviruses are rapidly becoming understood at the 
genome level, the molecular nature of early events in alphavirus-cell 
interactions is poorly understood (see Chapter 1). Productive receptor 
molecules on the cell surface have not been identified and binding sites on 
the virion for such receptors have not been defined. The alphavirus surface 
proteins El and E2 must mediate cell attachment and entry. By defining 
sites involved in attachment and penetration on these proteins, it may be 
possible to develop a better understanding of cell surface receptors and 
their role in virus infection in vitro. This may identify virus determinants 
of tissue tropism and pathogenesis in vivo. 
Because antibodies may neutralize alphaviruses by blocking 
attachment to cells (Roehrig et al.,1988; see Chapter 1) it is possible that 
some neutralization determinants on virus proteins are involved in 
receptor recognition or are close to receptor binding sites. Earlier studies 
with RRV had indicated that two m.Ab T1E7 escape mutants of RRV T48 
had increased penetration rates in BHK cells compared to the parent virus 
(Vrati, 1986). The variants examined had amino acid changes in epitope b2 
(Tvl, Asp246~Asn, and Tv3, Thr248~Pro). The triple variant Tv161 with 
changes at epitopes a, bl and b2 (Thr216~Ile; Lys234~Asn; Asp246~Asn) 
also penetrated faster in BHK cells than T48 (Vrati, 1986). The penetration 
rates of m.Ab escape mutants changed solely at epitopes a or b 1 has not 
been examined. 
The penetration assay used by Vrati (1986) was from Barie et al. 
(1981). This assay measures the percent of virus able to initiate productive 
infection at 36°, as judged by plaque formation, after the addition of 
polyclonal antiserum at various times. Virus which has "penetrated" is 
resistant to neutralization and so forms plaques. Thus the percentage of 
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virus which has penetrated at a given time after the inoculum was added 
to the cell monolayers can be calculated by comparison with controls to 
which no antiserum was added (see Methods). Virus is presumably 
susceptible to neutralization by added antibody until it is actually 
internalized (see Chapter 1). Therefore the penetration assay does not 
differentiate between faster attachment leading to faster entry and 
acceleration of post-attachment events such as receptor recruitment, 
translocation to coated pits and endocytosis which could also result in 
faster entry. The penetration assay differs from cell binding assays in that 
it measures productive infection and uses very small amounts of virus, 
approximately 100 pfu. 
In addition to increased rates of penetration, variants of T48 altered 
in epitope b2 were reported to have retarded growth, RNA synthesis and 
protein synthesis in BHK cells compared to T48 and epitope ~ orb 1 variants 
(Vrati, 1986). This suggested that a single amino acid change in E2 might 
be affecting not only penetration of RRV but might also be slowing 
uncoating and release of the viral genome from the endosome into the 
cytoplasm. 
This chapter describes attempts to test the hypothesis that changes 
in epitope b2 increase the penetration rate of RRV in tissue culture and to 
assess whether changes in the a and bl epitopes, at residues 216 and 232-
234 of E2, affect penetration. To define the extent of possible amino acid 
changes in the b2. epitope seven further T1E7 resistant variants were 
selected and the E2 gene sequenced in the region of the b2 epitope. By 
examining the penetration characteristics of a series of natural isolates 
and laboratory variants of RRV the role of epitope b2 in fast penetration 
was further defined. In preliminary experiments the binding of RRV T48 
to cultured cells was also examined using radiolabelled virus. 
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3.2 Materials and Methods 
3.2.1 Virus stocks 
The stocks of T48 and NB5092, have been described in Chapter 2. 
NB0/10/7 is a mouse passage derived variant of NB5092 with only 
(Lys25l~Asn) amino acid alteration in E2 and no changes in El (Meek et 
al.,1989). RRV dE2 is a variant of RRV T48 with a deletion from amino acid 
55 to 61 in E2 (Dalgarno et al.,1983; Vrati et al.,1986) 
Laboratory selected mAb resistant variants of T48 (Vrati et al., 1988) 
were described in part in Chapter 2. For clarity those mAb variants used 
in this chapter are described in Table 3.1. Geographic isolates of RRV used 
in penetration assays are described in Table 3.2. 
Virus stocks were prepared as described in Chapter 2. To prepare 
independent clones of T48 for mAb T1E7 selection, plaques were picked 
from BHK cell monolayers and amplified in BHK cells to produce working 
stocks. Titration was on Vero and BHK monolayers as in Chapter 2. 
3.2.2 Cell culture 
The growth of Vero and BHK cells is described in Chapter 2. 
Mosquito cells (Aedes albopictus, C6/36) cells were grown in Eagle's basal 
medium (EBM) supplemented with 10% FCS, at 28°, 5% CO2. 
3.2.3 Plaque assays 
Plaque assays were as described in Chapter 2 
3.2.4 Plaque Reduction Neutralization Assays (PRNA) 
These assays were as described in Chapter 2. 
Table 3.1 
Laboratory selected mAb resistant variants of RRV T48 used in this 
chapterl 
Virus Selecting mAb Amino acid change 
and epitope2 
Tvl T1E7 Asp246~Asn (b2) 
Tv2 T1E7 Arg251~Ser (b2) 
Tv5 T1E7 Asp246~Val (b2) 
Tv42 TlOC9 Thr216~I1e (a) 
Tv61 NB3C4 Lys234~Gln (bl) 
Tv62 NB3C4 Lys234~Ile (bl) 
Tv63 NB3C4 Lys234~Asn (bl) 
Tv64 NB3C4 Lys234~Glu (bl) 
Tv161 TlOC9 Thr216~I1e (a) 
NB3C4 Lys234~Asn (b 1) 
T1E7 Asp246~Asn (b2) 
lData shown is from Vrati et al. (1988). 
2Amino acids are numbered from the N-terminus of the E2 glycoprotein of 
RRV T48; epitopes are shown in brackets. 
Table 3.2 
Geographic variants of RRV used in penetration assays 
Isolatel Area and year of Reference 
isolation 
PB629 Lake Poomah, Vic., Marshall et al. (1982) 
1974 
GG2227 Gol Gol, NSW, 1974 Marshall et al. (1982) 
BH38019 Barmah Forest, Vic., Dr. I.D. Marshall, 
1983 ( unpublished) 
F9073 Fiji, 1979 Aaskov et al. (1981) 
lAil isolates were obtained from Dr. I.D. Marshall (John Curtin School of 
Medical Research, Canberra, Australia). 
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3.2.5 Antiserum 
The production of high titre polyclonal antiserum and rnAb T1E7 
ascitic fluid is described in Chapter 2. Antiserum was incubated at 56° for 
20 min prior to use. 
3.2.6 Penetration assays 
The method used for penetration assays was that described by Barie 
et al.,(1981) as adapted by Vrati (1986). Penetration was taken to be the 
percentage of virus which had acquired resistance to neutralization by 
added polyclonal antibodies compared to controls to which no antibody was 
added. The basic method was as follows: cell monolayers (BHK or Vero) in 
60mm tissue culture dishes were washed twice with HBSS (pH 7.2) and 
inoculated with -100 pfu of virus in 300µ1 of HESS. Monolayers were 
incubated at 36°, with frequent rocking, for 10, 20, 40 or 60 min. At each 
time point the appropriate monolayers were removed from the incubator 
and the inoculum aspirated. Antiserum (0.5ml of 1/10 dilution of anti-RRV 
mouse ascitic fluid) was added and the monolayers incubated for a further 
10 min. Antiserum was aspirated, the monolayers washed twice with 
HBSS and overlaid with agar for plaque development. Control monolayers 
were incubated for 60 min, the inoculum was aspirated, the monolayers 
washed twice with HESS and overlaid. Monolayers were stained with 
neutral red 24-30 hours post-infection (pi). Assays were in triplicate and 
the mean at each time point was expressed as a percentage of the mean 
control value. For experiments at different pH values, HBSS was either 
prepared at pH 8.0 using HEPES buffer (Sigma, St Louis, MO, USA) or at 
pH 6.5 using PIPES buffer (Sigma). 
Statistical analysis of penetration assays was designed and 
performed by Mr. Ross Cunningham, Dept. of Statistics, The Faculties, 
Australian National University. It was assumed that the number of 
plaques had a Poisson distribution and that the means were related to time 
and virus in a multiplicative way. This led to a statistical model of the 
form: ln(expected number of plaques) = 00 +(effect due to time)+(time.virus 
interaction effect). This model is a special case of a powerful general class 
of statistical models known as "generalized linear models" (McCullagh 
and Neldes, 1990). Models of the above form were fitted to all sets of data 
analysed, the fits being extremely good. In all cases the interaction term 
was significant suggesting that the profiles differed between viruses. 
Expected values together with standard errors were obtained from 
the fitted models. These summary data were appropriately 
backtransformed and are presented graphically in the text together with 
the original data shown as percent penetration. 
3.2. 7 Kinetics of viral RNA synthesis in BHK cells 
For each virus eight BHK monolayers in 35mm tissue culture dishes 
were infected (moi-1). Control monolayers were mock infected with HBSS. 
After adsorbing for 60 min (36°), the inoculum was aspirated from each 
monolayer and the cells washed twice with HBSS; 2ml GMEM+10% BS 
was added and the monolayers returned to 36°. At appropriate times 
medium was aspirated and the monolayers washed twice with PBS 
(pH 7 .2) and 0.5ml of EMEM containing AMD (5µg/ml) and [5-3HJ uridine 
(lOµCi/ml) was added. Controls were incubated with and without AMD. 
After two hours incubation, the monolayers were washed twice with PBS 
and dissociated in 200µ1 of 1 % sodium dodecyl sulphate (SDS; Bio-Rad 
Laboratories, Richmond, CA, USA). Duplicate 50µ1 samples were spotted 
onto glass-fibre discs, precipitated with 5% TCA and assayed in a 
Beckman liquid scintillation counter (Newton et al.,1981). For each time 
point, growth samples (100µ1 of culture fluid supernatant) were collected 
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into HESS and assayed for extracellular virus (EV) by plaque a ssay on 
Vero cell monolayers. 
3.2.8 Kinetics of virus growth in Vero cell monolayers 
Vero cell monolayers in 60mm tissue culture dishes were infected 
(moi-1). EV titres were measured at appropriate times pi by plaque assay. 
3.2.9 Labelling RRV with [35S]-metbionine 
The method used for labelling virus was adapted from Raghow 
(1974). Confluent BHK monolayers in 60mm tissue culture dishes were 
infected with RRV T48 (moi -1). Four hours pi, growth medium was 
aspirated and the monolayers washed twice with EMEM-minus-
methionine (EMEM-M), 5ml of EMEM plus [35SJ-methionine (5µCi /ml; 
NEN Research Products, Boston, MA, USA) was added to each dish and 
the dishes incubated at 36°/5% CO2 for a further 19 hours. Supernatants 
were harvested and 5ml of EMEM-M added to the monolayers which were 
incubated for a further 15 hours. Supernatants were clarified by 
centrifugation at lOK rpm for 10 min at 4°, virus was precipitated with one 
fourth volume polyethylene glycol ( 40% in NET) and purified on a sucrose 
gradient as described in Chapter 2. Fractions were collected and samples 
of each precipitated with 5% TCA and counted in a liquid scintillation 
counter to identify the peak fractions. Peak fractions were plaque assayed 
on Vero cell monolayers. The specific activity of virus labelled in this 
manner was 38 pfu/cpm in the peak fraction for the first harvest and 140 
pfu/cpm in the second harvest. The peak of radiolabelled virus coincided 
with the peak infectivity fraction. Compared with the virus titres in growth 
samples taken prior to harvest an efficiency of 33% of infectious purified 
virus was obtained. Protein concentrations in purified virus preparations 
were estimated using the Bio-Rad protein assay (Bio-Rad Laboratories , 
Richmond, CA, USA). Particle:pfu ratios were estimated from the virus 
titre and the protein concentration following the method of Marsh and 
Helenius (1980). 
3.2.10 Virus binding assays 
BHK cell monolayers in 35mm dishes were chilled to 4 °washed twice 
with ice cold HBSS (pH 7.2) and an estimated 30,000 cpm of 358-labelled 
virus was added (pfu:cell-0. 75) per monolayer and incubated at 4° for 
between 10 and 60 min. At the indicated time the inoculum was aspirated 
and the monolayers washed three times with ice cold HBSS. Following this 
200µ1 of 1 % N onidet P-40 (Sigma) was added and the monolayers scraped 
into 10ml of scintillation cocktail (see Chapter 2) for counting. Mock 
infected monolayers were used as controls. In some experiments 1 % SDS 
was used to disrupt cell monolayers and in one experiment samples were 
split, with one fraction TCA precipitated prior to counting and the other 
counted directly; no differences were noted between methods. Experiments 
were also performed at room temperature (approximately 20°) and at 37°. 
3.2.11 Selection of mAb T1E7 resistant variants of RRV T48 
120µ1 of T48 clones 1, 2 and 3 (3xl06-6xl06 pfu) were independently 
incubated with 120µ1 of mAb T1E7 ascitic fluid (diluted 1:10 in HBSS) for 60 
min at 37°. This mixture was then further diluted 1/10 in HBSS and 100µ1 
aliquots added to Vero monolayers; 20 monolayers per incubation mix 
were inoculated. Adsorption was for 60 min at 36° and monolayers were 
then overlaid for plaque development. Monolayers were stained with 
neutral red (0.1 %) 36 hours post-infection and 12 well isolated plaques were 
selected from each incubation. Plaques were amplified in BHK monolayers 
and the supernatants were harvested when the monolayers showed 
cytopathic effect (cpe). Supernatants (l0-4 dilution) were screened for 
resistance to mAb T1E7 in a PRNA using a 1/50 dilution of T1E7. Controls 
were incubated with normal ascitic fluid. T48 and Tvl were screened in 
parallel with these assays as positive and negative controls. Those clones 
with 50% or greater resistance to rnAb T1E7 were titrated against rnAb 
T1E7 in a PRNA. Resistant stocks were plaque purified on Vero 
monolayers, amplified in BHK cells and the resulting supernatants 
titrated against rnAb T1E7 in a PRNA. 
Virus was designated 1, 2 or 3 for the original clonal stock from 
which it was selected followed by a number from 1-12 representing the 
plaque picked following selection with T1E7. The entire number was 
prefaced with E7. Thus E7 /1/3 represents the third plaque picked from 
clone 1 of T48 after selection with T1E7. 
3.2.12 RNA extraction from infected cells 
High molecular weight RNA for sequence analysis was extracted 
from BHK cells essentially using the method of Shine and Dalgarno (1973). 
Confluent BHK cell monolayers were infected with virus (moi 0.5-1). At 16-
18 hours pi the growth medium was removed, the cells washed twice with 
PBS and nucleic acids extracted with 6% sodium p-aminosalicylate and 
phenol/m-cresol/8-hydroxyquinoline ( 4ml of each). This extract was 
transferred to 12ml disposable tubes (Sarstedt, West Germany) and held on 
ice while intermittently vortexing for 10 min. The phases were separated 
by centrifugation (10K rpm, 20 min, 4°). The aqueous phase was re-
extracted with 0.5 volume of phenol / m-cresol / 8-hydroxyquinoline 
following the addition of 0.2 volumes of 15% (w/v) NaCl solution. Following 
centrifugation as before, nucleic acids in the aqueous phase were 
precipitated with 2.5 volumes of ethanol and dissolved in 0.45ml of water. 
0.1 volumes of xlO NET (1.5M NaCl, 0.12M Tris (pH 7.4), 0.02M EDTA) was 
added followed by 0.5ml of 4M LiCl in water. The mixture was frozen in 
liquid nitrogen, thawed, and high molecular weight RNA pelleted by 
centrifugation, resuspended as above and reprecipitated with 4M LiCl. 
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RNA was resuspended in NET buffer and precipitated twice with ethanol; 
the final pellet was resuspended in 5mM Tris (pH 7.4), O.Olm1v1 EDTA. The 
RNA concentration was measured spectrophotometrically, adjusted to 
4- 5µg/µl for sequencing, aliquoted and stored at -70°. 
3. 2.13 Dideoxynucleotide sequencing of viral RNA 
Nucleotide sequencing followed the procedure of Faragher and 
Dalgarno (1986). Total intracellular RNA (IC/RNA) extracted from virus 
infected cells was used for all reactions. 
Primer/template mix: 3.5µ1 of IC/RNA (16µg) was mixed with 1.0µ1 
of primer (5-20pmol/µl) and incubated at 65-80° for 5 min, quick-cooled on 
wet ice and 1.0µ1 of 0.4M KCl added. 1.0µ1 of this mixture was added to 
each reaction tube. The primers used were E2 198 7, GATGATGCGCTCAGA; 
El 2752, TCCACCCCACATGAA; El 3178, GTATGGCACATGCAC; El 3386, 
ACCTGGCAGCTCAGG; E 1 3 5 5 6, CGCCGTGGAAAAGTG; (primers are listed 5' 
to 3'; the priming site is indicated; numbering is from the 5' end of the 
RRV NB5092 268 RNA, Faragher et al., 1988). 
Reaction mix; this consisted of 50mM Tris (pH 8.3), 8mM MgCl, 
50mM KCl, 0.4mM dithiothreitol (DTT), 50µM of each of the 
deoxynucleoside triphosphates (dNTP) (dTTP, dATP, dGTP) with the 
exception of dCTP which was 2.5µM,and one of the dideoxynucleoside 
triphosphates (ddNTP); ddCTP (0.125 µM), ddTTP (5.0µM), ddATP (5.0µM), 
ddGTP (4.0µM). For some reactions 0.5x these ddNTP concentrations were 
used. To this was added lOµCi [a32P]-dCTP, 4.0 U AMV reverse 
transcriptase (Molecular Genetics Resources, Florida, USA) and 1.0µ1 of 
primer I template to give a final volume of 5µ1. 
After incubation at 42.5° for 30 min. 1.0µ1 of chase (0.5mM of each of 
dCTP, dATP, dTTP, dGTP) was added to each reaction tube and the 
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reactions incubated for a further 20 min at 42.5°. Reactions were stopped by 
the addition of 10-20µ1 of sample buffer (96% deionized formamide, 25mM 
tris-borate (pH8.3), 0.5m.M Na2EDTA, xylene cyanol, bromophenol blue), 
followed by heating at 90° for 2 min. Reaction products were separated on 
40cm long, 0.4mm thick, 6% polyacrylamide gels (acrylamide:bis 
acrylamide 19:1; Bio-Rad). Gels were exposed to Kodak RX medical X-ray 
film. 
3.3 Results 
3.3.1 Penetration rate of RRV T48 and mAb resistant variants of T48 in 
BHKcells 
Previous work (Vrati, 1986) had demonstrated that variants of RRV 
T48 with amino acid changes in epitope 122. had increased penetration rates 
in BHK cells compared to T48. It was not known whether changes in 
epitopes a and b 1 also altered penetration rates. To compare the 
penetration rates of T48 and rnAb resistant variants altered in epitopes a, 
b 1 and b2 in BHK cells, penetration assays were performed as described in 
the Methods (3.2.6). There was no difference in penetration kinetics 
between T48, the epitope a mutant (Tv42) or the epitope bl mutant, (Tv61). 
However, the epitope b2 mutant (Tvl) had a greater proportion of virus 
resistant to neutralization, compared to T48, at every time point, as 
previously demonstrated by Vrati (1986). A statistical method for handling 
these data was developed (R. Cunningham; see Methods; 3.2.6) which 
allowed upper and lower confidence intervals to be plotted on a logarithmic 
transformation of the plaque numbers at each time point expressed as a 
proportion of the plaque numbers in the 60 minute controls. The resulting 
curves together with 95% confidence intervals are shown together with the 
results expressed as percentage penetration (Fig 3.1). 
Figure 3.1 
Penetration of mAb resistant variants of RRV T48 in BHK cells 
EHK cell monolayers in 60mm dishes were infected with -100 pfu of 
RRV T48 or them.Ab resistant variants, Tvl, Tv42, and Tv61 and incubated 
at 36°. At designated times the inoculum was removed and 0.5ml of 
polyclonal anti-RRV ascitic fluid (diluted 1:10 in HESS, pH 7.2) was added. 
After a further 10 min the ascitic fluid was aspirated and the monolayers 
washed twice with HESS (pH 7 .2) and overlaid for plaque development. The 
number of plaques obtained after 60 min adsorption, HESS wash but no 
antibody treatment was taken as 100%. Each assay was performed in 
triplicate and average values for each time point expressed as a percentage 
of the 60 minute controls (3. lA). This represents the proportion of virus 
resistant to neutralization at each time point. The same data is shown 
(3.lE) as a logarithm of the plaque numbers at each time point expressed as 
a proportion of the numbers in the 60 min controls. This allows statistical 
analysis of the data, as described in the Methods; 95% confidence limits are 
shown as error bars. 
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Rates of penetration varied from experiment to experiment, 
however, the differences between the fast penetrating types and T48 were 
always present. For example the percent of penetrated virus at 60 min in 
all the assays performed in BHK cells ranged from 28%-60% for T48 and 
from 50%-100% for Tvl. This variation from day to day presumably, in 
part, reflects variability in the cells used for the assays. Most experiments 
were repeated a number of times and typical results are shown. Similar 
variation between penetration assays has been demonstrated with SIN 
rapid penetration m·utants (Russell et al., 1989). 
All four epitope a mutants selected by Vrati et al. (1988), had a 
Thr216---)I1e substitution in E2, therefore only one (Tv42) was tested. 
However, the four b 1 variants of T48 selected had different amino acid 
substitutions at residue 234: Tv61, Lys---)Gln; Tv62, Lys---)Ile; Tv63, 
Lys---)Asn; Tv64, Lys---)Glu. Therefore the penetration rates of all the b 1 
variants were examined in BHK cells to determine whether the amino acid 
change at this site altered penetration kinetics. The four variants showed 
essentially the same pattern of penetration confirming that changes at 
position 234 did not alter the penetration rate of RRV T48 in BHK cells 
(Fig 3.2). 
It had previously been demonstrated that the epitope b2 variants Tvl 
(Asp246---)Asn), Tv3 (Thr248---)Pro) and the multiepitope variant, Tv161 
(Asp246---)Asn) had fast penetration characteristics in BHK cells (Vrati, 
1986). However, there were two epitope 122. variants which had not been 
examined, Tv2 (Arg251---)Ser) and Tv5 (Asp246---)Val) (Vrati et al.,1988). 
When compared with each other and with Tvl and T48 these variants also 
had fast penetration rates (Fig 3.3). Tv5 consistently had somewhat faster 
early penetration compared to the other viruses assayed. For further work, 
Tvl was chosen as a representative of the epitope b2 mutants for two 
Figure 3.2 
Penetration of epitope hl variants of RRV T48 in Bllli cells 
Percentage penetration in BHK cells (3.2A) and statistical analysis of 
the same data (3.2B) of the epitope b2 variants Tv61, Tv62, Tv63 and Tv64 are 
shown. Assays were performed in triplicate exactly as described in Figure 
3.1. Error bars represent 95% confidence limits. 
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Figure 3.3 
Penetration of epitope ~ variants of RRV T48 in BHK cells 
Percentage penetration in BHK cells (3.3A) and statistical analysis of 
the same data (3.3B) of the epitope b2 variants Tvl, Tv2, Tv5 and of the 
parental T48 are shown. Assays were in triplicate as described in Fig 3.1. 
Error bars represent 95% confidence limits. 
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reasons: ( 1) because it was the only representative of these variants that 
was completely resistant to the selecting mAb (data not shown) and (2) 
because the multi epitope variant, Tv161, was changed to the same b2 
residue and this particular alteration appeared to be the one most readily 
selected with mAb T1E7 (Vrati et al.,1988). 
3.3.2 Penetration of RRV T48 and mAb resistant variants in Vero cells 
To examine whether the amino acid change at epitope b2 only 
altered the penetration characteristics of RRV T48 in BHK cells, 
penetration assays were performed in Vero cells as for BHK cells. Results 
for Tvl, Tv42, Tv61 and T48 are shown in Fig 3.4. The epitope b2 variant, 
Tvl, penetrated Vero cells faster than T48; epitope a and bl variants had 
similar entry rates to T48. Statistical analysis of the data, (for clarity 
shown only for Tvl and T48) demonstrated that the difference in 
penetration rates is less significant in Vero cells than in BHK cells. When 
results for Tv42 were plotted (data not shown) a pattern intermediate 
between T48 and Tvl was obtained. For all variants tested, penetration in 
Vero cells tended to be faster than in BHK cells, although the variation 
between assays precludes direct comparisons. 
It was concluded from these experiments that alterations in epitope 
b2 changed the rate at which the virus entered BHK and to a lesser extent 
Vero cells. Amino acid changes in epitopes a and b 1 had no effect on 
penetration. Thus changes in the E2 glycoprotein of T48 defined by 
resistance to mAb T1E7 also appeared to define a fast penetration 
phenotype. 
I 
.... 
Figure 3.4 
Penetration of RRVT48 and mAb resistant variants in Vero cells 
Penetration assays were performed on Vero cell monolayers exactly 
as for BHK cell monolayers (Fig 3.1). The percent penetration of T48, Tvl, 
Tv42 and Tv61 is shown (3.4A). Statistical analysis of the data is presented 
(3.4B) for T48 and Tvl only. Error bars represent 95% confidence limits. 
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3.3.3 Selection and sequencing of variants of RRV T48 resistant to mAb 
T1E7 
In the light of the preceding data implicating epitope b2 in cell 
penetration it was of interest to determine whether other amino acid 
changes could be selected in this epitope and what effect these would have 
on penetration. Further variants of RRV T48 were selected for resistance to 
mAb T1E7 from three independently plaque purified virus stocks 
(Methods; 3.2.11). Seven variants strongly resistant to neutralization by 
mAb T1E7 were isolated (Table 3.3). 
Most of the selected variants were clearly either resistant or not 
resistant to the selecting mAb, however, variant E7 /3/9 was about 50% 
resistant to neutralization at virtually all m.Ab dilutions tested indicating 
that despite two plaque purification steps it was probably a mixed 
population. Four separate plaques were selected from this stock on Vero 
monolayers, and amplified in BHK cells. These stocks were then titrated 
against mAb T1E7. One stock (E7 /3/9a2) showed essentially complete 
resistance to neutralization by the m.Ab while the other three were as 
sensitive as the parental T48 (Table 3.4). 
The seven resistant variants were sequenced through the region of 
the E2 gene coding for epitope b2 using total intracellular RNA extracted 
from BHK cells infected with the appropriate virus. Sequencing was by 
primer extension using the dideoxy method (Methods; 3.2.13; Sanger et 
al. ,1977), T48 infected cell RNA was sequenced in parallel. For each 
variant except E7 /3/12 (see below), a single nucleotide change was found. 
This change coded for a nonconservative amino acid alteration in the b2 
epitope (Table 3.5). Four of the six variants sequenced had the 
Asp246~Asn alteration which produced a new potential N-linked 
glycosylation site at residue 246. The other two changes found were 
I 
Table 3.3 
Neutralization of mAb T1E7 selected variants of RRV T48 by mAb T1E7 
Selected variant Neutralization titrel 
E7/1/1 <50 
E7/1/8 100 
E?/1/12 <50 
E7/2/8 100 
E7/3/6 200 
E7/3/9 50* 
E7/3/12 200 
T48 400,000 
1 Titres are the reciprocals of the lowest antibody dilution at which greater 
than or equal to 50% neutralization occurred; two-fold dilutions were used 
starting from 1:50. 
* 3/9 appears to be a mixed population with approximately 50% of the virus 
neutralized at all dilutions tested (see text). 
Table 3.4 
Neutralization 1 by mAb T1E7 of plaque purified stocks selected from RRV 
E7/3/9 
Antibody Dilution2 
Virus 00 100 ~ 400 ~ 1600 ~ 
T48 100 100 100 00 94 92 94 
3/9 47 51 43 39 49 49 00 
3/9al 100 100 100 97 97 98 95 
3/9a2 10 23 9 0 23 18 21 
3/9a3 100 100 100 ffi 97 99 94 
3/9a4 100 100 100 00 9'2 92 93 
lThe percentage neutralization at each antibody dilution, in a PRNA, for 
the parental T48 and the mAb selected variant E7 /3/9 and four plaque 
purified stocks derived from E7 /3/9, shown as 3/9al to 3/9a4. 
2Antibody dilutions are shown as the reciprocal of the dilution of mAb T1E7 
ascitic fluid used. 
Table 3.5 
Sequence differences in E2 of mAb T1E7 selected variants of RRVl 
RRVT48 2position of Codon change Amino acid 
variant nucleotide chan~e3 
chan~e 
E7/1/1 1786 GAU~AAU Asp246~Asn 
E7/1/8 1803 AGG~AGU Arg251~Ser 
E7/1/12 1786 GAU~AAU Asp246~Asn 
E7/2/8 1786 GAU~AAU Asp246~Asn 
E7/3/6 1802 AGG~ACG Arg251~Thr 
E7/3/9a2 1786 GAU~AAU Asp246~Asn 
E7/3/12 nd nd nd 
lNucleotide and amino acid differences from the parental RRV T48 strain 
are shown. 2Nucleotides are numbered fom the 5' end of the T48 268 RNA 
(Dalgarno et al., 1983). 3 Amino acids are numbered from the N terminus of 
E2. 
nd not determined (see text). 
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Arg251~Ser and Arg251~Thr. Only the Arg251~Thr change was not 
seen by Vrati et al. (1988) and this is unlikely to result in different 
properties to the Arg251~Ser mutation which was found by Vrati et al . 
(1988). The Asp246~Asn alteration was found in all three selection series. 
In each case this resulted from a G~A nucleotide transversion which 
might be expected to occur more frequently than the other two changes 
found, both of which require transitions. For E7 /3/12 a four nucleotide 
compression between nucleotides 1,786-1,789 prevented determination of 
the sequence at this point. This compression covers the amino acid 246 
codon and is not found in T48, therefore it is likely that a nucleotide 
alteration has occurred in this codon in E7 /3/12 possibly corresponding to 
the Asp246~ Val mutation seen by Vrati et al. (1988). These workers also 
found a change at amino acid 248 (Thr~Pro); no changes at this position 
were found in the current study. 
3.3.4 Penetration of RRV NB5092 in BHK and Vero cells 
RRV NB5092 is a natural isolate of RRV that has undergone much 
less laboratory adaptation than RRV T48. The complete sequence of the two 
strains of RRV has been determined (Faragher et al.,1988). There are five 
amino acid differences in E2 and three in E 1 between these isolates; these 
are the only proteins that are likely to be involved in cell penetration. 
NB5092 is approximately 100 times more resistant to neutralization by 
mAb T1E7 than is T48 (Vrati et al.,1988) and this may be due to a 
conservative amino acid difference (Arg251~Lys) betvveen NB5092 and T48 
E2. NB5092 cannot be differentiated from T48 in neutralization assays with 
polyclonal anti-T48 sera (Chapter 2) or with mAbs TlOC9 and NB3C4 (C. 
Fernan and R. C. Weir, unpublished) and therefore provided a test of 
whether alteration from the T48 sequence in the b2 epitope affected 
penetration rate in an isolate of RRV somewhat closer in its passage 
history to the field situation. 
--
--
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The results of a penetration experiment in BHK cells using NB5092 
and T48 are shown in Fig 3.5. In this experiment Tv161 was used as a fast 
entry control. Also included is NB0/10/7, a variant of NB5092 derived by 
mouse passaging, which has a single, non-conservative Lys251-,Asn 
alteration in E2 (Meek et al.,1989). Both NB5092 and NB0/10/7 had the fast 
penetration phenotype compared to T48 with 90-100% of virus being 
resistant to neutralization by 60 min compared to 36% for T48. Similar 
differences in penetration for NB5092 and T48 were obtained in Vero cells 
with approximately 83% and 53% respectively being resistant to 
neutralization by 60 min (Fig 3.6). 
These results appear to confirm that changes from the RRV T48 
sequence in the T1E7 epitope lead to a fast penetration phenotype and 
suggest that the effect was not charge dependent since Arg 251-,Lys, Lys 
251-,Asn, Asp 246-, Val, Thr 248-,Pro or Asp 246-,Asn all gave similar 
penetration phenotypes. However, NB5092 does have other amino acid 
changes from T48 in El and E2 (Faragher et al., 1988). The effect of these 
changes on the rate of penetration could not be defined. 
3.3.5 Penetration of geographic variants of RRV in BHK cells 
To further test the premise that epitope b2 was a determinant of 
penetration rate of RRV in tissue culture, four more geographic variants 
of the virus were examined. There was no data on the penetration of 
geographic variants of RRV other than NB5092 and T48. However, the E2 
sequence for a number of isolates of RRV had been determined (Vrati, 
1986; Burness et al., 1988 ). To define penetration characteristics of RRV 
more completely four of these variants were chosen (Table 3.2). Based on 
the reported sequence these had differences to T48 in the b2 epitope 
( F9073 : Arg251-,Lys; Burness et al.,19881), near the b2 epitope (GG2227 
Figure 3.5 
Penetration ofRRVT48, NB5092, NB0/10/7 and Tv161 in Billi cells 
Percentage penetration in BHK cells (3.5A) and statistical analysis of 
the same data (3.5B) of the RRV variants NB5092, the mouse passage 
derived NB0/10/7 and the triple mAb resistant variant Tv161 are shown 
compared with T48. Assays were performed in triplicate as described in Fig 
3.1. Error bars represent 95% confidence intervals. 
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Figure 3.6 
Penetration ofRRVNB5092 and T48 in Vero cells 
Percentage penetration in Vero cells (3.6A) and statistical 
transformation of the same data (3.6B) of RRV T48 and NB5092 are shown. 
Assays were in triplicate as described in Fig 3.1. Error bars represent 95% 
confidence limits. 
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and BH38019: Lys253-,Arg; Vrati, 1986) or were not altered in the b2 
epitope (PB629: Ile67-,Leu; Vrati, 1986). 
F9073 is resistant to neutralization by mAb T1E7 (C. Fernan and 
R.C. Weir, unpublished) and was therefore predicted to have fast 
penetration kinetics. The BH38019, GG2227 and PB629 isolates were 
examined in a PRNA. with mAb T1E7. GG2227 and PB629 were neutralized 
similarly to T48, but BH38019 was neutralized approximately 100 fold less 
efficiently than the other viruses (data not shown). As indicated above 
GG2227 and BH38019 had previously been reported to have identical E2 
sequences (Vrati, 1986). Since the mAb neutralization did not correlate 
with this sequence, PB629, GG2227 and BH38019 were sequenced through 
the region of the E2 gene coding for the b2 epitope (Table 3.6). This 
indicated that BH38019 was identical in sequence to F9073 (Burness et 
al., 1988 ) in the sequenced region while PB629 and GG2227 had the same 
sequence as each other and no amino acid differences to T48 in this region. 
This explained the mAb reactivity pattern of these isolates and also 
correlated with restriction digest profiles for these viruses which indicated 
that BH38019 is considerably diverged from PB629 and GG2227 (P.J. Kerr 
and L. Dalgarno, unpublished). 
All four geographic variants had the fast penetration phenotype 
when tested in BHK cells. This assay was repeated three times and the 
results of two independent assays are shown (Fig 3. 7). T48 and Tvl were 
used as slow and fast penetrating controls in both these assays. Thus 
while BH38019 and · F9073 : were predicted to have fast penetration kinetics 
based on neutralization by mAb T1E7, isolates of RRV that are closely 
related to T48 in their E2 amino acid sequence (PB629, GG2227) and are not 
altered in b2 also had the fast penetration phenotype. In summary, 
changes from the T48 sequence at epitope b2 increased penetration rate , 
however, natural isolates of RRV which are not altered in this epitope also 
Table 3.6 
Amino acid sequence differences in the E2 protein between RRV T48 and 
geographic variantsl 
Virus 
T48 PB629 BH38019 GG2227 F9073 NB5092 
Amino 
acid 
3 Thr Ile 
m Ile Leu Leu Leu Leu Met 
119 Asp Asn 
132 Asp Asn 
200 Cys Trp 
251 Arg Lys Lys Lys 
002 Leu Val 
lThe amino acid differences from the T48 E2 protein for the geographic 
isolates of RRV used in this study are shown. A blank space indicates no 
change from T48. The T48 sequence is from Dalgarno et al. (1983); F9073 
from Burness et al. (1988); NB5092 from Faragher et al. (1988); PB629, 
BH38019 and GG2227 are from Vrati (1986) and from sequence studies 
reported in this chapter (see text). 
Figure 3.7 
Penetration of geographic variants of RRV in BHK cells 
Penetration assays were performed for the geographic variants of 
RRV: GG2227, PB627, BH38019 and F9073 in BHK cells. T48 and Tvl were 
assayed in parallel with the geographic isolates. All assays \Vere in 
triplicate as described in Fig 3.1. Data from two independent experiments 
(3.7A and 3.7B) are shown as the logarithm of the plaque numbers at each 
time point expressed as a proportion of the plaque numbers in the 60 
minute controls. Error bars represent 95% confidence limits. 
Tvl • 
T48 + 
F9073 A 
BH38019 T 
GG2227 • 
PB629 0 
-o.s 
-1.s 
-2.s 
~ 
~ 
0 
-3.5 ~ 
E-c A z 
0 
-4.5 u 
...........__ 
r:JJ 
~ 
~ 
0 
< 
-0.5 ~ 
,'::,,. 
C, 
0 
-1.s 
~ 
-2.5 
-3.5 
B 
-4.5 
10 20 40 60 
TIME (MIN) POST-INFECTION 
77 
have fast penetration. Both PB629 and GG2227 are reported to have a 
conservative Leu67 ~Ile difference from T48 in E2 (Vrati, 1986) and NB5092 
and F9073 also differ from T48 at this position (see discussion). Therefore 
it is possible that regions of E2 towards the N-terminus are important in 
determining penetration rate. To explore this further, the penetration 
rates in BHK and Vero cells of a variant of T48 (RRV dE2) with a deletion 
in E2 from amino acids 55-61 were determined. This deletion mutant 
showed no difference in penetration rates compared to T48 (data not 
shown). Similar results with RRV dE2 in Vero cells had been previously 
reported (Vrati et al., 1986). The possibility that changes in El are involved 
in determining penetration rate cannot be excluded, however, partial 
sequence analysis of the El gene ofBH38019, PB629 and GG2227, covering 
approximately 40% of the gene, did not reveal any changes from T48 for 
either GG2227 or PB629. Five silent nucleotide differences were found for 
BH38019 but no coding alterations (data not shown). 
3.3.6 The effect of growth in mosquito cells on RRV penetration rate in 
BHKcells 
In nature alphaviruses replicate alternately in an arthropod vector 
and a vertebrate host. In the case of RRV and most other alphaviruses the 
arthropod vector is a mosquito. Virus grown in mosquito cells is altered in 
membrane composition from that grown in vertebrate cells (Luukonen et 
al.,1977). In addition only high mannose oligosaccharide chains are added 
at N-linked glycosylation sites (Hsieh and Robbins, 1984). It has not been 
demonstrated that these differences lead to any changes in the antigenic or 
biological characteristics of alphaviruses (Stollar et al.,1976). However, it is 
possible that changes in the size or charge of the carbohydrate moieties on 
El and E2 could alter the interaction of the virion with the cell surface. 
--
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To examine the effect on cell penetration of host derived 
modifications of RRV, working stocks of RRV T48 or Tvl were prepared in 
mosquito (C6/36) cells derived from Aedes albopictus. For both Tvl and T48 
the virus grown in mosquito cells penetrated BHK cells faster than virus 
grown in BHK cells and assayed in the same experiment. Figure 3 .8 shows 
that 60% of T48(BHK) penetrated within 60 min while 76% of T48(mosq) 
penetrated in the same time. For Tvl the corresponding values were 89 
and 100%. Statistically these differences were very small (see Fig 3.8B), 
however, the same general pattern was observed in two experiments with 
Tvl and three with T48. Assuming no genetic changes occurred during 
growth in mosquito cells, these results indicated that host derived 
phenotypic differences, such as the absence of complex oligosaccharide 
moieties may be important in cell penetration . 
3.3. 7 The effect of pH on penetration of RRV T48, Tvl and NB5092 
Evidence from the preceding section suggested that virus grown in 
mosquito cells and therefore lacking complex carbohydrate moieties 
penetrated faster than virus grown in BHK cells. It is possible that the 
absence of negatively charged sialic acid on the virion surface proteins 
enhanced penetration rate. This may be a direct effect of the reduction of 
negative surface charge on the virion. In support of this, the surface 
charge on the virion was an important determinant of the ability of SIN to 
infect mouse plasmacytoma cells (Symington and Schlesinger, 1978). 
By altering the pH at "\vhich penetration assays were performed the 
surf ace charge on the cells and virions could be changed. In the fallowing 
experiments the effect of three pH values (6.5, 7.2 and 8.0) on penetration 
rates in BHK cells was examined for Tvl, T48 and NB5092. All previous 
experiments used medium and HESS at pH 7.2. For T48, penetration rate 
was virtually identical at all pH values (Fig 3.9). NB5092 had similar 
---
---
Figure 3.8 
Penetration in BHK cells of RRV T48 and Tv 1 gro"vn in either BHK or 
mosquito cells 
RRV T48 and Tvl were grown in either mosquito cells (C6/36) or BHK 
cells to prepare working stocks. Penetration assays in BHK cells were 
performed in parallel using virus prepared in each cell type. The 
percentage penetration with time for each virus is shown (3.8A) together . 
with the statistical transformation of the same data (3.8B). All assays were 
performed in triplicate as described in Fig 3.1. Error bars represent 95% 
confidence intervals. 
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Figure 3.9 
Penetration in Blll{ cells ofRRVTvl, T48 andNB5092 at pH 6.5, 7.2 
and 8.0 
EHK cell monolayers were washed twice with HESS at the 
appropriate pH prior to infection with -100 pfu of virus diluted in HESS at 
the same pH. Incubation was at 36°. At designated times the inoculum was 
removed and 0.5ml of polyclonal anti-RRV ascitic fluid (diluted, 1:10 in 
HESS of the appropriate pH) was added. After a further 10 min the ascitic 
fluid was aspirated and the monolayers washed twice with HESS at the 
appropriate pH and overlaid for plaque development. The number of 
plaques obtained after 60 min adsorption, HESS wash but no antibody 
treatment, was taken as 100%. Each assay was performed in triplicate and 
average values for each time point expressed as a percentage of the 60 
minute controls. This represents the proportion of virus resistant to 
neutralization at each point. Assays on each graph were performed 1n 
parallel. 
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penetration kine tics at pH 7.2 and 8.0, but was slightly accelerated at pH 
6.5. Tvl had markedly slower penetration at pH 8.0. For example at pH 7.2 
at 60 min approximately 90% of Tvl was resistant to neutralization while 
after the same time at pH 8.0 approximately 50o/o of the virus was resistant. 
This effect was reversed at pH 6.5,with the difference being most marked 
after 10 and 20 min. After 10 min 5% of Tvl at pH 7 .2 had acquired 
resistance to neutralization while at pH 6.5 over 40% was resistant, the 
corresponding figures for NB5092, which also shows fast penetration, were 
8% and 16%. 
The pH also had a marked effect on the specific infectivity of Tvl. At 
pH 6.5 the same volume of virus inoculum contained about six times more 
pfu than at pH 7.2 and had to be diluted accordingly. For NB5092 this 
difference was about three fold. T48 had no change in infectivity at pH 6.5. 
At pH 8.0 both T48 and Tvl had infectivity reduced by approximately 70%; 
the infectivity of NB5092 showed little change. 
It was concluded that the difference in the E2 glycoprotein of Tvl 
which altered the entry rate of the virus into BHK cells was extremely 
sensitive to pH compared with the parental T48 and the NB5092 isolate. 
This pH sensitivity was also accompanied by an increased specific 
infectivity at pH 6.5 which may reflect a modification of receptor structure 
on either the virus or the cell surface or possibly some undetermined effect 
on virus aggregation. It is also possible that direct fusion of the Tvl viral 
membrane with the plasma membrane of the cell may occur at this pH if 
the amino acid alteration in E2 alters the pH at which the fusion domain is 
exposed on the glycoprotein spike. 
--
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3.3.8 The effect of washing and salt concentration on penetration of RRV 
inBHKcells 
The penetration assay used here measures the proportion of the 
virus inoculum which is resistant to neutralization by added antiserum at 
a particular time post-infection. It had not been determined if virus bound 
to cells but not penetrated was still susceptible to neutralization at all time 
points or whether only free virus was neutralized and therefore the assay 
was effectively measuring rates of virus attachment to cells. 
To address this point the penetration rates of T48 and Tvl were 
compared in BHK cells using the standard assay. In parallel a separate 
pair of assays was performed in which, instead of adding antibody at each 
time point, the cell monolayers were washed three times with HBSS pH 7 .2 
and then overlaid with agar for plaque development. By comparing the 
percent penetration after each time interval for washed or antibody treated 
monolayers an estimate of the proportion of virus firmly bound to cells, as 
judged by resistance to washing, but still susceptible to neutralization 
could be made. Because of the 60 min endpoint both viruses have 100% 
penetration in the wash only treatment at 60 min. The results (Fig 3.10) 
indicated that virus attached to cells was still susceptible to neutralization 
by added antibody at all time points. This suggested that the penetration 
assay was measuring a combination of rate of virus attachment to cells 
and rate of internalization of attached virus. The results showed that Tvl 
was adsorbed to cells faster than T48 so a significant component of fast 
penetration appeared to be due to rapid attachment. 
Two types of binding to cells have been postulated for SIN (Pierce et 
al.,1974): a weak binding where 40-50% of virus can be removed from the 
cells using a high salt (0.2M NaCl) wash and a tight binding where virus 
could not be washed from the monolayer. To examine whether such a 
Figure 3.10 
Penetration of RRV T48 and Tvl in BHK cells without using antibody 
as a stop reagent 
BHK cell monolayers in 60mm dishes were infected with-100 pfu of 
RRV T48 or the rnAb resistant variant Tvl and incubated at 36°. At 
designated times the inoculum was removed and the monolayers were 
either washed twice with HESS (pH7 .2) and overlaid for plaque development 
or 0.5ml of polyclonal anti-RRV ascitic fluid was added. After 10 min 
incubation the ascitic fluid was removed and the monolayers washed twice 
with HBSS and overlaid for plaque development. The number of plaques 
obtained after 60 min adsorption, HBSS wash but no antibody treatment, 
was taken as 100%. Each assay was performed in triplicate and average 
values for each time point were expressed as a percentage of the 60 min 
controls. 
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weak binding occurred with RRV a penetration assay was done in which 
virus (T48) was either washed from the monolayer after each time interval 
or neutralized by the addition of antibody. Each treatment was performed 
in parallel with either a normal salt wash (HBSS) or a high salt wash 
(HBSS, 0.2M NaCl). In the wash experiments slightly more virus was 
removed by the high salt than by the normal salt wash, however, the 
differences were very small (data not shown). In the penetration assay, 
using antiserum, there vvas no difference between high salt and normal 
salt washes. Thus if RRV had a proportion of weak binding susceptible to 
high salt washing it was too small to demonstrate under these 
experimental conditions. 
3.3.9 Growth and RNA synthesis kinetics of RRV T48 and the m.Ab 
resistant variants Tvl and Tv161 in BHK cells 
A previous report had suggested that variants of RRV T48 which 
were altered in epitope b2 had retarded growth, viral RNA and viral 
protein synthesis in BHK cells compared to T48 (Vrati, 1986). In that work 
all the b2 variants were reported to have an approximately 10 fold lower EV 
titre during the early growth phase, between 4-8 hours post-infection. No 
difference was shown with epitope ll or bl variants. 
To re-examine these observations, BHK cell monolayers were 
infected with T48, the epitope b2 variant, Tvl and the multiepitope variant 
Tv161 and virus growth and AMD resistant RNA synthesis determined. 
Growth curves are shown in Figure 3 .1 la. There was no difference in 
virus titres between these variants in the early stages of virus replication, 
up to 11 hours post-infection, although Tvl reached somewhat higher final 
titres than T48 and Tv161. Similarly there was no appreciable difference in 
the time of onset of RNA synthesis for T48, Tvl or Tv161 infected cells. 
However, the rates of RNA synthesis by Tvl infected cells were higher 
--
Figure 3.11 
Kinetics of RRV T48, Tvl and Tv161 growth and AMD resistant RNA 
synthesis in Blll{ cells 
BHK cells were infected with RRV T48 or the mAb resistant variants 
Tvl and Tv161 (moi-1) or mock infected (MI). Growth samples were 
collected from the culture mediums at the indicated times post-infection. 
Extracellular virus (EV) titres were determined by plaque assay on Vero 
cell monolayers (Fig 3.lla). At appropriate intervals monolayers from each 
infection were pulsed with EMEM containing lOµCi/ml [5-3HJ-uridine and 
5µg/ml AMD. After incubation (2 hours, 36°), the medium was aspirated, 
monolayers washed twice with PBS (pH 7.2) and dissociated in 1 % SDS. 
Acid precipitable radioactivity of duplicate 50µ1 aliquots was determined by 
liquid scintillation counting. Times indicated in the figure (3. llb) are the 
mid-points of the labelling periods. Control monolayers were mock infected 
with or without AMD. 
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during the early stages of infection ie 4-12 hours, than the other two virus 
types (Fig 3. llb). 
3.3.10 Growth of T48 and mAb resistant variants Tvl, Tv42, Tv61 and 
Tv161 in Vero cells 
The growth of T48 and the mAb resistant variants, Tvl (epitope b2), 
Tv42, (epitope .a), Tv61 (epitope bl) and Tv161 (multiepitope) was also 
examined in Vero cells to compare biological properties of the variants in 
different cell lines. T48 grew to a higher EV titre in Vero cells than the 
mAb resistant variants, however, there was no difference in the time 
course of virus growth for any of the single amino acid variants. Tv161 had 
a lower titre than the other viruses assayed but titres began to rise at the 
same time as the other variants giving no evidence for a delay in Tv161 
replication, rather replication appeared to be less efficient than the other 
viruses tested (Fig 3.12). 
In summary no lag in virus growth in either BHK or Vero cells 
could be demonstrated for the epitope b2 variant, Tvl compared with T48. 
The onset of RNA synthesis for epitope b2 variants in BHK cells was also 
no later than for T48 and peak rates were increased for Tvl. It was 
concluded that the Asp246-,Asn substitution in E2 did not affect cell entry 
events post-attachment and penetration. Epitope b2 variants altered at 
other amino acid residues (Tv2 and Tv3) or with a different substitution at 
246 (Tv5) were not examined. 
3.3.11 An attempt to develop penetration assays in which virus is adsorbed 
to cells at 4° prior to shifting to 37° 
An attempt was made to develop a penetration assay in which RRV 
was first adsorbed to cell monolayers at 4°, at which temperature little 
penetration will occur (Fries and Helenius, 1979), followed by washing to 
---
-
Figure 3.12 
Growth of mAb resistant variants of RRV in Vero cells 
Vero cell monolayers were infected with RRV T48 or the mAb 
resistant variants Tvl, Tv42, Tv61 or Tvl61 (moi-1 ). Growth samples were 
collected from the culture medium at the indicated times post-infection. 
Extracellular virus titres were determined by plaque assay on Vero cell 
monolayers. 
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remove unbound virus and a shift to 36° t o allow penetration. In this way it 
was planned to separate differences in rates of cell attachment and cell 
entry. This would also provide a good system to examine whether the RRV 
neutralizing mAbs act by blocking virus attachment to cells or 
neutralizing virus bound to cells. Such experiments have been described 
for other alphaviruses (Johnson and Smith, 1988; Russell et al., 1989). 
When these experiments were attempted with RRV using either BHK or 
Vero cell monolayers, the number of plaques formed following the 
temperature shift was low and unpredictable with respect to virus input. 
In addition it was difficult to maintain the monolayers intact so that 
plaques could be counted and thus repeatable results were not obtained 
(data not shown). 
3.3.12 Bindmg assays using radiolabelled RRV T48 on BHK monolayers 
To overcome the difficulties involved in measuring the rate of RRV 
uptake by plaque formation, binding assays using [35SJ-methionine 
labelled RRV T48 were attempted (Methods; 3.2.10). At 4° and 20° the 
maximum amount of virus bound after washing was 4% and 10% 
respectively. There was little increase in binding between 10 and 60 min 
(Fig 3.13). Increasing the pfu:cell ratio did not increase the proportion of 
virus bound (data not shown). In contrast to the results at 4° and 20°, at 37° 
there was a progressive uptake of virus over a 60 minute period with about 
25% of virus cell associated by 60 min. Unfortunately at this temperature 
the assay cannot distinguish between rate of virus binding and rate of 
virus entry into cells. 
To examine the possibility that there was a very large amount of 
noninfectious virus competing for receptors in the binding assays 
described above, an estimate of particle:pfu ratio was made (Methods; 
3.2.9). Two independently purified preparations of RRV were used: the T48 
--
Figure 3.13 
Kinetics of binding of [35S]-methionine labelled RRV T48 to BHK cells 
at different temperatures 
RRV T48 labelled with [35SJ-methionine was allowed to attach to BHK 
cell monolayers (pfu:cell-1) at either 4° (Fig a ), room temperature (-20°, Fig 
b) or 37° (Fig c). At the indicated times monolayers were washed three 
times with HBSS (pH 7.2) at the same temperature as attachment. After 
draining, monolayers were dissociated in NP40 (1 %) and the bound 
radioactivity determined by liquid scintillation counting. Virus bound is 
expressed as a percentage of the input number of virus cpm. 
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preparation used above, with a titre of 9.6xl07 pfu/ml and a preparation of 
Tv161 with a titre of 2xl09 pfu/ml. For the two RRV preparations 
particle:pfu ratios of 2,400 and 2,500 were calculated. This is much higher 
than estimates made for SFV and SIN where particle:pfu ratios are often 
quoted as less than 10 (Marsh and Helenius, 1980, Pierce et al.,1974). This 
value for RRV may be somewhat high if copurification of non-viral protein 
with the virus occurred. However, the following data suggest that it is 
reasonably accurate. Allowing for the fact that recovery of infectious virus 
in purification was only about 33% (Methods; 3.2.9), and assuming that the 
remainder of the virus is recovered, in a noninfectious form, this leaves a 
particle:pfu ratio, in the original culture supernatant, of approximately 
800 for RRV in Vero cells. This value is supported by estimates of the 
infectious dose of RRV in mice, where approximately 0.02 pfu of RRV T48 
will kill 50% of neonatal mice (P. Kerr, unpublished). That is mice of this 
age are 50 times more sensitive to infection by RRV T48 than Vero cells. 
This brings the particle:pfu ratio much closer to that seen for other 
alphaviruses. In addition essentially the same particle:pfu ratio was 
obtained for two preparations with very different concentrations of virus. 
3.4 Discussion 
3.4.1 The effect of changes in neutralization epitopes .a, hl and~ on RRV 
penetration and growth in tissue culture 
This chapter has confirmed that alterations in the b2 neutralization 
epitope of RRV T48 lead to faster penetration in cultured cells. Changes in 
the neutralization epitopes a and b 1 which are close to b2 in the primary 
structure of the E2 protein did not alter penetration. Using a limited range 
of geographic variants with and without differences from T48 in the b 2 
epitope it was demonstrated that all variants had the fast penetration type 
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therefore this could be regarded as normal and T48 as slowly penetrating. 
This reasoning fits well with the observation that any of the amino acid 
alterations in the b2 epitope gave fast penetration suggesting that b 2 
interacts with other areas on the E2 protein involved in cell attachment 
and entry and that changes in this region are altering determinants 
involved in penetration. 
All of the mAb T1E7 selected variants used in this study had the fast 
penetration phenotype. Most of the assays described in this chapter were 
performed with Tvl which has an Asp-tAsn alteration at amino acid 246, 
this introduces a potential glycosylation site into the protein which, if 
utilized, may explain them.Ab T1E7 resistance of this variant and of Tv161 
which has the same change in epitope b2. (Vrati et al.,1988). The other b.2. 
variants have quite different amino acid alterations; Tv2: Arg251-tSer and 
Tv5: Asp246-t Val; Tv3 was not used here but has also been shown to have 
fast penetration in BHK cells (Vrati, 1986), it has a Thr248-tPro change in 
E2 (Vrati et al.,1988). Thus a positively charged amino acid changing to a 
hydrophilic or a negatively charged amino acid changing to a hydrophobic 
both produced a similar alteration in penetration rates to the Asp246-tAsn 
change. 
There does not appear to be any structural pattern in these amino 
acid alterations, it seems that an alteration in epitope b2 away from the T48 
sequence will increase penetration rate. Epitqpe b2 occurs in an extremely 
hydrophilic region of E2 and thus is likely to be on the surface of the protein 
(Vrati et al.,1988). The introduction of bulky carbohydrate molecules, 
hydrophobic side chains, pralines or charge changes could influence local 
protein structure and may affect neighboring functional sites. 
When further mAb T1E7 resistant variants of RRV T48 were 
selected similar changes to those reported by Vrati et al. (1988) were found. 
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This may imply some limitation to the changes acceptable at epitope b2 or 
may relate to the stringency of the screening assay for T1E7 resistance. 
Single nucleotide changes in the amino acid 246 codon could produce seven 
different amino acids, only one of which is conservative (Asp~Glu). A 
variant with this change would probably not be detected as resistant to 
T1E7 in the high stringency screening assay used. At the 251 codon six 
amino acid changes are possible from single base changes, two of these 
(Arg~Ser and Arg~Thr) were found in the present study. The only 
conservative change possible is Arg~Lys and this is seen in a number of 
natural isolates of RRV (Faragher et al.,1988; Burness et al.,1988; Vrati, 
1986; C. Fernan, R. C. Weir and L. Dalgarno, unpublished). 
Other fast penetrating variants of alphaviruses have been selected. 
Barie et al. (1981) selected a variant of SIN for rapid release from BHK cells 
and showed that this was associated with rapid penetration and 
replication in the line of BHK cells used for selection but not other cell 
lines, including other BHK lines. Russell et al. (1989) selected variants 
from a separate strain of SIN for rapid penetration of BHK cells. Selection 
of VEE for accelerated penetration of BHK cells (Johnston and Smith, 1988) 
produced variants with a range of increased penetration rates. In all cases 
selection of rapidly penetrating variants coselected for virulence 
attenuation in mice. The selection protocols used in these experiments do 
not appear to be selecting for an increased rate of virus binding to cells . 
Both Barie et al. (1981) and Pence et al. (1990) reported that the changes in 
penetration rate were not associated with alterations in the rate of virus 
adsorption. While in the selection protocol of Olmsted et al. (1984), 
Johnston and Smith (1988) and Russell et al. (1989) virus was allowed to 
adsorb to cells at 4° prior to shifting temperature to 37° for one minute and 
then treating cells with trypsin to remove virions that had not been 
internalized. 
........... 
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Using a full length cDNA infectious clone of SIN, Polo et al. (1988 ) 
demonstrated that the coselected fast penetration and low virulence of SIN 
mutants were caused by a Ser~Arg change at E2 114, demonstrated by 
Davis et al.,(1986). Ser(114) occurs in a hydrophobic stretch of 14 amino 
acids which is postulated to be buried inside the E2 protein. The need to 
accomodate a large, charged side chain from Arg could cause substantial 
rearrangements potentially modulating external domains involved 1n 
tissue tropism, receptor recognition and antibody binding (Davis et 
al.,1986). Thus it is predicted that amino acid 114 may not actually be 
directly involved in penetration. Some fast penetrating SIN variants 
selected by Russell et al. (1989) differed from the E2 114 variants by having 
an extra glycosylation site at amino acid one of E2. This prevented the 
cleavage of PE2; mutant virions contained PE2 instead of E2, had the fast 
penetration phenotype and were no longer neurovirulent for mice. The 
presence of PE2 could substantially alter the conformation of the virus 
spike. No sequence data are available for the VEE fast penetrating 
mutants. 
The increased penetration of RRV variants in tissue culture differs 
in several points from that seen with SIN. Increased penetration in SIN is 
specific for the selecting line of BHK cells (Barie et al.,1981). For RRV the 
fast penetration phenotype is also seen with Vero cells. Increased 
penetration rates in both SIN and VEE coselected for substantially reduced 
virulence in mice (Olmsted et al.,1984; Russell et al.,1989; Johnston and 
Smith, 1988). In the case of RRV, Vrati (1986) showed very small 
differences in virulence for only two epitope b2 variants (Tv2 and Tv5) in 
terms of their LD50 values for seven-day old mice. None of the RRV b2 
variants had faster replication in tissue culture which was a feature of the 
SIN variants (Barie et al.,1981), although this property of the SIN variants 
may have been due to a separate mutation. Finally there is some evidence 
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that the difference in penetration of Tvl compared to T48 is partly due to 
faster tight attachment to cells. 
The slower replication of RRV b2 variants during the early stages of 
infection reported by Vrati (1986) was not demonstrated in either BHK or 
Vero cells in the current work. (It is possible that under certain 
conditions, for example cells of a particular passage level or particular 
batches of bovine serum such an effect might be apparent). Tv161 grew less 
efficiently than the other virus types in Vera cells but this virus has three 
amino acid changes in the E2 glycoprotein and may not be well adapted to 
Vero cells. There was no evidence that changes in the b2 epitope had an 
effect at stages of cell entry other than attachment and binding to the cell 
surface, translocation and receptor mediated endocytosis. 
3.4.2 The penetration of natural and laboratory derived strains of RRV in 
BHKcells 
The NB5092 variant of RRV showed fast penetration kinetics in both 
BHK and Vero cells, as was predicted from its resistance to mAb T1E7. 
Similarly a mouse passage selected mutant of NB5092 (NB0/10/7; Meek et 
al.,1989) which is altered from NB5092 within the b2 epitope (Lys251~Asn) 
also had the fast penetration phenotype. This suggested that the 
substitution at this site is either not critical or that other amino acid 
changes in E2 and possibly El determine penetration rate for NB5092. 
Four further natural isolates of RRV were examined in penetration 
assays, two of these, F9073 and BH38019, are altered at epitope b2 as -I' 
demonstrated by mAb reactivity and sequence studies, the other two; PB629 
and GG2227 had the same reactivity to mAb T1E7 as RRV T48 and were 
unchanged at epitope b2. All four of these isolates had fast penetration in 
BHK cells. Thus variations in the El/E2 spike other than at epitope b2, 
must affect penetration rate. 
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The E2 sequences for F9073 (Burness et al.,1988 ) PB629, GG2227 
and BH38019 (Vrati, 1986) have been determined. The region of E2 around 
the b2 epitope has been resequenced in the work reported here for PB629, 
GG2227 and BH38019 (Table 3.6). PB629 and GG2227 have an amino acid 
difference from T48 (Ile~Leu) at residue 67 (Vrati, 1986) which has not 
been resequenced in this study. This is a highly conservative change and 
appears unlikely to affect the biological properties of the virus, however, it 
cannot formally be excluded. F9073 has the same change at position 67 
(Burness et al.,1988) and NB5092 is also altered from T48 (Ile~Met) at this 
residue (Faragher et al.,1988). A deletion of amino acids 55-61 of T48 E2 did 
not increase penetration rate in either BHK or Vero cells. NB5092 is also 
changed from T48 at 119 (Asp~ Asn) which is very close to the 114 
penetration change in SIN (Davis et al., 1986), at residue 3 (Thr~Ile), at 
251 (Arg~Lys) and at 302 (Glu~Val) (Faragher et al.,1988). In addition to 
the change at amino acid 67, F9073 differs from T48 at residues 132 
(Asn~ Tyr), 203 (Cys~Trp) and 251 (Arg~Lys) (Burness et al.,1988 ). 
While · the 251 residue remains the most likely to be involved in fast 
penetration it seems probable that the other changes are involved in 
stabilizing any protein structural alterations. It is also possible that a 
change exists in E 1 in these variants which may influence protein 
structure and function. Although limited sequence analysis of the El gene 
for PB629, GG2227 and BH38019 did not demonstrate any coding changes. 
3.4.3 The effect of pH on penetration of RRV T48, Tvl and NB5092 in BHK 
cells 
Experiments with penetration at a range of pH values indicated that 
Tvl is very sensitive to alterations in pH when compared to T48 or the fast 
penetrating NB5092. These experiments did not differentiate between pH 
effect on the cell surface and on the viral proteins. However, it appears that 
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the penetration rate of NB5092 is much more stable at mildly acidic or 
basic pH than that of Tvl, suggesting that amino acids apart from those at 
b2 stabilize the interactions involved in penetration. One possibility that 
has not been examined here is that the more rapid entry and higher 
specific infectivity of Tvl at pH 6.5 involves fusion of the virus at the cell 
plasma membrane as well as receptor mediated endocytosis especially 
since a large component of the extra penetration is within the first 10 min 
of infection. SFV fuses directly with the plasma membrane at pH 6.2, this 
implies that at this pH a structural alteration occurs in the viral spike 
glycoproteins which exposes the fusion · domain (Kielian and Helenius, 
1985). No data is available for RRV on the pH at which this occurs, 
however, the penetration rate of T48 is unchanged at 6.5, while NB5092 
may be a little faster. Direct membrane fusion could also explain the 
higher specific infectivity of Tvl at acid pH but does not alter the conclusion 
that the faster penetration at this pH implies a less stable E2 structure. 
3.4.4 The time course of binding of radiolabelled RRVT48 to BHK cells 
Only 4% of RRV bound to BHK cells at 4° and most binding occurred 
in the first 10 min pi. These results contrast with those reported for SIN 
and SFV on a variety of cell types where 15-90% of added virus was bound 
at this temperature (Pierce et al.,1974; Smith and Tignor, 1980; Fries and 
Helenius, 1979) and for SFV where the time for half maximal binding was 
approximately 30 min (Fries and Helenius, 1979). 
Two points can be made about the behaviour of RRV in these assays: 
(1) at 4° it is possible that few virions are tightly bound, as receptor 
recruitment by translocation in the plasma membrane may be inhibited. 
However, Birdwell and Strauss (1974) have demonstrated that in chick 
cells such receptor mobility may occur at 4°. At room temperature about 
twice as much virus was bound but attachment was still essentially 
........... 
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complete within 10 min. (2) At 36° virus continued to attach to cells over the 
60 minute period of the assays. This suggested that either receptor 
recruitment and tighter binding, together with internalization, were 
occurring thus making the virus difficult to remove by washing and that 
this was a prolonged process, or that greater receptor availability occurred 
at this temperature perhaps because of receptor recycling, implying that 
the number of receptors on the cell surface for RRV was very limited. 
Particle to pfu ratios indicated that a large amount of noninfectious RRV 
was competing for binding sites on cells. Numbers of binding sites for SIN 
and SFV have been estimated as between 5xl04 and l.5x1Q6 (Birdwell and 
Strauss, 1974; Smith and Tignor, 1980; Fries and Helenius, 1979). If 
comparable numbers of binding sites were available for RRV, 
noninfectious virus is unlikely to have inhibited binding. These 
experiments were preliminary attempts to develop a cell binding assay for 
RRV, further work is needed to determine whether higher levels of RRV 
binding can be obtained with other strains of RRV. SIN or SFV should also 
be used as positive controls. 
3.4.5 Conclusions and further work 
This work has established that penetration rate of RRV is affected by 
epitope b 2 but not epitopes a and b 1. The mechanism of this is not 
understood. In a simple model, penetration of alphaviruses can be 
envisaged as a four step process. Initial, non-specific association of virions 
with the cell surface is followed by specific receptor binding and 
recruitment of additional receptors. Binding is virtually irreversible. 
Translocation of the virus-receptor complex to coated pits then occurs and 
finally endocytosis (Kielian and Helenius, 1986). An increase or decrease 
in penetration rate could result from changes at any of these steps. It is 
tempting to speculate that the changes at epitope b2 leading to fast 
penetration are increasing receptor affinity of the virus , especially as fast 
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penetration of Tvl appears to involve an increased rat e of attachment. 
Furthermore epitope b2 is a neutralization site and while little is known of 
the mechanism of RRV neutralization it is possible that rnAb T1E7 acts by 
blocking virus binding to a receptor molecule on the cell. 
Further work could be done to develop cell binding assays for RRV 
using fast entry types such as Tvl and NB5092. This would allow testing of 
the hypothesis advanced in this discussion that changes in epitope b2 lead 
to faster penetration by increasing the rate of receptor binding. Use of an 
infectious centre assay for measuring penetration could also overcome the 
problems found with adsorbing virus at 4° prior to performing a 
penetration assay (Johnson and Smith, 1988). Additional sequencing 
studies of El for isolates such as PB629 and GG2227 could also define 
amino acids involved in penetration. Another set of experiments would be 
to select variants of RRV T48 and NB5092 for fast penetration using the 
protocol of Olmsted et al. (1984). An interesting experiment would be to 
passage T48 and Tvl together in BHK cells and examine whether Tvl 
became dominant, that is whether the difference in penetration rate would 
provide a competitive advantage in tissue culture. Such work should lead 
to better definition of the regions of RRV involved in cell entry and may 
enable strategies for isolating cell receptors to be developed. 
-
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Chapter Four 
The selection of genetic variants of RRV by passaging in avian cells and 
the analysis of three selected variants with altered antigenic and biological 
properties 
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4.1 Introduction 
Passaging in tissue culture has been used to select attenuated 
strains of VEE (Berge et al.,1961) and other viruses such as yellow fever 
(Theiler and Smith, 1937) for use as vaccines. In addition passaging RRV 
in tissue culture selected for reduced virulence in mice (Taylor and 
Marshall, 1975a). It appears that variants, either pre-existing or arising by 
mutation, that replicate more efficiently than the wild-type, in the 
particular tissue culture system, outgrow the wild-type to become the 
dominant population. In some cases this leads to reduced efficiency of 
replication or altered tissue tropism in the original host and thus 
attenuation. 
Little is known of the molecular mechanism of selection in tissue 
culture. Changes could occur at the level of structural or nonstructural 
proteins or in untranslated regulatory regions of a virus. The results of 
several passaging studies with alphaviruses are consistent with the idea 
that adaptation to new cell types may involve selection for enhanced cell 
binding and entry, resulting from changes in the surface proteins of the 
virus (see Chapter 1). Thus mouse plasmacytoma cell adapted SIN had an 
increased negative charge on the envelope glycoproteins of the virus 
associated with enhanced binding to these cells (Symington and 
Schlesinger, 1978). VEE attenuated by cell passage to produce the vaccine 
strain, TC83, had only one nucleotide alteration outside the envelope 
protein genes (Kinney et al.,1989). Selection for rapid penetration of SIN in 
BHK cells involved a single amino acid change at position 114 of E2 which 
was also responsible for attenuation in mice (Davis et al.,1986; Polo et 
al., 1988). 
The studies described in Chapter 3 showed that single amino acid 
alterations in the b2 epitope of RRV E2 can alter virus entry kinetics in 
......... 
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BHK and Vero cells. This suggested that a determinant on the E2 protein 
may be involved in cell attachment or receptor recognition. By passaging 
RRV in avian cells it was planned to select variants with adaptations to 
these cells and identify determinants on the viral glycoproteins involved in 
cell tropism. Using a cell type to which RRV is not biologically adapted (see 
below) provided the potential for a strong selection pressure while a low 
number of passages limited background changes. 
Avian cells were selected because serological surveys and attempts 
to isolate RRV had indicated that birds were unlikely to be involved in the 
epizootology of this virus (Doherty et al.,1966; Gard et al.,1973; Marshall et 
al .,1982a). There is only one report of the isolation of RRV from birds 
(Whitehead et al., 1968) and RRV replicated poorly in birds following 
experimental infection (Whitehead, 1969; Gard, 1970). This is in contrast to 
the biology of some other alphaviruses, such as SIN, WEE and EEE, for 
which birds are important hosts (Chamberlain, 1980). Chick embryo 
fibroblasts (CEFs) have not been routinely used with RRV in laboratory 
studies so there was very limited data on the growth of RRV in these cells. 
RRV field isolates from Nelson Bay did not form plaques on primary chick 
embryo fibroblast (CEFs) monolayers when first isolated, however, some 
plaque formation was noted following two passages of the virus in suckling 
mouse brain (Gard, 1970). 
In this chapter the development of conditions for passaging RRV in 
chick embryo fibroblasts is initially described. Following five passages in 
these cells, three independent clones of RRV were selected and 
characterized by antigenic analysis, growth in mice and nucleotide 
sequencing. Variants were altered at either amino acid 4 or 218 of E2. 
Those altered at 218 had attenuated growth in mice. 
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4.2 Materials and Methods 
4.2.1 Vims Stocks 
Plaque purified stocks of RRV NB5092 were produced from single 
plaques picked from Vero cell monolayers and amplified once in BHK cells 
to give three independent plaque purified stocks designated: NB 1/0, NB2/0 
and NB3/0. Stocks were titred by plaque assay on Vero monolayers. 
Production of plaque purified stocks of RRV T48 has been described in 
Chapter 3. Sindbis virus (HR, large plaque strain) was obtained from Dr. 
J.H. Strauss (California Institute of Technology, Pasadena, California). 
4.2.2 Tissue culture 
Primary chick embryo fibroblasts (CEFs) were prepared from 4-12 
embryos between 9 and 10 days old. Embryos were removed from the eggs 
into cold PBS using sterile technique. The heads and feet were removed 
and the bodies transferred to fresh PBS prior to homogenization through a 
10ml disposable syringe. After washing twice with ice-cold PBS the tissue 
fragments were digested with 0.25% trypsin in PBS, 7ml / embryo (5 min, 
37°, with constant stirring). The supernatant was decanted, through four 
layers of gauze, into a 50ml centrifuge tube containing 1/10 volume of 
growth medium (M199 LAH+10% BS) on ice. Fresh trypsin was added to 
the remaining tissue fragments and the digestion repeated; this process 
was then performed a third time. 
Cell suspensions were centrifuged (1600rpm, 4°, 15 min.) the 
supernatant discarded and the cells resuspended in growth medium; the 
cell suspension was made up to 50ml and the centrifugation repeated. 
Cells were resuspended in fresh growth medium and counted in a 
haemocytometer. 
/ 
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Primary cells (2-4xl07) were seeded into 75cm2 tissue culture flasks 
in M199 LAH+10% BS and grown to confluency. They were then harvested 
using trypsin/EDTA, seeded as secondary CEFs into 35mm dishes at 
1-1.5xl06 cells per dish in M199 LAH+10% BS and incubated at 36°/5% CO2 
until confluent. For passaging experiments secondary cells rather than 
primary cells were used so as to maintain the cells as constant as possible 
from batch to batch and to remove macrophages and other cells from the 
primary cells which could allow growth of RRV in non-fibroblast cells or 
could potentially modify fibroblasts by secreting cytokines. 
Growth of Vero and BHK cells has been described in Chapter 2. 
4.2.3 Passaging RRV in CEFs 
Preliminary experiments in secondary CEFs were performed using 
the T48 and NB5092 strains of RRV at 36°. For passaging experiments 
confluent secondary CEF monolayers were infected with RRV (moi-0.5-1) 
and the culture medium harvested at 24 hours post-infection; 100µ1 of each 
supernatant was used to inoculate the next cell monolayer for up to five 
passages. Following experiments described in the results section the 
conditions were altered to growing virus at 30°/5% CO2 for 40-48 hours and 
the NB5092 strain of RRV was used for passaging and the selection of 
passaged variants. 
The fifth passage level stock of each passage series was plaque 
purified on Vero cell monolayers. Single plaques were amplified once in 
CEFs to produce seed stocks. Working stocks (ws) were prepared in CEFs 
from each seed stock and unless otherwise stated, all subsequent 
experiments were done with these working stocks. For antigenic analysis 
of virus from intermediate passage levels plaques were picked from Vero 
cell monolayers and amplified in BHK cells (see results). 
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4.2.4 Backpassagi.ng CEF selected variants in BHK cells 
Plaques from 1/5ws, 2/5ws and 3/5ws were picked from Vero cell 
monolayers and amplified in CEFs. Approximately 106 pfu of virus was 
used to infect BHK cell monolayers in 35mm dishes. Incubation was at 36°. 
The culture supernatant was harvested at the onset of cpe and 100µ1 used 
to infect the next monolayer in the series for a total of five passages. 
4.2.5 Virus Nomenclature 
RRV clones derived from NB5092 are identified by the number 1, 2 or 
3 of the original NB5092 clone followed by the passage number ie NB 1/5 
refers to the fifth passage stock of NB5092 clone 1. Working stocks are 
identified by "ws" following the passage number. For backpassaging, 
plaques were picked from the working stocks and identified with a plaque 
number, thus NBl/5/1 refers to the first plaque picked from the NB1/5ws. 
These stocks are then further identified with the number of backpassages, 
thus 1/5/1BP5 refers to the first plaque from NB 1/5ws after five 
backpassages in BHK cells. 
4.2.6 Growth kinetics and RNA synthesis kinetics 
These analyses were performed as described in Chapter 3. 
4.2. 7 Antigenic analysis 
Antigenic analysis was performed using PRNA with mAbs and 
polyclonal antiserum; these were produced as described in Chapter 2. Two 
additional mAbs, TlDll and T4D2 were used (Vrati et al.,1988). 
4.2.8 Extraction of infected cell RNA 
RN A was extracted from infected CEFs or BHK cells as described in 
Chapter 3. 
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4.2.9 Nucleotide sequencing 
Nucleotide sequencing of CEF selected variants was as described in 
Chapter 3. RNA from NB5092 infected BHK cells was sequenced in parallel 
with the CEF variants. Most of the CEF variants nucleotide sequences were 
obtained using RNA extracted from RRV infected CEFs, however, in some 
regions it proved difficult to obtain clear sequence ladders using this RNA. 
These regions were sequenced using RNA extracted from infected BHK 
cells after it had been demonstrated that antigenic reversion did not occur 
on growth in these cells (see Results). The following oligonucleotide 
primers were used: 
3'-UT/3853, TCTATTTGTCTACTT; El 3556, CGCCGTGGAAAAGTG; 
El 31 78, GTATGGCACATGCAC; El 2752, TCCACCCCACATGAA; 
El 338 6, ACCTGGCAGCTCAGG; 6K 2472, TGCGGAGGCTCCCAG; 
6K 2347, GGTTTTGTTCTCGTC; E2 1987, GATGATGCGCTCAGA; 
E2 1632, TTGTACCTGATAGTC; E2 1452, ACTTCTCTCTACCCACC; 
E2 1225, GGGCGTGGGTACCTG. 
Primer DNA sequences are written in the 5'-3' direction. Priming sites are 
numbered from the 5' end of NB5092 26S RNA, (Faragher et al.,1988) 
The primers at the 3' end of the El and E2 genes produced 
considerable cross-banding. Efforts were made to resolve these using 7-
deazaGTP (Boehringer-Mannheim, West Germany) to replace dGTP in the 
incubation and chase mixtures (Barr et al.,1986), this was succesful in 
some instances but did not resolve the majority of cross-bands. Terminal 
deoxynucleotide transferase (Pharmacia LKB Biotechnology, Uppsala, 
Sweden) was also used (De Borde et al.,1986), together with a range of 
primer/template ratios and annealing temperatures. A major cross band 
at nucleotide 3437 caused problems finishing the sequence of E 1. In 
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addition using the 2350 primer at the 3' end of E2 it was not possible to read 
the 3' terminal 120 nucleotides of the NB2/5ws sequence despite repeated 
attempts. These particular problems were largely overcome by using two 
new primers, E 1/3386 and 6K/24 72 but 55 nucleotides (3382-3437) of NB 1/5ws 
E 1 were not obtained. Where the cross-banding structure was the same for 
NB5092 as for the variants then the sequence was assumed to be 
unchanged. There were sometimes problems obtaining long ( 400-450 
nucleotide) runs of sequence from CEF RNA, which may reflect high levels 
of ribonuclease in CEFs leading to fragmented viral RNA. For regions 
where this was a difficulty final sequence was obtained using IC/RNA 
extracted from BHK cells. 
4.2.10 Temperature shift experiments 
Duplicate monolayers of CEFs were infected with NB5092, (moi 0.51); 
adsorption was at either 36° or 30° for 60 min. At the end of this time the 
monolayers were washed twice (HESS, pH7.2) and either shifted to the 
other temperature or allowed to continue at the original temperature; 
growth medium at the appropriate temperature was added. Growth 
samples were collected at 1, 24 and 50 hours pi and EV titres determined 
on Vero cell monolayers. 
4.2.11 Growth and tissue tropism of CEF selected variants in mice 
Litters of neonatal, Swiss White, outbred mice ( <24 hours old) were 
randomized and fostered back onto mothers in litters of 10-12. For each of 
NB 1/5ws, NB2/5ws, NB3/5ws and NB5092 three litters of mice were injected 
subcutaneously (sc) with 100 pfu of virus in HESS. At 24 hour intervals 
three mice from each group were killed by exsanguination while 
anaethesized with ether. Blood was collected using heparinized capillary 
tubes after opening the thoracic cavity with scissors. As much blood as 
possible was removed from the mice to minimize the effects of viraemia on 
........... 
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virus levels in the tissues. Brains were removed intact and the hind leg 
and pelvic muscle tissue collected. For this, the skin over the pelvis and 
hind legs was removed and the leg below the stifle joint discarded, thus 
some of the femur was included. Tissues were collected into weighed tubes 
on ice and stored at -70° prior to processing. 
Brains were homogenized in glass, hand-operated homogenizers 
followed by sonication (3 x 5 sec at an amplitude of 10 mA). For muscle 
tissue a motor-driven teflon-glass homogenizer was used followed by 
sonication, as above. All operations were performed on ice and dilution 
was in ice cold HESS (pH 7 .2) to produce 10% w/v suspensions. Blood was 
diluted to 10% v/v. Virus in each tissue was measured by duplicate plaque 
assay on Vero cell monolayers. Statistical analysis was by analysis of 
variance for blood and muscle virus titres. This was performed by Mr Ross 
Cunningham, Department of Statistics, The Faculties, Australian 
National University. 
Brain titres were variable and to ensure that quantitative recovery of 
NB5092 from 10% brain homogenates was achieved, the following control 
experiment was performed. Duplicate samples of a mouse brain 
homogenate (10% w/v in HESS, pH 7.2) with no detectable virus on plaque 
assay, were inoculated with approximately 8xl06 pfu of NB5092. One of the 
samples was clarified by centrifugation and the supernatant transferred t o 
a fresh tube, the other was left unclarified. Both tubes were then allowed to 
stand on ice for 60 min at room temperature, frozen at -70° overnight and 
then thawed and plaque assayed. Full recovery of virus was made from 
both samples, indicating that there was no loss of virus infectivity during 
processing. 
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4.2.12 Virulence assay of NB5092 and NBl/5 ws in neonatal mice 
To compare the virulence of NB5092 and the CEF selected variant 
NB1/5ws, randomized litters of neonatal mice (<24 hours old) were injected 
sc with 102, 103, 104 or 105 pfu of virus diluted in HESS and observed daily 
for clinical symptoms and deaths. Clinical symptoms were graded as; (-): 
no symptoms; ( +/-): mild hind leg weakness; ( + ): dragging one or both hind 
legs. 
4.2.13 Hydropathy profiles and protein secondary strncture predictions 
The computer analyses of protein secondary structure predictions 
and hydro pa thy profiles were done using the PeptideStructure program 
and presented graphically using PlotStructure (Jameson and Wolf, 1988; 
Wolf et al.,1988). 
4.3 Results 
To select avian cell adapted variants of RRV attempts were made to 
grow and passage strains of RRV in secondary chick embryo fibroblasts 
(CEFs). Preliminary growth experiments using RRV NB5092 and T48 in 
CEFs at 36° indicated that neither virus grew to high titres. Although in 
some experiments NB5092 appeared to replicate more efficiently than T48, 
on passaging both viruses were generally lost by the second or third 
passage. No evidence of cytopathic effect (cpe) was observed in any 
experiment with either strain of RRV in CEFs. In a series of experiments 
with T48, the use of high moi (50-100) to initiate passage series, the 
presence of AMD or the use of virus grown in mosquito cells did not 
increase the efficiency of replication of RRV in CEFs (data not shown). 
-
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4.3.1 Growth experiments and plaque assays on CEF monolayers 
To examine replication of RRV in CEFs more rigorously, growth 
and viral RNA synthesis, at 36°, for RRV T48 and NB5092 were examined. 
SIN was used as a positive control (Fig 4.1). T48 maintained a constant EV 
titre from 3-23 hours pi. The NB5092 titre was constant for the first 11 
hours pi and then showed a slight increase. There was no detectable 
increase in AMD-resistant RNA synthesis for either NB5092 or T48. SIN 
gave a strong peak of RNA synthesis between 5-7 hours post-infection (pi). 
It appeared from this experiment that RRV replication in CEFs was 
blocked at the stage of cell entry or RNA synthesis. 
As there was no evidence of cpe in RRV infected CEFs, plaque 
formation by RRV was examined on CEF cell monolayers. Adsorption was 
at 30° or 36° for 60 min. Monolayers were incubated at 30° or 36° for 48 
hours prior to staining. No plaques were observed with either RRV T48 or 
NB5092. SIN was used as a positive control and formed large plaques at 
both temperatures with twice as many at 30° as at 36°. 
4.3.2 The effect of temperature on the growth of RRV T48 and NB5092 in 
CEFs 
In an attempt to define conditions under which RRV could be 
succesfully passaged in CEFs the effect of temperature on RRV replication 
in CEFs was examined. In a preliminary experiment CEF monolayers 
were infected (moi-5) with either T48 or NB5092. Adsorption and 
incubation were at either 30° or 36°. NB5092 grew to a titre of 8.3xl07 pfu/ml 
at 30° but the titre was reduced 20 fold at 36°. T48 grew poorly at 36° and at 
30° gave similar EV titres to NB5092 at 36° (Fig 4.2). This experiment 
indicated that the replication of RRV in CEFs showed strain specific 
Figure 4.1 
Virus growth and AMO resistant RNA synthesis at 36° in CEFs infected 
with RRV T48, NB5092 or Sindbis virus 
CEF monolayers in 35mm dishes were infected (moi-1) with RRV 
T48, NB5092 or Sindbis virus. Control monolayers were mock-infected with 
HESS. Incubation was at 36°; growth samples were taken from the 
supernatants at the indicated times and assayed for EV titres by plaque 
formation .on Vero cell monolayers (Fig 4. la). 
To measure the kinetics of viral RNA synthesis cells were pulsed at 
appropriate times pi for 2 hours with 0.5ml of EMEM containing [5-3H]-
uridine (lOµCi/ml), AMD (5µg/ml). After incubation (2 hours, 36°) the 
medium was aspirated, monolayers washed twice with PBS (pH 7.2) and 
dissociated with 200µ1 of 1 % SDS. Acid precipitable radioactivity of 
duplicate 50µ1 aliquots was determined by liquid scintillation counting. 
Mean values of the duplicate samples are plotted (Fig 4.3b), time points 
represent the midpoint of each labelling period. 
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Figure 4.2 
Growth ofRRVT48 and NB5092 in CEFs at 30° or 36° 
CEF monolayers in 35mm dishes were infected with either RRV T48 
or NB5092 and duplicate monolayers incubated at 36° or 30°. Growth 
samples were collected at the indicated times and EV titres were 
determined by plaque formation on Vero cell monolayers at 36°. 
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differences and was temperature sensitive. There was no evidence of cpe in 
CEF monolayers infected with NB5092 at 30°. 
To further characterize the growth of RRV in CEFs at 30°, EV titres 
and AMD resistant RNA synthesis were examined for NB5092 and T48 
(Fig. 4.3). NB5092 RNA synthesis was detected between 12-24 hours pi. This 
followed the first increase in EV titre. No virus specific RNA synthesis was 
detected in the T48 infected cells and only a small increase in EV titre by 25 
hours pi, consistent with previous results. T48 did not replicate efficiently 
in secondary CEFs at either 30° or 36° due either to a failure of viral entry 
or a failure in RNA replication. NB5092 replicated efficiently in CEFs but 
was temperature sensitive (ts). The ts block occurred either at virus entry 
or RNA synthesis, although an additional block at later stages in 
replication cannot be ruled out. The effect of temperature on adsorption of 
RRV was explored in temperature shift experiments, RRV NB5092 was 
allowed to adsorb to CEF monolayers for 60 min at either 36° or 30° followed 
by washing. Incubation for growth was at either the same temperature as 
adsorption or shifted to the alternative temperature. The temperature of 
adsorption did not influence EV titres (data not shown). This suggested 
that the block in replication was not at the cell attachment level. 
4.3.3 Serial passaging of NB5092 in CEFs at 30° 
To obtain variants of RRV that were selected by growth in CEFs, 
three independent clones of NB5092 were serially passaged in CEFs at 30° 
to produce three independent passage series. For each passage series 
initial moi was approximately one; culture medium was harvested at 48 
hours pi for each passage and 100µ1 used to infect the next monolayer in 
the series. Five serial passages were performed in this manner. 
The clones derived from NB5092 grew to high titres (-108 pfu/ml) in 
the first passage, consistent with previous results. However, in succeeding 
Figure 4.3 
Virus growth and AMD resistant RNA synthesis at 30° in CEF monolayers 
infected with RRVT48 or NB5092 
CEF monolayers in 35mm dishes were infected (moi-1) with RRV 
T48 or NB5092. Control monolayers were mock-infected with HESS. 
Incubation was at 30°; growth samples were taken from the supernatants 
at the indicated times and assayed for EV titres by plaque formation on 
Vero cell monolayers at 36° (Fig 4.3a). 
To measure the kinetics of viral RNA synthesis, cells were pulsed at 
appropriate times pi for 2 hours with 0.5ml of EMEM containing [5-3H]-
uridine (lOµCi/ml), AMD (5µg/ml). After incubation (2 hours, 30°) the 
medium was aspirated, monolayers washed twice with PBS (pH 7.2) and 
dissociated with 200µ1 -0f 1 % SDS. Acid precipitable radioactivity of 
duplicate 50µ1 aliquots was determined by liquid scintillation counting. 
Mean values of the duplicate samples are plotted (Fig 4.3b), time points 
represent the midpoint of each labelling period. 
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passages virus titres fell, becoming as low as 105-106 pfu/ml, until the fifth 
passage when they rose sharply (Fig 4.4). This was associated with a high 
moi (-5) at the second passage followed by a drop in moi at each subsequent 
passage down to a moi of 0.05-0.1 at the fifth passage. 
CEF passaged virus did not cause cpe or form plaques on CEF 
monolayers. Plaque morphology on Vero cell monolayers altered during 
passaging from the normal large ( 4mm diameter) NB5092 plaques to a very 
small pinpoint plaque (<0.5 mm diameter). This was observed after the 
second passage for series 3 and by the fifth passage for the other two series. 
[During the course of this work the Vero cells used in the laboratory were 
replaced by fresh cells from the American Type Culture Collection; the 
small plaque phenotype was not observed with the new cells]. 
4.3.4 Investigation of titre decreases that occurred during passaging of 
RRVinCEFs 
Interferon produced by cultured cells can limit growth of 
alphaviruses (Heller, 1963). To investigate whether the decreases in titre 
which occurred during passaging were due to interferon production, virus 
from the first or fourth passage level was used to infect CEF monolayers in 
the presence or absence of AMD (O.Olµg/ml). Extracellular virus titres 
were measured after 48 hours incubation at 30°. There was no difference in 
growth with or without AMD (data not shown). It was concluded that the 
drop in titre during passaging was probably not due to interferon 
production. 
RNA synthesis and virus growth were examined in CEFs for 
NB5092, NB 1/1 (NB clone 1 after the first passage) and NB 1/5 (NB clone 1 
after the fifth passage). AMD resistant RNA synthesis was first detected 
between 6-8 hours for NB 1/5 and between 8-10 hours for NB5092. There was 
a consistently greater rate of incorporation of 3H-uridine for cells infected 
.... 
Figure 4.4 
Extracellular virus titres of NB5092 clones during passaging in 
CEFs at30° 
Three independent clones of NB5092 were blind passaged five times 
1n CEFs at 30°. Monolayers were in 35mm dishes; initial moi was 
approximately one. Supernatants were harvested at approximately 48 
hours pi and 100µ1 of each supernatant was used to inoculate the next 
monolayer. Titres for each passage level were measured by plaque assay 
on Vero cell monolayers at 36°. The arrow represents the total initial 
inoculum of 106 pfu per monolayer. 
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with NBl/5 compared to NB5092. RNA synthesis for NBl/1 was only 
marginally above that of the control cells. The lag period for EV NB 1/5 was 
shorter than for NB5092 but EV titres were then similar up to 24 hours pi 
with NB5092 subsequently reaching a higher final titre. NBl/1 increased in 
EV titre at the same time as NB5092 but then grew considerably slower 
before reaching the same final titre as NBl/5 (Fig 4.5). 
4.3.5 Antigenic analysis of plaque purified virus from CEF passage level 5. 
The fifth passage level stock of each passage series was used for 
plaque purification on Vero cell monolayers. Working stocks derived from 
the plaque purification of each passage series were prepared in CEFs and 
designated: NB 1/5ws, NB2/5ws and NB3/5ws. These were the stocks used 
in all subsequent experiments unless otherwise stated. 
Having established conditions for passaging NB5092 in CEFs and 
produced plaque purified passaged stocks, the next step was to determine 
the effects of host cell selection on virus structural proteins and in 
particular the E2 glycoprotein which contains the predominant 
neutralization epitopes (see Chapter 2) and determinants involved in cell 
penetration (see Chapter 3). Therefore NB 1/5ws, NB2/5ws and NB3/5ws 
were subjected to antigenic analysis using plaque reduction neutralization 
assays (PRNA) with polyclonal antiserum and a panel of mAbs. It was 
anticipated that amino acid alterations in functionally important regions 
of the glycoprotein could be reflected in changes in neutralization titres. 
The NB5092 stock from which clones 1, 2 and 3 were derived was used as 
the control virus after it was demonstrated that the unpassaged clones did 
not differ antigenically from each other, or from the parental NB5092 in 
PRNA with the panel of m.Abs used (data not shown). 
RRV NB5092, NB 1/5ws, NB2/5ws and NB3/5ws were compared in 
PRNA using serial two-fold dilutions of polyclonal anti-RRV ascitic fluid. 
Figure 4.5 
Vims growth and AMD resistant RNA synthesis at 30° in CEF monolayers 
infected with RRV NB5092, NB 1/5 or NB 1/1 
CEF monolayers in 35mm dishes were infected (moi-0.5) with RRV 
NB5092 or the CEF passaged populations NB 1/1 or NB 1/5. Control 
monolayers were mock-infected with HESS. Incubation was at 30°; growth 
samples were taken from the supernatants at the indicated times and 
assayed for EV titres by plaque formation on Vero cell monolayers at 36° 
(Fig. 4.5a). 
To measure the kinetics of viral RNA synthesis, cells were pulsed at 
appropriate times pi for 2 hours with 0.5ml of EMEM containing [5-3H]-
uridine (lOµCi/ml), AMD (5µg/ml). After incubation (2 hours, 30°) the 
medium was aspirated, monolayers washed twice with PBS (pH 7.2) and 
dissociated with 200µ1 of 1 % SDS. Acid precipitable radioactivity of 
duplicate 50µ1 aliquots was determined by liquid scintillation counting. 
Mean values of the duplicate samples are plotted (Fig. 4.5b), time points 
represent the midpoint of each labelling period. 
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In two separate assays NB2/5ws and NB3/5ws were neutralized more 
efficiently than NB5092. The differences were small, less than two dilution 
intervals, but reproducible. NB 1/5ws showed no difference in 
neutralization with polyclonal antiserum compared to NB5092 (Fig 4.6). 
The data suggested a structural protein change which altered the 
neutralization epitopes of NB2/5ws and NB3/5ws and further analysis was 
performed using a panel of mAbs. 
Five mAbs were used to compare the neutralization of NB 1/5ws, 
NB2/5ws, NB3/5ws and NB5092. MAbs, TlOC9, NB3C4 and T1E7 define 
epitopes on E2 at amino acids 216 (a), 234-232 (hl) and 246, 248 and 251 (122) 
respectively (Chapter 2). MAbs TlDll and T4D2 bind to E2 but their 
epitopes have not been mapped by selection of escape mutants (C. Fernon 
and R.C. Weir unpublished). 
The three CEF passaged clones could also be divided into two 
antigenic groups on the basis of neutralization by mAbs. NB 1/5ws was 
poorly neutralized by mAbs NB3C4 and TlDll compared to the other 
viruses. NB2/5ws and NB3/5ws could not be distinguished from each other 
in neutralization assays and were less efficiently neutralized by mAb 
T10C9 than were NB5092 and NB1/5ws (Table 4.1). 
4.3.6 Backpassaging plaque purified clones ofNBl/5, 2/5 and 3/5 in BHK 
cells 
If the antigenic types represented by NB 1/5ws, NB2/5ws and 
NB3/5ws were selected during CEF passaging because of enhanced growth 
in avian cells then these antigenic types might be selected against in 
mammalian cells. To examine the stability of the new antigenic types 
during passage in mammalian cells, plaques from NB1/5ws, NB2/5ws and 
NB3/5ws were picked from Vero cell monolayers and amplified in CEFs. 
One stock from NB1/5ws and two independent stocks from each of NB2/5ws 
Figure 4.6 
Neutralization ofRRVNB5092 and the CEF passaged variants NBl/5, 
NB2/5 and NB3/5 by polyclonal anti-RRV sernm 
Neutralization of NB5092, NB 1/5, NB2/5 and NB3/5 by polyclonal 
anti-RRV serum was measured by PRNA. Approximately 220 pfu of each 
virus stock were incubated with each dilution of antiserum for 60 min at 
36°. Control virus was incubated with 1:400 normal ascitic fluid. Duplicate 
100µ1 aliquots were plaque assayed on Vero cell monolayers and the 
percentage neutralization at each dilution calculated as the reduction in 
mean plaque numbers compared to the controls. The four viruses were 
assayed in parallel. The results of two independent PRNAs are shown in 
each panel as solid lines: assay 1, or broken lines: assay 2. 
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Table 4.1 
Neutralization of NB5092 and the CEF derived variants ~~1/5ws, NB2/5ws 
and NB3/5ws by anti E2 mAbs 
Neutralization titres of mAbs a 
Virus T1QC9 NB3C4 T1E7 T1Dll T4D'2 
NB5092 5.10 5.69 (5. 78, 5.92) 3.65 4.02 (3.44) 4.89 
NB1/5ws 5.49 3.94b (nd, nd) 3.35 <2.0b(l.53) 4.69 
NB2/5ws 3.48b 6.94C (6.31, 5.61) 4.56 3.37 (nd) nd 
NB3/5ws 3.26b 5.55 (5.68, 5.42) 4.38 3.65 (nd) nd 
a Neutralization titres were determined in PRNA (Methods; 4.2. 7) and are 
shown as the log10 mAb dilution producing 50% reduction in plaque 
numbers. Dilutions were 10 fold. Differences in titre of more than 10 fold · 
were regarded as significant. Values for separate, repeat experiments are 
shown in brackets. 
b significantly different to NB5092 
c an aberrant value that was not supported by repeat assays 
nd not tested 
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and NB3/5ws were then blind passaged five times in BHK cells (initial moi 
0.5-1). Incubation was at 36°, supernatants were harvested at the onset of 
cpe and 100µ1 of each supernatant was used to initiate the next passage. 
During backpassaging all stocks grew to high titres (> 108 pfu/ml as 
measured on Vero cell monolayers) in BHK cells, at all passage levels and 
caused cpe (data not shown). They retained the small plaque phenotype. 
After the fifth passage the five, non-plaque purified, passaged populations 
were compared with the starting stocks in a PRNA against NB3C4 or 
TlOC9 (Table 4.2). There was no significant difference in neutralization of 
passaged and unpassaged virus by these mAbs. 
It was concluded that the antigenic changes defined by mAbs T10C9 
and NB3C4 selected on passaging in avian cells were stable on 
backpassage in BHK cells. Passaging CEF adapted virus in BHK cells, 
even at high multiplicities of infection, did not lead to the decreases in titre 
that occurred on initial passaging in CEFs. In addition the viruses were 
all able to grow to high titres at 36° indicating that replication was not 
temperature sensitive in BHK cells. 
4.3. 7 The proportion of antigenic variants in CEF passage levels 2 and 3 
Following repeated passage of NB5092 in CEFs, at least two 
independent antigenic types had arisen, these were defined by decreased 
sensitivity to neutralization by mAbs NB3C4 or TlOC9. One type, resistant 
to mAb TlOC9 was selected twice independently. These variants were 
plaque purified from a limit dilution of the fifth passage stocks and may or 
may not have been representative of the population. To examine at what 
passage level these variants could be detected and what proportion of the 
population they represented, a series of plaques was picked from passage 
levels 2 and 3 of each passaging series. These plaques were amplified in 
BHK cells (BHK cells were used since no antigenic reversion had occurred 
Table 4.2 
Antigenic analysis of CEF passaged antigenic variants of NB5092 after 
backpassaging in BHK cells 
Neutralization titre ofm.Abs a 
Virus b NB3C4 TlOC9 
NBl/5/1 3.59 nd 
1/5/1/BP5 3.75 nd 
NB2/5/2 nd 3.10 
2/5/2/BP5 nd 2.58 
NB2/5/4 nd 2.73 
2/5/4/BP5 nd 2.58 
NB3/5/2 nd 2.44 
3/5/2/BP nd 2.51 
NB3/5/4 nd 2.37 
3/5/4/BP5 nd 2.22 
a Neutralization titres are shown as the log10 mAb dilution producing 50% 
neutralization. Dilutions were 10 fold. Differences in titre of more than 10 
fold were regarded as significant. 
b Plaques of NB 1/5ws, NB2/5ws, NB3/5ws, were picked and amplified in 
CEF cells. One clone of NB 1/5ws, denoted NB 1/5/1, and two clones of 
NB2/5ws and NB3/5ws, designated NB2/5/2, NB2/5/4, NB3/5/2,and NB3/5/4, 
were passaged five times in BHK cells (indicated as BP after the virus code). 
The final passage stocks were assayed in parallel with starting stocks in a 
PRNA against the mAb defining the antigenic type. 
nd not tested 
J 
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on backpassaging the CEF selected variants and CEFs were not routinely 
available) and stocks were analysed using PRNA with mAbs TlOC9 and 
NB3C4. 
For NBl/3 two of three isolates were resistant to NB3C4 indicating 
that the antigenic change had become dominant by the third passage. For 
passage series 2, three of four isolates examined at passage level 2 were 
resistant to mAb TlOC9. The one sensitive isolate was also sensitve to 
NB3C4 indicating that it had the NB5092 phenotype. A similar result was 
obtained for isolates examined from the third passage level. In passage 
series 3, one of four isolates was resistant to m.Ab T10C9 at the third 
passage level. One of the sensitive isolates was also assayed for resistance 
to mAb NB3C4 and proved sensitive (Table 4.3). 
Thus during the three passage series, three independent clones of 
NB5092 have generated two antigenic types independently and · at 
apparently different rates. The clones were antigenically equivalent prior 
to passaging. Mixed population of antigenic variant and wild-type occurred 
but a mixture of the two antigenic types was not detected. 
4.3.8 Antigenic analysis of the non-plaque purified fifth passage stocks. 
To examine the dominance of the antigenic variants in the fifth CEF 
passage populations, the non-plaque purified stocks NB 1/5, NB2/5 and 
NB3/5 were examined using a PRNA with mAbs NB3C4 and T10C9 and 
compared with the plaque purified stocks and NB5092 in the same assay 
(Table 4.4). The plaque purified and non-plaque purified stocks of NB 1/5 
were both increased in resistance to NB3C4, however, the plaque purified 
stock was 10 fold more resistant suggesting that wild-type NB5092 was still 
present at this level. For passage series 2 there was no difference between 
the plaque purified and non plaque purified fifth passage stocks and both 
were increased in resistance to mAb TlOC9. Passage series 3 showed no 
) 
Table 4.3 
aSingle plaques picked from second and third level CEF passages were 
amplified in BHK cells and assayed for neutralization in PRNA using 
mAbs TlOC9 and NB3C4. Dilution intervals were 10 fold. Differences in titre 
of greater than 10 fold were regarded as significant. All experiments were 
performed using NB 1/5ws, NB2/5ws, NB3/5ws and NB5092 as controls. 
Sensitivity or resistance were assigned accordingly. Intermediate 
sensitivities were not detected. 
b indicates the NB5092 clone, followed by the passage number from which 
the plaque was selected. 
S sensitive 
R resistant 
nd not tested 
Table 4.3 
Summary of antigenic analysis of plaques from intermediate CEF passages 
ofNB5092a 
Monoclonal antibody 
Virus b plaque no. NB3C4 T10C9 
NBl/3 3 R nd 
NBl/3 4 s nd 
NBl/3 8 R nd 
NB2/2 1 s s 
NB2/2 2 nd R 
NB2/2 3 nd R 
NB2/2 4 nd R 
NB2/3 1 nd R 
NB2/3 2 nd R 
NB2/3 3 nd R 
NB2/3 4 nd s 
NB2/3 5 nd R 
NB3/3 1 s s 
NB3/3 2 nd s 
NB3/3 4 nd s 
NB3/3 6 nd R 
Table 4.4 
Neutralization assays of the non-plaque purified, fifth CEF passage virus 
stocks a 
Virus mAbTlOC9 mAbNB3C4 
NB5092 6.0 CS) 5.82 CS) 
NB1/5ws 6.0 CS) 3.57 CR) 
NB1/5np 6.0 CS) 4.57 CR*) 
NB2/5ws 2.33 CR) 5.74 CS) 
NB2/5np 2.37 CR) 5.47 CS) 
NB3/5ws 2.41 CR) 5. 71 CS) 
NB3/5np 5.86 CS) 5.54 CS) 
aNeutralization of NB1/5ws, NB2/5ws, NB3/5ws and the non plaque 
purified, fifth CEF passage stocks from which these were derived, was 
compared to NB5092 in a PRNA. Neutralization titres are shown as the 
log10 mAb dilution producing 50% neutralization for mAbs T10C9 and 
NB3C4. Ten fold dilution intervals were used throughout. Differences in 
titre greater than 10 fold were regarded as significant. S, sensitive to 
neutralization by the mAb; R, resistant to neutralization compared to 
NB5092; R*, intermediate resistance; np, non-plaque purified. 
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difference in neutralization titre between the non-plaque purified stock and 
the NB5092 control. Since plaque purified NB3/5 was resistant to mAb 
T10C9 it appeared that this antigenic type was a minority of the population. 
It was also apparent that non-plaque purified NB3/5 was sensitive to mAb 
NB3C4 thus it appeared that the NBl/5 antigenic type was not significantly 
represented in this population and that the NB5092 antigenic type was 
predominant. 
4.3.9 Growth of RRV NB5092 and of CEF selected variants in CEFs 
One possible approach to confirming a selective advantage of the 
selected antigenic variants in CEFs is to examine the early growth kinetics 
of the viruses in CEFs. This was done by infecting CEF monolayers in 
triplicate with NB1/5ws, NB2/5ws, NB3/5ws or NB5092 (moi-0.5) and 
taking growth samples over the first 25 hours post-infection. The infected 
monolayers were incubated at 30°. 
NB5092 had a latent period of 7-9 hours, followed by a steady rise to a 
mean titre of 5xl07 pfu/ml. In contrast all the antigenic variants had a 
latent period of 11-13 hours (Fig 4.7). This experiment does not support the 
idea that selection of the antigenic variants in CEFs has been due to an 
early growth rate advantage. Interestingly the reverse appears to be the 
case with the selected virus growing slower than NB5092. 
4.3.10 Growth in mice of NB5092, NB1/5ws, NB2/5ws and NB3/5ws 
The NB5092 strain of RRV has been characterized extensively in 
mice (Mims et al.,1913; Murphy et al.,1913; Taylor and Marshall, 1975a). 
Unadapted NB5092 has low virulence for neonatal mice but on passaging 
in mice rapidly becomes virulent (Taylor and Marshall, 1975a; Meek et 
al.,1989). The increased virulence was accompanied by changes in the E2 
glycoprotein (Meek et al.,1989). These changes were not essential for 
Figure 4. 7 
Growth of RRV NB5092, NB1/5ws, NB2/5ws and NB3/5ws in CEFs at 30° 
CEF monolayers in 35mm dishes were infected (moi-1) with RRV 
NB5092, NB1/5ws, NB2/5ws or NB3/5ws and incubated at 30°. Each virus 
was used to infect triplicate monolayers. Growth samples of the culture 
supernatants were taken at appropriate times and EV titres assayed by 
plaque formation on Vero cell monolayers at 36° .Statistical analysis was by 
analysis of variance. Error bars represent least significant difference. 
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virulence although they may have enhanced it (Meek et al.,1989 ). Some 
amino acid alterations in E2 were also detected as antigenic variants using 
neutralization assays with the same panel of mAbs used in the current 
work (Meek, 1986). These observations, together with the earlier 
demonstration of Taylor and Marshall (1975a), that some strains of RRV 
could be attenuated for mice by passage in tissue culture, suggested that it 
was of interest to examine the growth and virulence in mice of the CEF 
passaged viruses. 
Three randomized litters of neonatal mice were injected 
subcutaneously (sc) with 100 pfu of NB1/5ws, NB2/5ws, NB3/5ws or NB5092. 
At 24 hour intervals three mice from each group were killed and blood, 
brain and muscle tissue removed for analysis of viral growth. Mice in all 
groups showed either no clinical symptoms of RRV infection or very mild 
hind leg stiffness, during the course of this experiment. A number of 
deaths occurred in the group infected with NB 1/5ws; all were between days 
3-5 post infection, because of this only enough mice were available to assay 
for virus growth for 8 days instead of the 10 day period used for the other 
three groups. These dead mice were not observed with clinical symptoms 
of RRV infection before death. 
Both NB2/5ws and NB3/5ws had mean peak 
. . 
v1raem1as 
approximately 100 fold lower than NB5092. The peak viraemia occured 3-4 
days later and virus disappeared from the blood 2 days earlier in the course 
of infection with these two variants compared to NB5092. NB1/5ws also had 
a somewhat different pattern of viraemia to NB5092; peak levels occurred 
at day 5 for NB 1/5ws compared to day 1 for NB5092 (Fig 4.8a). Virus titres 
in muscle followed the pattern set by the blood levels. NB2/5ws and 
NB3/5ws had substantially lower peak titres (10-100 fold) than NB5092 and 
virus disappeared from muscle tissue at around day 8-9, compared to 
NB5092 where virus was isolated from some mice at day 10. NB1/5ws had a 
Figure 4.8 
Titres ofRRVNB5092, NB1/5ws, NB2/5ws andNB3/5ws in the blood, 
muscle and brain of infected infant mice 
Litters of neonatal mice were inoculated (sc) with 100 pfu of NB5092, 
NB1/5ws, NB2/5ws or NB3/5ws. At 24 hour intervals three mice from each 
group were killed; blood, hind leg muscle and brain were harvested. Virus 
titres were determined for each tissue, from each mouse, as pfu/g (wet 
weight) or pfu/ml, by plaque assay on Vero cell monolayers. Samples were 
collected until 10 days pi except for NB 1/5ws where, due to the early deaths 
of several mice, samples were only collected up to day 8 pi. On day 10 only 2 
mice infected with NB2/5ws or NB3/5ws were available. 
Figure 4.8a 
Titres of RRV NB5092, NB1/5ws, NB2/5ws and NB3/5ws in the blood 
of infected infant mice 
Titres are the mean pfu/ml of the three mice assayed for each virus 
on each day, except as indicated above. Error bars represent least 
significant difference. Baseline titres are <500 pfu/ml, this is indicated by 
the arrow. All plaque assays were the mean of the number of plaques on 
duplicate monolayers. Where this was less than five plaques at the lowest 
dilution but some plaques were present, the titre was recorded as "trace". 
This is indicated by "t" on the graphs where a trace of virus was present in 
at least one mouse but the mean titre for all mice on that day was less than 
500 pfu/ml. 
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Figure 4.8b 
Titres ofRRVNB5092, NB1/5ws, NB2/5ws andNB3/5ws in the 
muscle of infected infant mice 
Titres are the mean pfu/g of the three mice assayed for each virus on 
each day, except as indicated above. Error bars represent least significant 
difference. Baseline titres are <500 pfu/g, this is indicated by the arrow. All 
plaque assays were the average of the number of plaques on duplicate 
monolayers. Where this was less than five plaques at the lowest dilution 
but some plaques were present, the titre was recorded as "trace". This is 
indicated by "t" on the graphs where a trace of virus was present in at least 
one mouse but the mean titre for all mice on that day was less than 500 
pfu/g. 
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Figure 4.8c 
Titres of RRV NB5092, NB1/5ws, NB2/5ws and NB3/5ws in the brains 
of infected infant mice 
Brain titres for each mouse are shown as this data was too scattered 
for meaningful statistical analysis. Baseline titres are <500 pfu/g, this is 
indicated by the arrow. All plaque assays were the average of the number 
of plaques on duplicate monolayers. Where this was less than five plaques 
at the lowest dilution but some plaques were present, the titre was 
recorded as "trace". This is indicated by "t" on the graphs. 
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similar pattern of muscle virus growth to NB5092 although titres were 
consistently lower (Fig 4.8b). Brain titres for all viruses were quite variable 
which precluded meaningful statistical analysis (Fig 4.8c). In mice 
infected with NB5092 titres in brain were inconsistent, especially in the 
first seven days, with often only a trace of virus detected in the brains of 
individual mice. In general the passaged variants grew to higher titres in 
brain than NB5092. Virus was still present in brain tissue for all variants 
at the conclusion of the experiment. 
In summary the CEF passaged variants NB2/5ws and NB3/5ws 
replicated substantially less efficiently in mice than the NB5092 strain 
from which they were derived. Specifically NB5092 had a higher and more 
prolonged viraemia and grew to higher titres in muscle than either of 
these variants. There was a trend for the CEF passaged variants to grow to 
higher titres in mouse brain than NB5092, however, the significance of this 
is unclear. 
4.3.11 A comparison of intracerebral and subcutaneous injection of 
NB5092 in mice 
The high variability of brain titres of RRV in mice, especially with 
NB5092, prompted a further investigation of the growth of this virus in 
mouse brain. Meek et al. (1989) reported a similar pattern of growth of 
NB5092 in mouse brain but the individual variability appeared to be much 
less. In this experiment neonatal mice were injected either sc or 
intracerebrally (ic) with lOOpfu of RRV. On days one to five pi brain and 
blood samples were collected, as previously described, from two mice in 
each group and assayed for virus. 
The mean brain titre of NB5092 following sc injection was low for the 
5 days post infection, reaching titres of 103-104 pfu/g. Intracerebral 
injection produced growth in brain to titres of 105-107 pfu/g (Table 4.5). This 
Table 4.5 
NB5092 growth in mice injected either subcutaneously or intracerebrally a 
Brain titre Blood titre 
(log10 pfu/g) Oog10 pfu/ml) 
Route of inoculation b 
~ • • ~ ~ ~ ~ 
1 <3 6.15 5.70 6.25 
2 <3 5.57 4.30 6.04 
3 4.0 6.45 3.70 5.48 
4 3.18 6.32 3.84 5.08 
5 3.40 7.32C <3 4.64 
aNeonatal mice were injected subcutaneously or intracerebrally with 100 
pfu of NB5092. Blood and brain were collected from two mice from each 
group on days 1-5 post-infection. Virus titres in each tissue were 
determined in pfu/ml or pfu/g (wet weight) on Vero cell monolayers and the 
mean titres are shown for each day. 
b sc, subcutaneous injection; ic, intracerebral injection. 
c on day 5 only one mouse was available from the ic group. 
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difference would be expected if the block in brain replication was due to 
interference in brain entry rather than an inability to replicate in brain 
tissue. This experiment provided further corroboration that the assay 
technique used was adequate to detect virus in the brain as high titres were 
found in the ic injected mice while the sc injected mice had similar brain 
titres to those found in the previous experiment. 
Two further observations are of interest: (1) brain titres in the sc 
infected group did not start to rise until after day two which is comparable 
with those of the CEF passaged clones in mouse brain (see Fig 4.8c). (2) 
Blood titres for NB5092 can be quite variable but the same pattern of highest 
titre on day 1, that was observed in the mouse growth assays (Fig 4.8a) was 
also seen in both the ic and sc infected groups in this experiment. 
4.3.12 Virulence assay of NB1/5ws and NB5092 in mice 
A number of observations suggested that NB1/5ws may have been of 
higher virulence for mice than NB5092. These included the death of several 
mice during growth assays and the higher brain titres observed in some 
mice infected with NB1/5ws compared with mice infected with NB5092. 
Meek et al. (1989) noted that increased growth of NB5092 variants in mouse 
brain was correlated with increased virulence. Therefore the virulence of 
NB5092 and NB1/5ws was compared in neonatal mice. 
Litters of 10-12 neonatal mice were injected sc with 102, 103, 104 or 
105 pfu of each virus and observed daily for clinical symptoms. No deaths 
occurred in either treatment group. For NB5092 clinical symptoms of 
mild/moderate hind leg weakness were observed in all four dose groups 
between days 8 and 13. Signs of severe hindleg paralysis were observed in 1 
of 10 mice in each of the two highest dose groups. All mice were clinically 
normal by day 14. For NB 1/5ws mild symptoms of hind leg stiffness were 
seen in all groups from day 8-12. No severe clinical symptoms were 
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observed and all mice recovered uneventfully by day 14. It was concluded 
that NB1/5ws was not more virulent than NB5092 and may be slightly less 
virulent, as the clinical effect of infection appeared somewhat milder. 
Therefore the deaths in the previous experiment were presumably due to 
factors other than the injected virus and may have related to 
mismothering or some other form of stress. 
4.3.13 Antigenic analysis of virus recovered from mouse muscle 
To examine whether antigenic revertants were selected during virus 
growth in mice, virus isolated from muscle from the day of peak muscle 
titre was examined using a PRNA against mAbs NB3C4 and T10C9. 
Working stocks of each virus were assayed in parallel as controls (Table 
4.6). The populations assayed showed no evidence of antigenic reversion at 
the epitopes characterized by these mAbs. 
4.3.14 Nucleotide sequencing studies of CEF passaged variants ofNB5092 
The results presented above show that two classes of antigenic 
variants were isolated after passaging RRV NB5092 in avian cells. These 
antigenic variants did not revert on backpassaging in BHK cells and were 
associated with alterations of virus growth in mice. Nucleotide sequencing 
of the complete E 1 and E2 genes of the antigenic variants was performed to 
determine the changes in structural glycoproteins associated with 
passaging. Sequence data was obtained for NB1/5ws, NB2/5ws and 
NB3/5ws using IC/RNA from either CEFs or BHK cells. NB5092 IC/RNA 
(extracted from BHK cells) was sequenced in parallel with the passage 
variants. The dideoxy chain termination method (Sanger et al., 1977) using 
extension from oligonucleotide primers was used in all studies (Methods; 
4.2.9). 
Table 4.6 
Antigenic analysis of virus isolated from muscle of mice infected with 
NB5092, NB1/5ws, NB2/5ws or NB3/5ws 
mAb neutralization titre a 
Virus b NB3C4 T10C9 
NB5092 5.71 5.53 
NB5092 (m) 5.50 5.66 
NB1/5ws 3.98 nd 
NBl/5 (m) 3.88 nd 
NB2/5ws nd 2.58 
NB2/5 (m) nd 3.06 
NB3/5ws nd 2.48 
NB3/5 (m) nd 2.63 
a The neutralization titres, with either mAb NB3C4 or mAb TlOC9, of virus 
isolated from infected mouse muscle and the stock used for infection, are 
shown as the log10 mAb dilution producing 50% neutralization in PRNA. 
ten fold dilution intervals were used. Differences in titre of greater than 10 
fold were regarded as significant. 
b Mouse muscle virus is indicated by (m) after the virus code. Mouse muscle 
virus was from the day of peak titre as follows; NB5092(m)=mouse 1, day 6; 
NB1/5(m)=mouse3 day 7; NB2/5(m)=mouse2 day 5; NB3/5(m)=mouse 1 day 5. 
nd, not tested 
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The E2 gene runs from nucleotide 1,048 in the NB5092 268 RNA to 
nucleotide 2,313 and encodes 422 amino acids in 1,266 nucleotides. The E 1 
gene extends from nucleotide 2,494 to nucleotide 3,807 and encodes 438 
amino acids in its 1,314 nucleotides (Faragher et al.,1988 ). A single G--,A 
transition was identified in the E2 gene of NB 1/5ws at position 1,057 leading 
to a deduced amino acid alteration of Glu--,Lys at amino acid 4 of the E2 
glycoprotein. No other nucleotide changes were identified in either E 1 or E2 
for this variant, however, sequence was not obtained for 55 nucleotides in 
El (Methods; 4.2.9). The variants NB2/5ws and NB3/5ws both had a single 
C--,A transversion in the E2 gene at nucleotide 1,701, leading to an amino 
acid change of Asn--,Lys at position 218 in the E2 glycoprotein. No other 
nucleotide alterations were detected (Table 4. 7). Thus all three variants 
had a change to a positively charged amino acid in E2. Amino acid 218 is 
close to epitope a whereas position 4 is not near any known neutralization 
epitope in the primary sequence. 
4.3.15 Location of amino acid alterations in the E2 glycoprotein of CEF 
passaged RRV in relationship to conserved amino acid sequence, 
hyclropathy profile and predict.ed secondary structure 
To obtain further information about the possible significance of the 
amino acid changes at position 4 and 218 of E2 the amino acid sequence of 
NB5092 E2 was compared with the aligned sequence for RRV T48, SFV and 
SIN. Hydropathy profiles, using the Kyte and Doolittle (1982) algorithm, 
and secondary structure predictions using the methods of Chou and 
Fasman (1978) and Garnier et al. (1978) were generated for NB5092 and the 
CEF passaged variants using the PeptideStructure program and presented 
graphically using PlotStructure (Jameson and Wolf, 1988; Wolfe et 
al., 1988). 
Table 4.7 
Nucleotide changes and deduced amino acid changes in CEF passaged 
variants 
Variant 
NB1/5ws 
NB2/5ws 
NB3/5ws 
nucleotide change 
andnumbera 
GAG-tAAG (1057) 
AAC-tAAA (1701) 
AAC-tAAA (1701) 
amino acid change 
andnumber 
Glu(4)-tLys 
Asn(218)-tLys 
Asn(218 )-t Lys 
a Nucleotides are numbered from the 5' end of the NB5092 26S RNA; amino 
acids are numbered from the N-terminus of E2 (Faragher et al.,1988). 
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The alteration at amino acid 218 in E2 of CEF passaged NB5092 is in 
a hydrophilic region of the protein as predicted by the Kyte and Doolittle 
(1982) algorithm. The hydropathy profile is not strongly conserved in the 
region surrounding amino acid 218 between RRV NB5092, T48, SFV and 
SIN (Fig 4.9). Amino acid 218 is in the middle of a five amino acid motif; 
Thr-Ile-Asn-Thr-Cys, which is completely conserved between NB5092, T48 
and SFV (Fig 4.10). The substitution of a charged lysine residue for the 
uncharged asparagine, could increase the hydophilicity of this region 
which is adjacent to epitope a, at position 216, and is within the major 
neutralization domain previously identified on E2 (Vrati et al.,1988). 
Amino acid 4 is at the beginning of a strongly conserved region of amino 
acid sequence for the alphaviruses RRV, SFV and, to a lesser extent, SIN 
(Fig 4.10). The N-terminus of NB5092 is predicted to be hydrophobic because 
of an Ile residue at position 3 and thus differs from RRV T48 which has a 
Thr at this position and a predicted hydrophilic N-terminus (Fig 4.9). 
Secondary structure predictions are of limited accuracy with a predictive 
value for any residue of approximately 66%, this is improved where two 
methods predict similar structures (Schulze and Schirmer, 1979). In this 
case secondary structure analysis predicted that the Glu-,Lys change at 
amino acid 4 altered a region of alpha helix to ~-sheet while that at 218 is 
in a region of predicted reverse turns and random coil structure (Fig 4.10). 
The location of the amino acid 218 change within a hydrophilic 
region of the E2 glycoprotein together with the change in antigenic 
reactivity strongly suggests that this residue is on the surface of the protein 
and that the predicted change, involving an alteration in charge, could 
alter the surface conformation of the E2 glycoprotein and its interactions 
with other molecules. Amino acid 4 is predicted to be adjacent to a 
hydrophobic region caused by the need to bury the hydrophobic side chain 
of the Ile at position 3. The change in NB 1/5ws charge together with the 
Figure 4.9 
Hydropathy profiles of the E2 protein of RRV NB5092, RRV T48, 
SFVandSIN* 
The hydropathy profile of E2 of RRV NB5092, RRV T48, SFV and SIN 
was determined using the algorithm of Kyte and Doolittle (1982). 
Hydrophobicity increases with distance above the horizontal line, 
hydrophilicity increases with distance below the horizontal line. The 
location of amino acid changes in CEF passaged variants (T) and of 
glycosylation sites ( +) are indicated. Tick marks on the baseline represent 
50 amino acid intervals. Search length was seven amino acids. 
Sequence data was from the following sources: RRV T48, Dalgarno 
et al. (1983); NB5092, Meek (1986); SFV, Garoff et al. (1980); SIN, Rice and 
Strauss (1982). 
* adapted from Meek (1986). 
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A colisting of the amino acid sequence of E2 for RRV NB5092, RRV T48, 
SFV and SIN. Dots indicate that the residue is identical to the NB5092 
sequence, gaps have been introduced to maximize homology. Potential 
glycosylation sites are underlined. The positions of differences between 
NB5092 and the CEF passaged variants are indicated CT). Sequence data is 
from Dalgarno et al. (1983) and Faragher et al. (1988). 
Figure 4.10 
Colisting ofRRV NB5092, T48, SFVand SIN E2 amino acid sequences 
T 
NB S V I E H F N V y K A T R p y L A X C A D C G D G y F C y s E2 (30) 
T48 T y ( 3 0) 
SFV . s Q I A H S H ( 3 0) 
SIN . D G . T L s . G T s y H H T E p F ( 2 7) 
NB p V A I E K I R D E A S D G M L K I Q V s A Q I G L D K A G E2 ( 60) 
T48 p ( 60) 
SFV . . A V . s T . F . I S D ( 6 0) 
SIN . . K . . Q V W . D . N T I R Q T F . y Q s (57) 
NB T H A H T K M R y M A G H D V Q E s K RD s L R V y T E2 (87) 
T48 . . I ( 87) 
SFV N . D y . I A D A I E N A V s K A (87) 
SIN A A S A N y s L K Q D T . K G T M D I K I s ( 8 7) 
NB s A A C s I H G T M G H F I VA H C P P G D y L K X S F E D E2 (117) 
T48 . V . (117) 
SFV . G D . F V . . . . . L . K . E F . Q V I Q (117) 
SIN . G P . A A L s y K . y . L . . K s VT V I V S (117) 
NB AN s H V KA C K V Q y K H D P L p V G R E K F V V R p H F E2 (147) 
T48 . D . . . . . (147) 
SFV T RN A . R . . R I . H . Q . T I . y (147) 
SIN s N s A T s . T L AR . I K K F . . y D L p . V H ( 14 6) 
NB G V E L p C T s y Q L T T A p T D E E I D M H T p p D I P D E2 (177) 
T48 . (177) 
SFV . K . I . T . . Q . E V . . . . . M . T (177) 
SIN . K K I . . V . D R L K E T A G y . T . . R . R p H A y ( 176) 
NB R T L L s Q T AG NV K I T A G G R T I R Y t:I C I C G R D E2 ( 2 0 6) 
T48 . . . . . . . . . ( 2 0 6) 
SFV . Q s . V . . K.K.V K T G ( 2 0 6) 
SIN T s y . E E s s . K . Y A K P p s . . t:::I I E . K . . D y ( 2 0 6) 
T 
NB NV G T T s T D K T I N T C K I D Q C HA A V T s H D K W E2 ( 235) 
T48 . . . . . . . . ( 235) 
SFV . . . N S . M L . E . V S . . D K . ( 235) 
SIN K T . . V . . R T E T G T A . K . . V y K s D Q T ( 23 6) 
NB X F T s p F V P RAD Q T A R K G K V H V P F p L T t:::I V I C E2 ( 2 65) 
T48 Q . . . . . . . R . . . . ( 2 6 5) 
SFV Q . N . E p . I D I ( 2 6 5) 
SIN V N . . D L I H D H T A Q . L L . . K . I p s . ( 2 6 6) 
NB R V P L A R A P D VT y G K K E V T L R L H p D H P T X F s E2 ( 2 9 5) 
T48 . L ( 2 9 5) 
SFV . . M . E . T I H R . H L (2 95) 
SIN M . . V . H N I H F H I s Q D T L L L T ( 2 9 6) 
NB Y R S L G A V P H P Y E E W V D K F s E R I I p V T E E G I E2 ( 325) 
T48 . E . . ( 325) 
SFV . . T . E D . Q y H T A AV . . T . p V D . M ( 325) 
SIN T R N . E . T T I V GK TV N E I D R D . L ( 32 6) 
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change in mAb reactivity and the predicted change in secondary structure 
suggest that the mutation at this site possibly alters local protein 
conformation. 
4.4 Discussion 
Passaging in avian cells selected variants of RRV NB5092 which had 
single amino acid changes in the E2 glycoprotein. Two types of variant 
were found; one, changed at amino acid 4 (Glu~Lys) and the other at 218 
(Asn~ Lys). Both classes of variant were defined by changes in 
neutralization by m.Abs. Variants with the Asn218~Lys difference were 
less efficiently neutralized by mAb TlOC9 than the parental NB5092. The 
Glu4~Lys alteration in NB1/5ws produced less efficient neutralization by 
m.Abs NB3C4 and TlDll. The two variants with the alteration at 218 
(NB2/5ws and NB3/5ws) were both characterized by attenuated growth in 
mice, as measured by virus levels in blood and muscle. 
4.4.1 Antigenic changes in E2 of CEF selected variants 
Monoclonal antibody TlOC9 defines epitope a at amino acid 216 on E2 
(Vrati et al.,1988). This is within the region between 216-251 identified as 
containing a major neutralization determinant of RRV. The data 
presented in this chapter demonstrated that an alteration in 218 from a 
neutral to a positively charged amino acid is sufficient to inhibit, but not 
abolish, neutralization by this m.Ab. 
Epitope b 1, defined by mAb NB3C4, has been mapped to amino acids 
232 and 234 of E2 by selection of escape mutants (Vrati et al.,1988). A 
deletion of amino acids 55-61 in E2 of RRV T48 also reduces neutralization 
by this mAb (Vrati et al.,1986). The demonstration of a third site, at amino 
acid 4, affecting neutralization by m.Ab NB3C4 suggests that the N-
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terminal region of the E2 protein is folded into apposition with epitope b.l. 
This is supported by the results with mAb TlDll which defines epitope .Q 
(Vrati et al.,1988). This epitope has not been mapped by escape mutants as 
it has not proved possible to select resistant variants in vitro. NB5092 is 
neutralized less efficiently by this rnAb than T48 (P.J. Kerr unpublished) 
and in competitive binding assays (CBAs) it competes with rnAbs NB3C4 
and T1E7 which define epitopes bl at 232-234 and b2 at 246-251 on E2 (Vrati 
et al.,1988). Neutralization of NB5092 by TlDll is almost abolished by the 
Glu4~Lys change in NB 1/5ws which suggests this amino acid is very close 
to the binding site of TlDll. Although the possibility that the amino acid 
change is affecting a binding site at a distance cannot formally be ruled out 
(Blondel et al.,1986). 
4.4.2 Attenuation in mice of the CEF selected variants NB2/5ws and 
NB3/5ws 
The two variants changed at E2 218 had similar patterns of mouse 
growth characterized by a low level of viraemia of short duration and 
reduced growth in muscle compared to NB5092. Two independently 
selected variants with the Asn218~Lys change in E2 had virtually the 
same mouse growth characteristics, while a third variant selected in 
parallel but with a change at amino acid 4 had a different pattern of mouse 
growth that more closely resembled that of NB5092. This is consistent with 
amino acid 218 being involved in modulating RRV NB5092 replication in 
mice, possibly by altering tissue tropism. It is not possible to exclude 
changes in nonstructural proteins or untranslated regions from 
involvement in this attenuation. This would require isolating clones 
without the change at 218 and assaying their growth in mice. Meek et al. 
(1989) showed that amino acid changes in E2 were selected during 
passaging RRV NB5092 in mice. Changes at positions 212, 232 and 251 
were close to or within defined neutralization epitopes. It was proposed 
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that alterations in E2 were involved in adaptation to mouse cells. It is 
interesting to note that the only amino acid change found in E2 during the 
course of the RRV epidemic in the Pacific Islands, where humans appear 
to have been the principal vertebrate host, was at residue 219; Thr4Ala 
(Burness et al.,1988). However, this did not result in changes in 
neutralization by the mAbs used here (Burness et al.,1988). 
A similar interaction between single amino acid alterations in 
neutralization epitopes, tissue tropism and virulence is seen in other 
viruses. For SIN, as already discussed in Chapter 3, selection for rapid 
penetration in tissue culture leads to changes in mAb reactivity and 
alterations in mouse virulence. These phenotypic changes are due to an 
alteration at amino acid 114 or to the addition of a glycosylation site at 
amino acid one of E2 which prevents PE2 cleavage (Olmsted et al.,1986; 
Davis et al.,1986; Polo et al.,1988; Russell et al.,1989). For influenza virus, 
passaging in avian or mammalian cells or selection of mAb resistant 
variants can lead to changes in tissue tropism or receptor recognition 
which appear to be generated by single amino acid alterations, in the 
haemagglutinin protein, adjacent to the receptor binding site (Philpott et 
al., 1990; Robertson et al., 1985; Deom et al.,1986; Rogers et al., 1983). 
Selection of mAb resistant variants produced similar effects on tissue 
tropism and virulence for other viruses, for example reovirus (Spriggs and 
Fields, 1982) and rabies (Tuffereau et al.,1989). For human 
immunodefficiency virus a single amino acid alteration in the gp120 
protein abrogates receptor binding, while other amino acid changes in the 
same region alter tissue tropism (Cordonnier et al.,1989). 
4.4.3 Mechanism of selection of NB5092 antigenic variants in CEFs 
It is highly probable that the amino acid changes in E2 have been 
specifically selected during passaging in avian cells, for the following 
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reasons. Starting from three independently cloned stocks, the number of 
passages was very small providing little opportunity for the accumulation 
of neutral mutations. In support of this no silent nucleotide changes \Vere 
found in some 7 .5 kb of nucleotide sequence analysis, covering the E 1 and 
E2 genes from three independently passaged and plaque purified virus 
populations. For comparison the NB5092 strain of RRV differs from the T48 
strain at 284 nucleotides; 81 % of nucleotide differences in the coding 
regions are silent (Faragher et al.,1988). In the E2 gene, 5 of 32 changes are 
coding while in E 1 only 3 out of 30 changes are coding. 
By passaging a virus in tissue culture it is possible to select variants 
with genetic and phenotypic alterations. This raises the question of 
whether such alterations relate to adaptation to the new cell type or are a 
response to selection pressure generated by the process of passaging itself, 
for example, generation of interfering activity, different temperature 
conditions (perhaps relaxing constraints on protein conformation), or 
different composition of culture medium. 
The mechanism of selection of the antigenic variants in CEFs is 
unclear. The simplest hypothesis is that the antigenic variants were able to 
outgrow the parental NB5092. Limited experimental data indicated that for 
NBl/5, non-plaque purified virus had a shorter lag period in CEFs than 
NB5092, supporting the idea of more rapid growth in chick cells. However, 
detailed analysis of extracellular virus production, using the plaque 
purified NB1/5ws, NB2/5ws and NB3/5ws showed that all three had a 
substantially longer lag period in CEFs than NB5092. Domingo et al. (1978) 
showed in competition experiments with bacteriophage Q~ that the faster 
growing wild-type outgrew mutants which had a relative replication rate 
of 0.8-0.9. Thus it appears that effects on growth rates under the conditions 
of passaging must be different to those in the growth assays to allow the 
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slower growing antigenic variants to become a substantial proportion of 
the population. 
It is possible that the increased positive charge on the variants is 
associated with an enhanced affinity for chick cells which in some 
circumstances gave the variant an advantage over NB5092. Analysis of 
RNA synthesis kinetics would provide further information on the lag 
period of viral replication. It is also possible that there are nonstructural 
protein changes or mutations in regulatory regions which were involved in 
selection in CEFs. Further experimentation along the lines indicated 
would be required to understand the mechanism by which selection has 
proceeded. 
All three passage series had a dramatic decrease in extracellular 
virus titre from the second passage with recovery on fifth passage. 
Antigenic analysis of plaques picked from intermediate passage levels 
indicated that the NB 1/5ws and NB2/5ws types were a major proportion of 
the passaged population after two to three passes. This was confirmed by 
antigenic analysis of the fifth passage non plaque purified populations. 
However, in passage series three the selected NB3/5ws antigenic variant 
did not become predominant. This suggests that selection of the analysed 
variants had little to do with the increase in titre on the fifth passage. It is 
possible that the major selection occurred during the first and second 
passages and that titre changes were related to extrinsic factors in the 
passaging. 
It appears that some form of interfering activity developed in the 
early stages of passaging which inhibited viral replication and that this 
was either selected against or diluted out during passaging. Experiments 
in which virus at various passage levels was grown in the presence or 
absence of AMD indicated no advantage to this treatment suggesting that 
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interferon was not responsible. The drop in titre followed by recovery and 
the very low levels of RNA synthesis observed when first passage virus was 
used to infect CEFs are suggestive of defective interfering (DI) particles 
(Holland et al.,1982). Martin et al. (1979) demonstrated DI particle RNA 
and interfering activity in RRV passaged in BHK cells. This was 
associated with higher rates of RNA synthesis compared to the 
unpassaged controls although both RNA synthesis and virus growth 
lagged behind that of the unpassaged virus. Defective interfering activity 
has been reported in a number of viral systems (Holland et al., 1982) 
usually associated with high moi passaging or persistent infections. In the 
case of RRV in CEFs, if DI particles were to play a role they would have to 
accumulate very early in the passage series, it is possible that passaging in 
an avian cell line at 30° encourages this. The demonstrated heterogenous 
nature of the CEF population may also play a role. Similar drops in titre 
have been described in yellow fever virus passaged in HeLa cells (Hardy, 
1963; Converse et al.,1971; Dunster et al.,1990). 
4.4.4 The temperature sensitive replication of RRV in CEFs 
Work with RNA synthesis kinetics and virus growth at 36° in CEFs 
showed a failure of detectable RNA synthesis. NB5092 but not T48 
replicated efficiently in CEFs at 30°. This, combined with temperature shift 
experiments, suggests that the ts block is at the post-attachment stage, 
involving cell entry and uncoating or RNA synthesis. The genetic 
differences between RRV T48 and NB5092 (Faragher et al.,1988) are too 
great for further molecular dissection of this difference between the 
viruses. An additional complication in investigating this ten1perature 
sensitive block was that growth of NB5092 was quite variable in secondary 
CEFs at 36°, this probably reflected the heterogenous nature of the cell 
population. It is possible that the lower temperature requirement is one 
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reason for the poor replication of RRV in birds which typically have higher 
body temperatures than mammals. 
One aspect that has not been considered in this discussion until now 
because of its speculative nature, is that the passage of NB5092 in CEFs at 
30° was also selecting for virus, with ts or other mutations, which did not 
plaque on Vero cell monolayers at the standard temperature of 36° and that 
this then resulted in an apparently decreased titre. This hypothesis would 
require that such virus was then outgrown by the antigenic variants or 
other variants, which would appear dominant in the population at early 
passage levels because other virus types did not form plaques. No attempt 
was made in this work to look for ts mutations, however, there was no 
evidence that the antigenic variants characterized had any growth 
disadvantage in mammalian cells at 36° based on the titres of the variants 
when grown in BHK cells. 
4.4.5 Conclusion 
In summary, passaging RRV NB5092 in CEFs selected variants 
with amino acid alterations in the E2 protein at either position 4 or 218. 
Both changes involved selection of a basic lysine residue. The mechanism 
of selection is unclear but three lines of evidence suggest that these 
changes oc-curred in functionally important regions of the protein. Firstly 
both amino acid changes altered neutralization by one or more mAbs 
indicating that the conformation of neutralization epitopes was altered. As 
already discussed neutralization epitopes are likely to be adjacent to, or 
part of, sites on the protein involved in virus replication. Secondly no other 
changes, either silent or coding were found in the nucleotide sequence of 
El or E2 of the passage variants suggesting that there had been positive 
selection pressure for the changes found. Thirdly the amino acid 
alterations altered the growth characteristics of NB5092 in mice. This was 
-
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most obvious for the change at 218 which was associated with a lowered 
viraemia and decreased muscle titre. 
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Chapt.er5 
The effect of growth and passaging in human or arthropod cells on the E2 
glycoprot.ein of RRV 
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5.1 Introduction 
In Chapter 4 the selection and characterization of passage variants 
of RRV NB5092 in avian cells was examined. These variants had been 
selected during passage in CEFs and were defined by antigenic and 
genetic changes in the E2 glycoprotein. RRV does not normally replicate in 
birds, therefore these changes may represent specific adaptation to avian 
cells. It was of interest to define changes in E2 selected on passaging RRV 
in other cell lines, examine the relationship of such changes to those that 
were selected in avian cells and to define whether different changes were 
selected in different strains of RRV. As discussed in chapter 4, such 
changes could be important in defining regions associated with virus-cell 
interactions. Therefore two strains of RRV (T48 and NB5092) were 
passaged in human and mosquito cells. 
Humans are frequently regarded as an incidental host for 
alphaviruses rather than being involved in transmitting virus to 
mosquitoes (Chamberlain, 1980). However, during the epidemic of 
polyarthritis in the Pacific Islands humans appeared to be the 
predominant vertebrate host for RRV and, in contrast to previous 
epidemics within Australia, the virus was isolated routinely from people 
with clinical symptoms (Aaskov et al.,1981a; Rosen et al.,1981; Tesh et 
al.,1981; Marshall and Miles, 1984; see Chapter 1). During the course of 
this epidemic only one nucleotide alteration was found in E2. This led to an 
amino acid alteration at position 219 (Burness et al.,1988) which is very 
close to epitope .a at 216 and to 218, at which changes were selected on 
passaging in CEFs. 
For alphaviruses, Durbin and Stollar (1986) demonstrated that 
passaging a strain of SIN in mosquito cells selected for amino acid 
alterations in E2 one of which was associated with host cell restriction. In 
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another group of arboviruses, the Bunyaviruses, neutralization of La 
Crosse virus by some mAbs depended on whether the virus was assayed in 
mosquito or vertebrate cells suggesting that the mAb epitope is 
neutralizing in one cell type but not the other. One epitope was only 
neutralizing in mosquito cells and it was suggested that this may 
represent an important determinant in the interaction of Bunyaviruses 
with insect cells (Grady and Kinch,1985). In addition a mAb resistant 
variant of LaCrosse virus was restricted in its ability to infect mosquitoes 
(Sundin et al., 1987). Stable genetic changes accumulating in the surface 
glycoproteins on passaging in mosquito cells also altered neutralization of 
Bunyaviruses by a panel of mAbs (James and Millican, 1986). It is possible 
that these epitopes are important determinants of cell specificity in 
Bunyaviruses and that similar determinants could be defined for RRV. 
A further aspect of alphavirus biology is the change in glycoprotein 
structure caused by host cell modification. This is exemplified by 
replication in mosquitoes. Mosquito cells do not add complex 
oligosaccharide chains containing sialic acid to E 1 and E2, but only add 
high mannose carbohydrate moieties (Stollar et al.,1916; Luukkonen et 
al.,1977; Hsieh and Robbins, 1984). Differences in the size and charge of 
carbohydrate moieties could change the antigenic reactivity of virus grown 
in mosquito cells compared to vertebrate cell grown virus. For SIN, Stollar 
et al. (1976) did not demonstrate any differences in antigenicity, using 
polyclonal antisera, between virus grown in mosquito, avian or 
mammalian cells. However, there is no data on antigenic changes 
involving mAb epitopes. 
The RRV mAbs, T1E7, T10C9 and NB3C4 have been mapped to 
epitopes close to the glycosylation sites at asparagine 200 and 262 on the 
RRV E2 glycoprotein (Vrati et al.,1988; see Chapter 2). By analogy with 
Sindbis virus (Mayne et al.,1985) the first of these sites is expected to have a 
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complex oligosaccharide. Therefore it was of interest to examine whether 
RRV strains grown in mosquito cells and therefore phenotypically altered 
in carbohydrate and charge at complex glycosylation sites were altered in 
neutralization by these mAbs. As part of this experiment, the same strains 
of RRV were passaged in mosquito cells to determine whether genetic 
changes were selected in E2 by growth of RRV in mos qui to cells and to 
compare any amino acid changes with those found in RRV passaged in 
human and avian cells. 
This chapter describes the passaging of the NB5092 and T48 strains 
of RRV in three human cell lines; SW13, 293 and HeLa and in the C6/36 
Aedes albopictus mosquito cell line. Neither strain of RRV was isolated 
from humans and they have not been passaged in human cell lines in the 
laboratory (although both have been plaque purified in an African green 
monkey cell line). The passaged virus populations were not plaque purified 
but were subjected to antigenic and sequence analysis to determine 
whether alterations had occurred in E2 on passaging. Initially only the 
region around the defined neutralization epitopes (amino acids 216-251) 
was sequenced, however since no alterations were found in this area, 
sequence analysis was extended to cover the 5' three-quarters of the E2 
gene and in several cases the entire E2 gene. Sequence alterations were 
analysed in terms of their location in the E2 glycoprotein and changes to 
hydropathy and predicted secondary structure. 
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5.2 Materials and Methods 
5.2.1 Virus stocks 
The plaque purified clones of RRV T48 and NB5092 used in this work 
were as described in Chapter 4. 
5.2.2 Cell lines 
SW13 cells, a continuous human adenocarcinoma line were 
provided by Dr. J.H. Strauss (California Institute of Technology, Pasadena, 
USA). 293 cells, a human foetal kidney cell line transformed with the ElA 
gene of adenovirus and HeLa cells, a continuous human adenocarcinoma 
line, were provided by Dr. A. Bellett (John Curtin School of Medical 
Research, Canberra, Australia). All human cell lines were grown · at 
36°/5% CO2, in EMEM plus 10% FCS. The propagation of mosquito cells 
(C6/36, Aedes albopictus) has been described in Chapter 3. The growth of 
Vero cell monolayers was as described in Chapter 2. 
5.2.3 Antiserum 
Monoclonal antibodies used in these studies were as described in 
Chapters 2 and 4. 
5.2.4 Plaque assays 
Plaque assays were performed on Vero cell monolayers as described 
in Chapter 2. 
5.2.5 Passaging RRV in human and arthropod cells 
Confluent human cell monolayers in 35mm dishes were infected 
with clones 1/0, 2/0 or 3/0 of either RRV T48 or NB5092 at a moi of 0.5-1. The 
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monolayers were incubated for the development of cpe, at which time the 
culture medium was harvested; if cpe was not apparent the medium was 
harvested after 48 hours. 100µ1 of the culture medium was used to infect 
the next monolayer in the series for a total of 10 passages. 
For passaging RRV in mosquito cells an initial low moi (-0.01), of 
the virus clones described above, was used (see Results). The mosquito cell 
line used in these passaging experiments does not develop cpe when 
infected with RRV and the culture medium was harvested after 24 hours . 
100µ1 of the first passage supernatant was used as the inoculum at the 
second passage and then 100µ1 of a 10-2 dilution of the preceding culture 
medium was used as the inoculum in subsequent passages. A total of five 
passages was performed in mosquito cells. For each cell line, virus 
obtained from the final passage was titrated on Vero cell monolayers and 
used as a working stock for subsequent experiments. 
5.2 6 Extraction of infected cell RNA 
Infected cell RNA was extracted from the cell line in which the 
passaging had been done infected with the appropriate working stock, as 
described in Chapter 3. 
5.2. 7 Nucleotide sequencing reactions using infected cell RNA 
Sequencing reactions and electrophoresis were as described in 
Chapter 3. The following primers were used: 
6K 2347, GGTTTTGTTCTCGTC; E2 1987, GATGATGCGCTCAGA; 
E2 1632, TTGTACCTGATAGTC; E2 1452, ACTTCTCTCTACCCACC; 
E2 1225, GGGCGTGGGTACCTG. Primer DNA sequences are written in the 
5'-3' direction. Priming sites are numbered from the 5' end of RRV NB5092 
268 RNA (Faragher et al.,1988). The sequences of unpassaged T48 and 
NB5092 were obtained in parallel using IC/RNA from BHK cells. Where 
crossbanding could not be resolved but the pattern was identical to that of 
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the unpassaged virus it was assumed that no nucleotide change had 
occurred. 
5.2.8 Plaque reduction neutralization assays 
PRNA on Vero cell monolayers were as described in Chapter 2. In 
all cases non-plaque purified virus was used. The NB5092 working stock 
from which clones 1/0, 2/0 and 3/0 were obtained was used as a control in 
all assays as it had previously been demonstrated that the clones did not 
differ antigenically from each other or the parent stock with these mAbs 
(see Chapter 4). Similarly the T48 working stock was used as a control for 
PRNA with passaged T48 after demonstrating that the clones did not differ 
from each other or the parent stock in neutralization. 
5.2.9 Protein structure analysis 
The computer analyses of protein secondary structure predictions 
and hydro pa thy profiles were done using the PeptideStructure program 
and presented graphically using PlotStructure (Jameson and Wolf, 1988, 
Wolf et al.,1988) as for Chapter 4. 
5.2.10 Virus nomenclature 
Virus stocks were named for the strain of RRV used ie T48 or NB, 
the cell line in which it was passaged, the original clonal stock ie 1, 2 or 3 
and the number of passages in that cell line, thus NB-SW13-1/10 represents 
clone 1 of NB5092 after 10 passages in SW13 cells. 
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5.3 Results 
To determine whether passaging RRV in human or arthropod cells 
selected for changes in E2, strains T48 and NB5092 were serially passaged 
in SW13, 293, HeLa and C6/36 cells. Passaging, nucleotide sequence 
analysis and antigenic analysis are described below for each cell line. 
Sequence analysis is summarized in Table 5.1. 
5.3.1 Passaging RRV NB5092 and T48 in SW13 cells 
Three clones of RRV T48 and three clones of RRV NB5092 were each 
serially passaged in SW13 cells ten times. Virus was harvested according 
to the appearance of cpe (Methods; 5.2.5). For NB5092 clones cpe took about 
24 hours to develop at the first passage this increased to 48 hours until 
passage 6, when it occurred about 30 hours pi, subsequent passages 
showed cpe at 24 hours pi. Clones of T48 showed cpe in all cases within 20-
24 hours pi. For T48 clones the titres obtained during passaging fell from 
2.9-4.3xl07 at passage 1 to 3.5-6.lxl06 at passage 6 and 2.3-3. 7xl06 at 
passage 10 (all titres are expressed in pfu/ml). NB5092 titres were only 
measured at passage 10 and were 1.6-2.7xl07 pfu/ml. The observations on 
cpe suggest that NB5092 decreased in titre during passaging but 
subsequently returned to a fairly constant titre . 
5.3.2 Sequence analysis of the E2 gene of RRV NB5092 and T48 clones 
passaged 10 times in SW13 cells 
To determine whether amino acid changes were selected in E2 
during passaging in SW13 cells the complete E2 gene was sequenced for 
NB-SW13-1/10, 2/10 and 3/10 (Methods; 5.2.7). For NB-SW13-1/10, NB-SW13-
2/10 and NB-SW13-3/10, a G~ U transversion was found at nucleotide 1,580 
(numbering from the 5' end of NB5092 26S RNA, Faragher et al.,1988 ). This 
caused a codon alteration from CGC~CUC leading to a predicted non-
Table 5.1 
Regions examined and amino acid changes and location in the E2 protein 
of RRV T48 and NB5092 passaged in human and arthropod cells a 
aThe RRV NB5092 and T48 passage populations sequenced are shown. The 
regions of E2 sequenced are indicated in terms of the regions of the protein 
covered. Predicted amino acid changes and position are given; numbering 
is from the N-terminus of E2. Nil indicates no amino acid change was 
found; * indicates a change at which the wild type nucleotide was still 
present in the population. No silent nucleotide changes were found. 
Virus RegionofE2 Amino acid changes 
examined 
NB-SW13-1/10 1-422 Argl 78~Leu * 
NB-SW13-2/10 1-422 Argl 78~Leu* 
NB-SW13-3/10 1-422 Argl 78~Leu,* 
Asn119~Tyr 
T48-SW13-1/10 1-297 nil 
T48-SW13-2/10 1-298 nil 
T48-SW13-3/10 1-308 Pro162~Ser 
NB-293-1/10 1-308 nil 
NB-293-2/10 1-308 nil 
T48-293-1/10 1-305 Alall~Thr 
T48-293-2/10 1-305 nil 
T48-293-3/10 209-306 nil 
T48-HeLa-2/10 204-303 nil ) 
T48-HeLa-3/10 220-303 nil 
NB-mosq-1/5 1-307 nil 
366-422 
NB-mosq-2/5 1-307 nil 
366-422 
T48-mosq-1/5 1-126 nil 
146-185 
218-308 
T48-mosq-2/5 1-126 nil 
149-183 
217-308 
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conservative amino acid change (Argl 78~ Leu) in E2. In all three 
populations a faint G band could also be seen at this position suggesting 
that the population was heterogenous at this nucleotide. For NB-SW13-3/10, 
a second change was found at nucleotide 1,402; an A~ U transversion 
produced a codon alteration from AAU~ UAU and a predicted amino acid 
change (Asn119~Tyr). No other nucleotide changes were found in any of 
the variants sequenced. Of the three passaged clones, NB-3/10 also retained 
the strongest G band at nucleotide 1,580. All three clones had previously 
been sequenced following passage in CEFs (Chapter 4). No changes from 
the NB5092 sequence were identified at these nucleotides, therefore it is 
reasonable to assume that the nucleotide changes described occurred 
during passaging in SW13 cells. 
The T48 tenth passage stocks T48-SW13-1/10, T48-SW13-2/10 and T48-
SW13-3/10 were sequenced between nucleotides 1,051-1,942, 1,051-1,944 and 
1,051-1,976 respectively (numbering from the 5' end of the T48 268 RNA, 
Dalgarno et al., 1983) and corresponding to amino acids 1-297, 1-298 and 
1-308. A single change was found in T48-SW13-3/10 at nucleotide 1,534, a 
C ~ U transition causing a codon change of CCC-, UCC leading to a 
predicted, non-conservative, amino acid alteration in E2 (Pro162~Ser). No 
changes were found in the other clones. To confirm that this change was 
selected on passaging in SW13 cells, T48-293-3/10 and T48-HeLa-3/10 were 
sequenced through the region coding for amino acid 162; no change was 
found from the T48 sequence (data not shown). 
5.3.3 PRNA of NB5092 clones following 10 passages in SW13 cells 
To determine whether the predicted amino acid changes at position 
178 or 119 in NB5092 clones altered neutralization epitopes, antigenic 
analysis of the NB5092 tenth passaged clones was done using PRNA with a 
panel of mAbs consisting of T1E7, NB3C4, T10C9 and TlDll (Table 5.2). 
Table 5.2 
The neutralization of RRV NB5092 populations, passaged 10 times in 
SW13 cells, by a panel of mAbs a 
Monoclonal antibody 
Virus TlDll T1E7 NB3C4 TlOC9 
NB5092 4.02 4.46 5.96 5.45 
NBl/10 3.25 4.48 5.84 5.51 
NB2/10 3.38 4.57 5.82 5.48 
NB3/10 3.95 4.35 5.88 5.38 
aTitres shown are the reciprocal of the log10 mAb dilution producing 
50% reduction in plaque numbers in a PRNA for NB5092 and the SW13 
passaged populations 1/10, 2/10 and 3/10 by mAbs TlDll, T1E7, NB3C4 and 
TlOC9. Ten fold dilution intervals were used in all assays. Differences in 
titre of less than one dilution interval were not regarded as significant. 
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There was no significant difference between the neutralization of the 
NB5092 population and the NB1110, NB2/10 and NB3/10 populations. 
5.3.4 Passaging RRV NB5092 and T48 in 293 cells 
Three clones ofT48 and two clones ofNB5092 (NBl/0 and NB2/0) were 
serially passaged ten times in 293 cells. T48 clones caused rapid cpe in 293 
cells between 18-20 hours post-infection during the first three passages, 
time to cpe then increased to 27-36 hours from passages 4-8 decreasing to 
18 hours at passages 9 and 10. Titres after passage 1 were 1.1-1.6xl07 
pfu/ml, after passage 3, 4.3-5.5xl06 and after passage 10, 7.2xl06-1.2xl07 
pfu/ml. Thus the increased time to show cpe appears to correlate well with 
a drop in titre during passaging. 
When NB5092 clones were passaged in 293 cells cpe was initially 
observed after 36 hours. No cpe was observed, up to 48 hours, for passages 2 
and 3 but for subsequent passages, cpe was consistently observed between 
20-24 hours. During passaging titres were 8.0xl06 and 1.lxl07 pfu/ml at 
passage 1 and 1.3 and 1.8xl08 pfu/ml at passage 10, therefore the decreased 
time to cpe was associated with an increased moi during passaging. 
5.3.5 Sequence analysis of the E2 gene ofRRVT48 andNB5092 passaged in 
293 cells 
The NB5092 passaged viruses NB-293-1/10 and NB-293-2/10 were 
sequenced between nucleotides 1,048 and 1,958 (numbering from the 5'end 
of the 268 RNA). This corresponds to amino acids 1-308 of E2. No nucleotide 
alterations were found in this region for either virus. The T48 passaged 
clones T48-293-1/10 and T48-293-2/10 were sequenced from nucleotides 
1,051-1,965 corresponding to amino acids 1-305; T48-293-3/10 was sequenced 
between nucleotides 1,679-1,970, which corresponds to amino acids 209-306, 
this includes the neutralization epitopes described between the RRV E2 
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glycosylation sites (Vrati et al.,1988) A single alteration was found in T48-
293-1/10; a G~A transition at nucleotide 1,081 leading to a codon change of 
GCU ~ACU which gives a predicted, non-conservative, amino acid change 
(Alal 1 ~Thr) in E2. No other nucleotide changes were found. 
5.3.6 PRNA of clones of NB5092 and T48 passaged 10 times in 293 cells 
To confirm that no changes had been selected in neutralization 
epitopes during passaging in 293 cells antigenic analysis of the NB5092 
passaged virus clones was done using a panel of three mAbs; T1E7, T10C9 
and NB3C4 to perform PRNAs (Table 5.3). No significant changes in titre 
were observed between the tenth passage populations and NB5092. T48-293-
1/10 was also assayed against NB3C4, TlD 11, T1E7 and T10C9 to determine 
whether an alteration at amino acid 11 altered neutralization by these 
mAbs. No differences in titre were found for the passaged populations 
compared to T48 (data not shown). 
5.3.7 Passaging RRV T48 and RRV NB5092 in HeLa cells 
Three clones of RRV T48 were passaged serially ten times in HeLa 
cells; passaging was also attempted with NB5092, however, while NB5092 
grew to titres of -107 pfu/ml in the first passage, the virus was consistently 
lost after 3-4 passages (data not shown). For this reason passaging of 
NB5092 was not pursued in HeLa cells and only a limited analysis of T48 
passaging was undertaken since one of the aims of this work was to 
compare changes between these two genetic types of RRV. 
Titres of T48 clones during passaging were 3.4-4. lxl06 after the first 
passage and 7 .0-9.4x1Q6 pfu/ml after the tenth passage. Unequivocal cpe 
was not observed until passage 4 and after this, consistently occurred 22-36 
hours post-infection. Thus while T48 also does not appear to have grown 
particularly well in HeLa cells there is evidence of some adaptation to this 
Table 5.3 
The neutralization of RRV NB5092 populations, passaged 10 times in 293 
cells, by a panel of mAbs a 
Virus 
NB5092 
1/10 
2/10 
Monoclonal antibody 
T1E7 NB3C4 TlOC9 
4.34 (4.34) 5.51 (5.65) 4.82 
5.36 (5.12) 6.00 (5.86) 5.26 
5.07 (4.70) 6.00 (nd) 4.82 
aTitres shown are the reciprocal of the log10 mAb dilution producing 
50% reduction in plaque numbers in a PRNA for NB5092 and the 293 
passaged populations NBl/10 and NB2/10 by mAbs T1E7, NB3C4 and 
TlOC9. Ten fold dilution intervals were used in all assays; values in 
brackets represent repeat determinations. Differences in titre of less than 
one dilution interval were not regarded as significant. 
nd not determined 
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cell line during passaging. T48 clones 1/10 and 2/10 were sequenced 
between nucleotides 1664-1958 and 1710-1958 respectively, corresponding to 
amino acids 204-303 and 220-303. No nucleotide alterations were found in 
the regions sequenced. No antigenic analysis of the T48 passaged clones 
was done. 
5.3.8 Growth and passaging of RRV T48 and RRV NB5092 in arthropod 
cells 
Three clones of RRV T48 and NB5092 were passaged five times in 
C6/36 (Aedes albopictus ) cells. The passaging protocol used in this cell line 
differed from the previously used serial passaging by incorporating a low 
moi first passage. This was to enable growth of first passage virus that 
would have no or minimal genetic alterations but would be changed in the 
phenotypic characters typical of mos qui to cell grown virus ie membrane 
composition and lack of sialic acid in added carbohydrate chains (Stollar et 
al.,1976; Luukkonen et al.,1977; Hsieh and Robbins, 1984). It was of interest 
to examine whether this effect alone could be distinguished, in virus 
grown in mosquito cells, using mAbs with epitopes around the 
glycosylation sites on the E2 glycoprotein. The second intention of this work 
was to examine the E2 glycoprotein for genetic changes following passage 
in mosquito cells. Because of the high titres (>108 pfu/ml) obtained at each 
passage level the later passages were made at a 10-2 dilution to minimize 
the potential for interference. 
5.3.9 Antigenic analysis of RRV T48 and RRV NB5092 passaged in C6/36 
cells 
PRNA using mAbs T1E7, T10C9 and NB3C4 with T48-1/5, T48-2/5, 
T48-3/5 and NB-1/5 and NB-1/1 showed no difference in neutralization titres 
compared with the unpassaged controls (Table 5.4). This implied that 
neutralizing antigenic sites associated with these three m.Abs were not 
Table 5.4 
The neutralization of RRV NB5092 and T48 populations, by a panel of 
m.Abs, following passaging in mosquito cells a 
Monoclonal antibody 
Virus T1E7 NB3C4 TlOC9 
T48 5.30 5.72 5.76 
T48-1/5 5.37 5.74 5.92 
T48-2/5 5.30 5.62 5.35 
T48-3/5 4.97 5.56 5.35 
NB5092 4.91 6.23 5.07 (5.22) 
NB-1/1 4.54 6.04 5.21 (5.43) 
NB-1/5 5.07 6.17 5.53 (5.53) 
aTitres shown are the reciprocal of the log10 mAb dilution producing 
50% reduction in plaque numbers in a PRNA for RRV T48 and NB5092 and 
the mosquito cell passaged populations T48-1/5, T48-2/5, T48-3/5, NB-1/1 
and NB-1/5. The T48 and NB passage series were assayed on separate 
occasions and the results are shown together for convenience, therefore no 
comparison can be made between NB5092 and T48 neutralization titres. 
Ten fold dilution intervals were used throughout; repeat determinations 
are shown in brackets. Differences in titre of less than one dilution interval 
were not regarded as significant. 
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altered either phenotypically by growth of the virus in mosquito cells or 
genetically by limited passaging in mosquito cells. 
5.3.10 Sequence analysis of the E2 gene of RRV T48 and RRV NB5092 
passaged in C6/36 cells 
Nucleotide sequence was obtained for NB-mosq-1/5 and NB-mosq-2/5. 
The region sequenced was from nucleotides 1,048-1,973 and from 2,145-
2,330 corresponding to amino acids 1-307 and 366-422 of E2. No nucleotide 
changes were found. For T48-mosq-1/5 and T48-mosq-2/5, nucleotides 1,051-
1,427, corresponding to amino acids 1-126; nucleotides 1,488-1,603 and 
1,496-1,600, corresponding to amino acids 146-185 and 149-183; and 
nucleotides 1,706-1,975 and 1,704-1,975, corresponding to amino acids 218-
308 and 217-308 were sequenced. No nucleotide alterations were found in 
either of these mosquito-cell passaged populations. Although there are 
gaps in this sequence the regions in which changes had previously been 
found in other passage series are covered. 
5.3.11 Analysis of amino acid changes in terms of amino acid sequence 
conservation, hydropathy profiles and predicted protein structure 
The passaging done, the cell lines used, regions of E2 sequenced, 
and predicted amino acid alterations are summarized in Table 5.1. The 
majority of changes in E2 were found in virus clones passaged in SW13 
cells. A consistent alteration of arginine to leucine at amino acid 178 was 
found for all three NB5092 passaged populations. 
The arginine at position 178 is conserved between RRV and SFV and 
is in a region of strong amino acid conservation between these two viruses, 
however, there is virutually no sequence conservation with SIN (Fig.5.1).It 
might be expected that the virus surface structure could be altered in this 
region to bury the hydrophobic side chain of leucine in the interior of the 
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A colisting of the amino acid sequence of E2 for RRV NB5092, RRV T48, 
SFV and SIN. Dots indicate that the residue is identical to the NB5092 
sequence, gaps have been introduced to maximize homology. Potential 
glycosylation sites are underlined. The positions of differences between 
NB5092 and the human cell passaged variants are indicated ('Y). Sequence 
data is from Dalgarno et al. (1983) and Faragher et al. (1988). 
Figure 5.1 
Colisting ofRRV NB5092, T48, SFVand SIN E2 amino acid sequences 
... 
NB S V I E H F N V Y K A T R p y L A X C A D C G D G y F C y s E2 (30) 
T48 T y ( 30) 
SFV . s Q I A . H s H ( 30) 
SIN . D G . T L s G T . s y H H T E P F ( 2 7 ) 
NB p V A I E K I R D E A S D G M L K I Q V s A Q I G L D K A G E2 (60 ) 
T48 . p (6 0 ) 
SFV . . A V . s . . T . . . . . . F I S D ( 6 0) 
SIN . . K . Q V W . D . N T I R . Q T . F y Q s (57) 
NB T H A H T K M R y M A G H D V Q E s KR D s L R V y T E2 ( 8 7) 
T48 . I (87) 
SFV N . D y . I A D . A I E NA V s . K A (87) 
SIN A A S A N . y . . . s L K Q D . T . K G T M D I K I s (87) 
NB s A A C S I H G T M G H F I V A H C P P G D Y L K X s F E D E2 (117) 
T48 . 
. . V . . . . (117) 
SFV . G D . F V . L . K . . . E F . Q V . I Q . (117) 
SIN . G P . A A L s y K . y . L . K . . . . . s V T V . I V s (117) 
T 
NB A N S H V KA C K V Q y K H D P L p VG R E K F V V RP H F E2 (147) 
T48 . D . . . . . . . . (147) 
SFV T RN A . R . . R I . H Q . . . . . T I . . . y (147) 
SINS N S A T S . T L AR . I K . K F . . . y D L p . V H ( 14 6) 
T NB G VE L p C T s Y Q L T T AP T D E E I D M H T p p D I p D E2 (177) 
T48 . 
. . . (177) 
SFV . K . I . T . . Q . . E V . . M . T (177) 
SIN . K K I . . . V . D R L K E T . A G y . T . . R . R p H A y ( 176) 
T 
NB R T L L s Q T AG NV K I T A G G R T I R y N C I C G R D E2 ( 20 6) 
T48 . . . . . . . . . . ( 2 0 6) 
SFV . . Q s . V . . K.K.V K T G ( 2 0 6) 
SIN T s y E E s s . K . YAK p p s . . N T . E . K . . D y ( 2 0 6) 
NB NV G T T s T D K T I N T C K I D Q C HA A V T s H D KW E2 ( 235) 
T48 . . . . . . . . . . . ( 235) 
SFV . . N S M . . . L . E . V S . . D . K ( 235) 
SIN K T . . V . . RT E . T G . T A . K V y K s D Q T ( 23 6) 
NB X F T s p F V P RAD Q T A R K G KV H V P F p L T N V T C E2 (2 65) 
T48 Q . . . . . . R . . . (2 65) 
SFV Q N . . E p . . . . . I . . D I (2 65) 
SIN V . N . D L I H . D H T A Q . . L L . . K I p s ( 2 6 6) 
NB R V P L A R A P D V T y G K K E V T L R L H p D H P T X F s E2 ( 2 95) 
T48 . L ( 2 95) 
SFV . M . E T I H . R . . H . . L ( 2 95) 
SIN M . . V . H N . I H F H I s . Q D T . . L L L T ( 2 9 6) 
NB y R S L G A V P H p y E E W V D K F s E R I I P V T E E G I E2 ( 325) 
T48 . E 
. . . . . . . ( 325) 
SFV T . E D . Q y H . . . T A A V . . T . p VD . M (325) 
SIN T . R . . N . E . T T . . I V G K T V . N E I . D R D . L ( 32 6) 
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protein. This was examined using hydropathy profiles generated for the 
passaged virus and NB5092 E2 sequence. The change from an arginine to a 
leucine altered a hydrophilic region to a strongly hydrophobic peak (Fig 
5.2). There was no change in predicted secondary structure using either 
the Chou and Fasman or Garnier algorithm, al though, the two methods 
do not agree on the predicted structure of this region (Fig. 5.2). NB-SW13-
3/10 is also altered at a second residue Asnl 19~Tyr. This is in a region of 
poorly conserved amino acid sequence and the amino acid at this position 
is not conserved between NB5092 and T48 (Fig 5.1). This residue is in a 
moderately hydrophilic part of the protein in a region of predicted alpha 
helix. The Asn~Tyr change reduces hydrophilicity slightly but does not 
change the predicted secondary structure (data not shown). 
For T48 passaged in SW13 cells one amino acid alteration was found 
in one passage series (SW13-3/10 Pro 162~Ser ). This residue of E2 is not 
strongly conserved but is within a region of amino acid sequence 
conservation between RRV and SFV (Fig 5.1). The change from a praline 
might be expected to alter predicted secondary structure but this amino 
acid is in a short unstructured region of the protein and no change was 
observed in predicted secondary structure or in hydropathy (data not 
shown). Only one other change in E2 was detected in these passaging 
experiments (T48-293-1/10; Alall~Thr). The amino acid sequence at this 
position is conserved between RRV and SFV but not SIN. This is in a 
hydrophilic region of E2 and the change to a polar amino acid increased 
the hydrophilicity of the region marginally. The Chou-Fasman algorithm 
predicted that amino acid 11 was at the end of a weak helix forming region 
which was abolished by the amino acid change, however, the Garnier 
model predicted a segment of turns and random coil, which was not 
changed by the Ala~Thr substitution. 
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In summary, based on hydrophobicity plots, changes in amino acid 
sequence occurred at positions that were likely to be exposed on the surface 
of the protein. None of the changes occurred in the region of known 
neutralization epitopes on E2 nor did these changes alter the antigenic 
reactivity of the passaged populations. 
5.4 Discussion 
5.4.1 Amino acid changes selected in E2 during passaging in human cell 
lines 
Non-conservative amino acid alterations were selected in the E2 
glycoprotein on passaging clones of RRV NB5092 and T48 in human cell 
lines. Most of the changes occurred in SW13 cells. In all three passage 
series of NB5092 in SW13 cells a change at Argl 78~Leu was selected. The 
NB-SW13-3/10 passage population had two predicted amino acid sequence 
changes in E2; the change at position 178 described above and in addition a 
change at position 119 (Asn~Tyr). The nucleotide at position 1,580 (amino 
acid 178 codon) was heterogenous on sequencing gels but there was no 
evidence of heterogeneity at nucleotide 1,480 (amino acid 119 codon) 
suggesting that this change was selected early in the passaging series 
before the change at nucleotide 1,580. Amino acid 178 is in a region of E2 
which is strongly conserved between RRV and SFV. T48 passaged in SW13 
cells did not alter in this region, however, a change did occur in one T48 
passage series (T48-SW13-3/10) at amino acid 162 (Pro~Ser). This residue 
is in a highly conserved region of E2 but the amino acid at 162 is not 
conserved. This may imply that the residue is not critical in terms of 
protein structure and function and therefore that alteration at this position 
Figure 5.2 
Hydro pa thy profiles and secondary stnicture predictions for the E2 
glycoprotein of RRV NB5092 and RRV NB-SW13-1/10 
Analysis of protein hydropathy profiles and secondary structure 
predictions were done using the PeptideStructure program and presented 
graphically using PlotStructure (Jameson and Wolf, 1988; Wolf et al.,1988). 
These programs use the method of Kyte and Doolittle (1982) for prediction 
of hydropathy (indicated as KD). Note that values are multiplied by -1 so 
that hydrophilicity increases with distance above the axis and 
hydrophobicity increases with distance below the . axis. Modified 
algorithms of Chou and Fasman (1978) and Garnier et al. (1978) are used 
for prediction of secondary structure (indicated as CF and GOR 
respectively). Glycosylation sites are indicated beneath the secondary 
structure predictions. 
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may be neutral. In support of this the alteration of Pro162~Ser did not 
change the predicted secondary structure of the protein. 
Only one nucleotide change, in one passage series, was found in 
clones of NB5092 and T48 passaged in 293 cells. This was in T48-293-1/10 
and caused a predicted amino acid change of Alall~Thr. The strong 
amino acid conservation of this residue and the change from a non-polar to 
a polar amino acid suggests that this may be a positive selection of an 
uncommon mutation. To an extent this can be examined by analysing the 
possible single base mutations in this codon. Any third position change is 
silent and only the observed G~A transition leads to Thr. Serine could also 
have been selected but this would have required the less common G~ U 
transversion. 
5.4.2 Significance of amino acid changes selected in E2 during passaging 
In this work only the E2 gene sequence has been examined and in 
some cases only partial sequence analysis has been performed. However, 
for RRV isolates passaged in human cell lines approximately 11,000 
nucleotides were sequenced to detect six nucleotide alterations, in addition 
another 3,700 nucleotides were sequenced for RRV passaged in mosquito 
cells and no nucleotide changes were detected. Thus for nearly 15,000 
nucleotides examined only six changes were found, all coding for non-
conservative amino acid alterations. For CEF passaged clones of NB5092 
(see Chapter 4) approximately 7,500 nucleotides were sequenced in E 1 and 
E2 to define three nucleotide changes in E2, again all leading to non-
conservative amino acid alterations. Thus a total of approximately 22 
kilobases was sequenced to define nine nucleotide changes none of which 
were silent and all of which coded for non-conservative amino acid 
substitutions. As discussed in Chapter 4 this suggests that amino acid 
changes at specific sites are the results of positive selection during 
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passaging. But the possibility of neutral mutations which do not affect 
protein stucture and function cannot be excluded. The change at position 
162 of T48 passaged in SW13 cells is a possible example of such a mutation 
as it is an amino acid which is not conserved between T48 and NB5092 and 
occurs in a region of the protein which is predicted to be relatively 
unstructured. 
One aim of this work was to compare the amino acid changes 
selected in E2 for two strains of RRV on passaging in human and 
arthropod cells with those selected in NB5092 passaged in avian cells. None 
of the changes selected on passaging in human cells were at the same 
amino acid position as the alterations selected in CEFs. Nor were changes 
to positively charged amino acids selected. In addition the neutralization of 
human passaged variants was not altered by the panel of mAbs tested. As 
the amino acid changes in CEF passaged NB5092 occurred in or around 
neutralization epitopes it seems that these changes may not be closely 
related to those selected during human cell passaging. This is exemplified 
by the changes in the N-terminal portion of E2: an amino acid change at 
residue 4 (Glu-,Lys) of NB5092 altered neutralization by mAbs NB3C4 and 
TlDll (see Chapter 4), however, a change at residue 11 (Ala-,Ser) of T48 
did not change neutralization by these mAbs. 
The T48 and NB5092 strains of RRV did not have the same amino 
acid changes selected on passaging in human cell lines. In the primary 
amino acid sequence of E2 the changes at 178 and 162 are quite close but it 
is unknown how these residues relate in the folded protein. It appears that 
changes selected during cell passaging of RRV were both cell and virus 
strain specific. 
The functional significance of those amino acid changes selected 
during passaging is unknown because, apart from neutralization assays, 
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no experiments have been done to examine altered phenotypic properties of 
the passaged virus populations. The changes may represent adaptations at 
different phases of the virus replication cycle. These include cell 
attachment, receptor binding, virus uncoating, intracellular processing 
and transportation or virus assembly and release. They may in some cases 
be selected under the pressures that develop during passaging that are 
virus rather than cell driven, for example, interfering activity. The 
simplest explanation is that these changes are an adaptation to a specific 
cell type although the adaptative value of changes in E2 may not be 
immediately apparent from simple sequence inspection. It is interesting to 
speculate that the Arg~Leu alteration at 178, which causes a significant 
increase in hydrophobicity in this region of the protein and occurred in all 
three passage series may have been associated with the change in growth 
characteristics of NB5092 clones in SW13 cells which was observed as a 
decreased time to cpe. 
Further studies would be required to define the adaptive significance 
of the amino acid changes which have been identified in E2 following 
passaging in human cells. These types of studies include plaque 
purification of virus from different passage levels and examination of virus 
isolates for phenotypic alterations as well as attempting to define genetic 
changes in other regions of the genome. Phenotypic studies such as in vivo 
and in vitro growth of virus, growth in different cell lines and RNA 
synthesis kinetics would all be useful in defining the mechanism of 
selection of such changes and helping to determine whether non-
structural proteins or non-coding regions of the genome were involved. 
Further development of a cell binding assay for RRV would allow study of 
cell attachment and internalization kinetics of RRV variants. 
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5.4.3 Conservation of antigenic properties and genetic sequence of RRV 
following growth and passaging in mosquito cells 
Passaging viruses in mosquito cells could alter antigenic reactivity 
by either selected genetic changes or by host cell derived phenotypic 
changes to the carbohydrate moieties at the E2 glycosylation sites. The 
neutralization of RRV NB5092 and T48, by a panel of neutralizing mAbs 
with epitopes close to the E2 glycosylation sites in the primary polypeptide 
sequence, was not affected by growth or passaging in mosquito cells 
compared with unpassaged virus grown in mammalian cells. It appears 
that the addition of sialic acid and consequent alteration in charge and 
hydrophilicity of these regions of E2 is not important in terms of antibody 
binding and neutralization. 
Two strains of RRV passaged in mosquito cells showed no 
alterations in nucleotide sequence in E2. This may indicate that for RRV 
there is little selective pressure for amino acid changes in E2 in these cells. 
This is in contrast to the situation with RRV strains passaged in avian or 
human cell lines and also to the situation in some Bunyaviruses passaged 
in mosquito cells CJ ames and Millican, 1986). Mutations in E2 selected on 
passaging alphaviruses in mosquito cells can affect virus assembly. 
Durbin and Stollar (1986) found mutations in the E2 gene of a strain of SIN 
following passage in mosquito cell culture. These mutations were 
associated with a range of phenotypic characteristics including host cell 
restriction. Amino acid differences to the parental virus were at positions 
55, 172 and 275, with the change at 275 introducing a new glycosylation 
site. Revertants selected by passage in CEFs had lost this glycosylation site 
which appeared to interfere with virus assembly in vertebrate cells. The 
changes at 55 and 172 did not revert. 
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Chapter6 
General Discussion 
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For RRV the three defined neutralization epitopes (a, b and .Q) appear 
to cluster into a major neutralization domain on E2. Sites at the N-
terminus of the protein, and around amino acids 55-61 (Vrati et al., 1986) 
possibly fold into apposition with sites at 232-234 (epitope bl) and are closely 
associated with epitope b2 (246, 248, 251). Monoclonal antibodies to epitope h 
compete with mAbs to epitope a at 216 (Vrati et al.,1988) and this epitope is 
also affected by changes at amino acid 218, (but not 219, Burness et al., 
1988). Epitope ~ is defined by mAb TlDll, which competes with mAbs 
defining epitope h (Vrati et al.,1988) and is at least partially defined by 
amino acid 4 on E2. 
Amino acid changes in epitope h2 increased the rate of penetration of 
RRV T48 suggesting that conformational changes of a broad nature in this 
epitope impinge on a site involved in cell penetration. Passaging RRV 
NB5092 in avian cells selected variants which were altered in epitopes .a 
and the combination of hand~ as judged by decreases in neutralization 
titres of mAbs. Both sets of variants were somewhat altered in their 
pattern of mouse growth compared with the parental NB5092 but those 
altered at epitope .a were attenuated for growth in mice. This suggested 
that changes in these epitopes were involved in adaptation to new cell lines 
and may also be involved in virus growth in mice, perhaps by influencing 
tissue tropism. Changes that were selected in E2 on passaging in human 
cell lines did not occur in known neutralization epitopes. Other phenotypic 
properties of variants selected in human cell passaging have not been 
examined. 
Meek et al. (1989) showed that variants of RRV NB5092 selected by 
passaging in mice had alterations in the E2 protein. Five of eight variants 
had E2 alterations at amino acids 212, 232, 234 and 251, within, or close to, 
neutralization epitopes. These changes were associated with increased 
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virulence in mice but were not the primary cause of this. It was postulated 
that they represented an adaptation to growth in mouse tissues. 
The only other alphavirus for which neutralization epitopes have 
been mapped by selection of mAb escape mutants is SIN. Three epitopes 
have been defined on E2; a, 190, b, 216 and c, 62, 96, 159 (Davis et al.,1987; 
Strauss et al.,1987; Pence et al.,1990). On the basis of CBAs, epitopes E2a 
and E2b appear to lie in relatively close proximity to each other while 
epitope E2c is spatially separate (Olmsted et al.,1986). This epitope defines 
functional domains on E2 of SIN associated with penetration and 
neurovirulence that interact in a complex manner as shown by selection of 
escape mutants (Pence et al.,1990). An equivalent epitope has not been 
defined on RRV E2, although epitope 122. shares some of these properties as 
discussed in Chapter 3. 
E2 is the most variable of the alphavirus structural proteins 
(Levinson et al.,1990). This can be correlated with its role as the protein to 
which the majority of neutralizing antibodies are directed (Dalrymple et 
al.,1976) and its position as probably the more exposed protein on the viral 
surface (Sefton et al.,1973; Dalrymple et al.,1976). It has been suggested 
that amino acid changes in alphavirus structural proteins may be 
immunologically selected (Levinson et al.,1990), however, there are several 
lines of evidence that suggest that antibodies may not be a major selective 
pressure on RRV under natural conditions. Firstly few changes were 
selected in neutralization epitopes during divergence of RRV strains 
NB5092 and T48 (see Chapter 2). Similarly during a major epidemic of 
RRV in the Pacific islands involving tens of thousands of infections only 
one amino acid change was found in E2, and al though this was close to 
epitope a, in the primary sequence, it did not alter neutralization with a 
panel of mAbs (Burness et al., 1988). These authors suggested that this low 
rate of mutation, compared with non-arboviruses, could be because 
147 
transmission to mosquitoes is likely to occur predominantly at the time of 
peak viraemia, whereas antigenic variants, selected under the pressure of 
antibodies, are likely to arise later during infection when successful 
transmission to mosquitoes is less probable because of the lower viraernia. 
In support of this, the work presented in Chapter 2 demonstrated that 
several amino acid alterations, at specific sites, were necessary for RRV 
T48 to acquire substantial resistance to polyclonal neutralization, 
especially during the primary immune response. Finally, passaging in 
tissue culture selected variants that had changes in neutralization 
epitopes on E2. As antibody was unlikely to have been involved in such 
selection it appears that variations in E2 neutralization epitopes were 
selected as an adaptation to host or growth conditions rather than by 
antigenic pressure. 
Several well characterized viral systems can be compared with 
RRV. The haemagglutinin (HA) of influenza A and B viruses 1s a 
homodimer of HAl and HA2 which exists as trimeric spikes inserted in 
the virion membrane (Wiley and Skehel, 1987). The structure of this 
protein has been extensively studied and it provides a useful paradigm for 
virus surface proteins. Like the surface spikes of RRV this molecule 
functions in cell attachment, entry and fusion and is the protein to which 
neutralizing antibodies are directed. Unlike RRV E2 it appears to undergo 
significant antigenic drift due to immune pressure. A large number of 
neutralizing antigenic sites have been mapped onto the three dimensional 
structure of this protein using m.Ab escape mutants and natural isolates. 
Most of the variation is in the HAI protein, involving residues covering the 
distal surface of the molecule (Wiley and Skehel, 1987). HAI also contains 
the receptor binding site, which is a conserved pocket in the distal portion 
of the molecule surrounded by a group of antibody binding sites. Because of 
the proximity of epi top es to the receptor binding pocket, certain amino acid 
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substitutions can prevent neutralization by mAbs, alter receptor specificity 
and affinity and may be associated with changes in tissue tropism and 
virulence in vivo (Deom et al.,1986; Wiley and Skehel, 1987; Philpott et 
al.,1990). 
For example escape mutants of a highly virulent avian influenza 
strain with single amino acid changes, within an epitope located near the 
distal tip of the HA molecule and close to the receptor binding site, were 
attenuated in chickens compared to the parental virus and appeared to 
have altered tissue tropism as the virus no longer replicated in splenic 
macrophages (Philpott et al.,1990). Thus attenuation of this virus probably 
resulted from changes in tissue tropism brought about by alterations in 
receptor affinity. This is in contrast to other attenuating mutations of avian 
influenza which involved alterations in the cleavage site of the HA 
molecule such that HAO was no longer efficiently cleaved to HAl and HA2 
by host cell proteases (Webster and Rott, 1987). Other workers have 
demonstrated that addition of an oligosaccharide chain close to the 
receptor binding pocket can reduce affinity for mammalian host cells and 
change antigenicity. Virus with this mutation was selected against during 
passage in bovine kidney cells while in CEFs both parental and mutant 
viruses grew equally well (Crecelius et al.,1984; Deom et al.,1986). 
Another example is poliovirus which contains a major antigenic 
loop to which neutralizing antibodies are directed (antigenic site 1) which 
is formed by a continuous sequence of amino acids 90-105 in VPl (Hogle et 
al.,1985). This domain is also an important determinant of host range for 
poliovirus. \Vhen this region of the mouse avirulent Mahoney strain of 
poliovirus 1 was replaced with the homologous region of the mouse 
adapted Lansing strain of poliovirus 2, the hybrid virus induced paralytic 
disease in mice (Murray et al.,1988). This demonstrated that a short 
sequence of amino acids in antigenic site 1 was responsible for 
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determining poliovirus host range and suggested that this site may be 
involved in attachment of poliovirus to cells of the mouse central nervous 
system. It has been proposed that an analogous site on VPl is involved in 
cell attachment of FMDV (Acharya et al.,1989). 
Similarly neutralizing mAb escape mutants of human reov1rus 
were attenuated in mice and restricted in their distribution in mouse brain 
compared to the parental virus suggesting that these neutralization 
epitopes defined regions involved in tissue tropism (Spriggs and Field, 
1982). It is clear that in a number of viruses there is a subset of 
neutralization epitopes clustered around domains involved in cell 
attachment and that definition of these neutralization sites has increased 
understanding of the interaction of the virus with host cells. 
From the evidence discussed, it seems reasonable to postulate that 
the cluster of neutralization epitopes .a, hand~ may interact in a domain 
on RRV E2 that mediates cell penetration, adaptation to novel cell types 
and growth in vivo. This is consistent with other viruses such as 
influenza, poliovirus and FMDV, where groups of neutralization epitopes 
cluster around or partially define domains involved in receptor 
recognition, tissue tropism and virulence. The value of such a model lies 
in focussing attention on this region of RRV and for developing further 
experiments which may define the structure and functions of this region of 
RRV more adequately. 
Such experiments would probably develop along three lines using 
techniques from immunology, molecular biology and cell biology. In the 
first instance the selection of further neutralizing mAbs could help to 
define functional domains on E2 and possibly El by selection of escape 
mutants. By analogy with the E2c epitope of SIN (Olmsted at al.,1984), 
selection of mAbs using variants of RRV that are altered in different 
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regions of E2, especially regions which alter functions or which are 
predicted to alter the local conformation of the protein, could provide a 
useful range of antibodies. For example NB 1/5ws altered at amino acid 4 
and NB-SW13 variants changed at residue 178 could be used to produce 
rnAbs which could in turn allow selection of a range of escape mutants. 
By using transcribable, complete cDNA clones of RRV specific 
changes in E2 could be made to test the functional relationships of 
alterations such as those at amino acid 218 to growth in mice. Preliminary 
constructs have already been prepared with this change but have not been 
tested in mice (J. Strauss, R. C. Weir and L. Dalgarno, pers. comm.). This 
technique provides a powerful tool for investigating the functions of RRV 
genes, proteins and regulatory regions and experiments such as those 
described in this thesis provide a starting point for studies using 
transcribable cDN A clones. 
Much can be done at the level of cell biology to investigate the 
interactions of RRV with cultured cells. Preliminary work on the 
development of a cell binding assay for RRV has been described in Chapter 
3. Further work should be done to examine the rate of binding of fast 
penetrating variants of T48 and other isolates of RRV. It would be 
extremely interesting to select fast penetrating variants of RRV using the 
selection protocol of Olmsted et al. (1984), where virus was allowed to 
adsorb to cells for 60 min at 4°, shifted to 37° for 1 min and unpenetrated 
virus was removed from the cell surface by protease digestion. Variants of 
both SIN and VEE selected for fast penetration using this protocol are also 
reduced in virulence in mice. In SIN such fast penetration mutants are 
changed in reactivity at neutralization epitope E2c. Fast penetrating 
variants of RRV selected using this protocol could then be compared with 
the fast penetrating variants of T48, altered at epitope b2 and with the 
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geographic isolates of RRV to further define regions of E2 involved in fast 
penetration and to explore the relationship of penetration and virulence. 
ffitimately, with an infectious clone of RRV, it may be possible to test 
specific mutations of E2 which prevent attachment of the virus to certain 
cell types or to all cell types and map regions involved in attachment to 
cells and thus receptor recognition. 
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